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ABSTRACT
INVESTIGATING THE DEVELOPMENTAL IMPACTS OF 3,3’DICHLOROBIPHENYL (PCB-11) IN ZEBRAFISH (DANIO RERIO)
SEPTEMBER 2021
MONIKA A. ROY, B.S., UNIVERSITY OF CALIFORNIA BERKELEY
M.S.P.H., TULANE UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Alicia R. Timme-Laragy
The environmental pollutant 3,3’-dichlorobiphenyl (PCB-11) is a lowerchlorinated polychlorinated biphenyl (PCB) congener present in air and water samples.
Both PCB-11 and its metabolite, 4-PCB-11-Sulfate, are detected in humans, including in
pregnant women. The work conducted for this dissertation takes a developmental
toxicology approach and uses zebrafish (Danio rerio) to investigate PCB-11’s potential
impacts to the liver and pancreas. Chapter 1 introduces PCBs and the current knowledge
gaps. Chapter 2 investigates PCB-11 interactions in short-term 4-day exposures with the
Aryl hydrocarbon receptor (Ahr) pathway in both 0-20 µM individual and mixture
exposures with other Ahr agonists. In Chapter 3, PCB-11 metabolites 4-OH-PCB-11 and
4-PCB-11-Sulfate are assessed in both 4-day and in longer-term 15-day chronic
exposures. Finally in Chapter 4, the role of Nrf2, a master regulator of oxidative stress, is
explored in the context of these short and long-term exposure settings. Throughout these
chapters, in vivo ethoxyresorufin-O-deethylase (EROD) bioassay, RT-qPCR, RNAseq,
Oil-Red-O (ORO) staining, fatty acid profiling, and fluorescence microscopy techniques,
as well as the use of Tg(ins:GFP) and Tg(gut:GFP) transgenic and nrf2afh318/fh318 mutant
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zebrafish, were used to assess toxicity. The results from this work indicate that PCB-11 is
a mild Ahr agonist, but in co-exposures can inhibit either the Ahr or downstream Cyp1a
enzyme activity depending on the co-exposure, resulting in different toxicity outcomes.
4-PCB-11-Sulfate can also inhibit Cyp1a activity but does not interfere with the toxicity
outcomes of co-exposures, however, chronic 15-day exposure to 4-PCB-11-Sulfate
increases hepatic neutral lipids 30%, increases pancreatic β-cell cluster area in the
primary Islet of Langerhans 8%, and leads to better survival at 80-85% compared to 6375% for unexposed fish. Nrf2a seems to play a minor role in the Cyp1a enzyme
inhibition and phenotypic effects observed with PCB-11 and 4-PCB-11-Sulfate 4-day
exposures but plays an important role in development as well as for DHA production in
the presence of 4-PCB-11-Sulfate. Chapter 5 discusses the findings from Chapters 2-4.
The data presented contributes to the understanding of this sub-class of PCB compounds
and provides insight into how PCB-11 could potentially impact human health.
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CHAPTER 1
INTRODUCTION
Over the last 150 years, humans have identified the molecular configurations of
natural chemicals in plants and mineral oils. Humans also learned out how to manipulate
atoms into new configurations, engineering entirely new substances which could be finetuned to serve as essential components of industrial manufacturing. Polychlorinated
biphenyls (PCBs) are one human-made class of substances inspired from similar-looking
compounds in mineral oil. They were first synthesized in the late 1800’s, and then mass
produced by the company Monsanto in the 1900’s (1). PCBs are characterized by a
connected double benzene ring structure, the “biphenyl” structure, surrounded by
anywhere from 1-10 chlorine atoms at any of the ortho (diagonal position facing towards
the center), meta (diagonal position facing away from the center), or para (at the utmost
ends) positions of the biphenyl structure. The number of chlorines and their position
determine the PCB congener, with a total of 209 different configurations (Figure 1.1).
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Figure 1.1: General PCB structure. The biphenyl structure can have between 1-10
chlorine substitutions at the denoted locations. Chlorine substitutions are also referred to
as “ortho”, “meta”, and “para” substitutions, also noted.
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PCBs have lubricating and flame-retardant properties and were used as insulating
substances for many types of industrial equipment, most notably for electrical
infrastructure such as transformers and capacitors. Many of the PCB congeners used for
this purpose had a higher number of chlorine atoms (4 or more), with 12 congeners
having a “co-planar” configuration, rendering the biphenyl structure inflexible. Co-planar
PCBs along with other PCBs were formulated into “Aroclor” mixtures, trademarked
under Monsanto, and while Aroclor mixtures were useful, they were also identified as
extremely toxic to humans. Co-planar PCBs have a mode of action similar to the
environmental pollutants polychlorinated dibenzodioxins, or dioxins, which can
bioaccumulate in humans and are also highly toxic. The most potent of these congeners is
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and can cause developmental effects and
cancer, among other health outcomes (2). Upon exposure, co-planar “dioxin-like” PCBs
activate the Aryl hydrocarbon receptor (Ahr) (3), a xenobiotic sensor of many
environmental contaminants that acts to biotransform contaminants for excretion, though
some intermediate metabolites have toxic effects.
The Ahr is normally located in the cytosol of a cell and bound to several
chaperone proteins, but when environmental contaminants like co-planar PCBs enter the
cell, they bind to the Ahr, activating its translocation to the nucleus where it dissociates
from its chaperone proteins, binds to the Ahr nuclear translocator (ARNT), and together
they bind to the xenobiotic response element (XRE) (4, 5). The XRE is located in the
promotor region of many genes that when upregulated and translated into their protein
constituents, can work to biotransform the contaminant (6) (Figure 1.2). Co-planar PCBs
like 3,3’,4,4’,5-pentachlorobiphenyl (PCB-126) activate the Ahr to upregulate a battery
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of genes that can work to potentially biotransform many environmental chemicals.
However, co-planar PCBs are not good substrates for biotransformation, remaining in the
body which results in severe toxicity outcomes for the individual (7). Documentation of
this toxicity resulted in the International Agency for Research on Cancer (IARC)
classifying PCBs as human carcinogens (8). Later, a ban on PCB production was
enforced by the U.S. Environmental Protection Agency (EPA) under the Toxic
Substances Control Act (TSCA) in 1979.

**Potential
metabolism**

Ahr Ligand

XRE

mRNA of
cyp1a and
other Ahrresponsive
genes

Nucleus
Cytoplasm

Figure 1.2: The Ahr pathway. A simplified version of the Ahr pathway showing Ahr
activation and translocation to the nucleus, binding with ARNT and to the XRE, and gene
transcription and translation of Phase 1 metabolism enzymes like Cyp1a.
Over time, co-planar and other higher-chlorinated PCBs used in Aroclor mixtures
were phased out of production, but despite this, these PCBs continue to pose public
health risks because they are “persistent organic pollutants”. Higher-chlorinated PCBs are
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particularly persistent because they are lipophilic, accumulating in tissue of organisms
like fish, and then biomagnifying up the food chain to human consumption. Organisms
lower in the food chain are still exposed to higher-chlorinated and Aroclor mixtures in the
environment from the many thousands of tons of untreated PCB waste that was disposed
of into the environment before regulations existed to control proper PCB waste disposal.
Additionally, transformers and capacitors that were manufactured with PCBs and are still
in use today contain PCBs and are sources of accidental release. Higher-chlorinated
PCBs may eventually break down into lower-chlorinated PCBs over time through
microbial dechlorination processes (9, 10). Lower-chlorinated PCBs are considered less
hazardous because they are more rapidly metabolized in the body and tend not to
accumulate compared to higher-chlorinated congeners (8). However, they are now being
evaluated more carefully because of their presence in the environment (11).
In addition to microbial dechlorination as a source for lower-chlorinated PCBs,
today lower-chlorinated PCB congeners are also produced inadvertently as byproducts of
industrial manufacturing (12). The release of these PCBs into the environment has been
allowed within certain limits, as long as the overall concentration of the sum of the 209
PCB congeners remains below 50 ppm for bulk PCBs, which is the regulatory cut-off for
disposal requirements as defined under Title 40 Part 761 of the Code of Federal
Regulations (13); the maximum contaminant level enforceable by the EPA for PCBs in
water sources is 0.0005 parts per million (ppm) (14). Both regulatory limits were set
because they are reasonably enforceable and greatly reduce the risk to human health from
exposure to PCBs compared to if these limits were higher. However, many ongoing
research studies indicate that detrimental health effects can be observed for both co-

4

planar and non-co-planar PCB exposures below these regulatory limits (15-17), which
might warrant revisiting these regulations.
Commercial pigment production has been identified as a major source of lowerchlorinated PCBs detected in the environment (18, 19). The focus of this dissertation is
on the congener 3,3’-dichlorobiphenyl (PCB-11), a by-product of diarylide yellow azotype pigment production, which utilizes its parent compound 3,3’-dichlorobenzidene,
classified by the Agency for Toxic Substances and Disease Registry (ATSDR) as a
“probable human carcinogen” (20). Many lower-chlorinated PCBs such as PCB-11 are
semi-volatile, and in several studies, it is one of the most abundantly detected lowerchlorinated PCBs in air samples in both rural and urban areas, and both inside and outside
of homes (21, 22). Importantly, while some lower-chlorinated PCBs were used as
components in Aroclor mixtures, PCB-11 was never one of those congeners (23),
indicating that its detection in the environment is relatively recent. While PCB-11 has
also been detected in water sources, particularly in urban zones near outflow pipes of
wastewater treatment plants (10), inhalation is a major route of exposure for humans (24,
25).
Once in the body, PCB-11 can undergo one of many biotransformations to
different metabolites, and as many as 30 metabolites have been identified in experiments
with hepatic HegG2 cells, ranging from Class 1 monohydroxylated metabolites and their
conjugates, Class 2 dihydroxylated metabolites and their conjugates, Class 3
methoxylated-hydroxylated metabolites and their conjugates, and Class 4 methoxylateddihydroxylated metabolites and their conjugates; it is also likely that through Cyp
enzymes that metabolites from Class 1 can biotransform to Class 2 metabolites, and that

5

metabolites from Class 3 can biotransform to Class 4 metabolites (26). A simplified
schematic of PCB-11 metabolism is depicted in Figure 1.3. In rodent inhalation studies,
PCB-11 has been shown to undergo Phase 1 biotransformation in the liver to
hydroxylated metabolites fairly rapidly, with a half-life of just a few hours (27), and then
to Phase 2 sulfate metabolites soon after that are distributed to the brain, kidney, liver,
and adipose tissue, and are subject to further metabolism (28). Oral exposures in rodents
have also shown that PCB-11 partitions mainly to adipose tissue, with hydroxylated and
sulfate metabolites detected in the liver, and sulfate and glucuronide metabolites detected
in serum (29). PCB-11 and the Class 1 metabolites 3,3’-dichlorobiphenyl-4-ol (4-OHPCB-11) and 3,3’-dichloro-4-sulfooxy-biphenyl (4-PCB-11-Sulfate) have been detected
in human serum, including in pregnant women (30-33), and because of PCB-11’s rapid
metabolism, its detection in serum indicates continuous exposure.
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Figure 1.3: A simplified version of PCB-11 metabolism, modified from Zhang et al.
2020 (26). PCB-11 is depicted in the upper left corner. The recognized primary metabolic
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pathway is shown in yellow, with Class 1 sulfate and glucuronide metabolites on the
right, also detected in humans. In gray on the bottom right shows Class 2 sulfate and
glucuronide metabolites detected in rodent studies. CYP = cytochrome p450 enzymes,
SULT = sulfotransferase enzymes, UGT = glucuronide enzymes, DHDH = dihydrodiol
dehydrogenase enzymes, EH = epoxide hydrolase enzymes.
There are thousands of chemicals used in the manufacturing of consumer products
or that are sold directly to consumers, many of which have very little toxicity data to
evaluate the potential risk to public health. Recently, exposure to environmental
chemicals, including PCBs, has been identified as playing a role in the development of
chronic metabolic diseases such as diabetes, obesity, and fatty liver disease, meaning that
these diseases can no longer be fully explained by diet and lifestyle factors alone (34, 35).
Particularly for higher-chlorinated PCBs, researchers have shown that PCBs can initiate
or accelerate disease development. For example, early developmental exposures can alter
liver and pancreas development, potentially inhibiting their functioning capacity in
adulthood (36, 37). Beyond morphological observations of organ tissue, exposure to
higher-chlorinated PCBs has been shown to alter glucose signaling pathways and lipid
transport and storage (38, 39), with potential cross-talk between these pathways and the
Ahr pathway (40, 41). As lower-chlorinated PCBs are slowly becoming the more
prevalent PCB congeners in the environment, it is important to evaluate whether they
might also contribute to disease development in either similar or different ways.
Much of the previous research on lower-chlorinated PCBs has been conducted in
vitro, including their impact on receptor activities in specific cell types. For instance,
several lower-chlorinated PCBs were found to have significant agonist or antagonistic
activity against nuclear hormone receptors including the estrogen receptors alpha and
beta, glucocorticoid receptor, androgen receptor, and the thyroid hormone receptor alpha
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1 (42). Hydroxylated and sulfate metabolites of lower-chlorinated PCBs have also shown
significant activity on hormone receptors, trending towards decreased cytotoxicity and
hormone activity with the sulfate metabolites, though still with observed effects at very
low concentrations (43). In particular, PCBs have a similar structure to thyroid hormones;
PCB-11 has been identified as reducing plasma total thyroxine levels (44), and 4-PCB11-Sulfate has been identified as a high-affinity ligand of the thyroid hormone transport
protein transthyretin (45). 4-OH-PCB-11 has also been evaluated for its effects on
mitochondrial metabolism in mouse embryonic fibroblasts, and Sirtuin 3 (SIRT3), a
hepatic mitochondrial protein, was found to help maintain redox homeostasis upon 4-OHPCB-11 exposure (46).
Because of the emerging evidence of PCB-11’s prevalence in the environment,
several groups have initiated in vivo studies on PCB-11. For instance, the Superfund
Research Program at the University of Iowa, which has led many of the air sampling
studies, also conducted detailed inhalation experiments in rats and found that PCB-11 is
rapidly absorbed and biotransformed in the liver within a half hour, that the majority of
parent and metabolite compounds translocate to skin and adipose tissue within a few
hours, and that 50% of the original exposure is excreted within 12 hours (47). This group
went on to investigate the metabolism of the 4-PCB-11-Sulfate metabolite in another
inhalation study with rats, and found that although the concentrations in the liver, kidney,
lung, and brain declined after initial uptake, only 4% of the initial 4-PCB-11-Sulfate was
excreted within 24 hours, suggesting that the majority of this metabolite remains in the
body and is distributed to tissues or undergoes further metabolism (28). Another research
group has also led in vivo studies in rats that have shown PCB-11’s potential for
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neurotoxicity (33, 48). While PCB-11 in its original form may not persist in the same
way as higher-chlorinated PCBs, it is not well-understood what impact the parent PCB11 compound has in the body as it undergoes metabolism, as well as what long-term
impacts its metabolites might impart.
This dissertation research focuses on PCB-11’s interactions with the Ahr
pathway. Usually, mono- and di-chlorinated PCBs have not been considered as strong
ligands of the Ahr, however, many have the potential for some degree of planarity. The
12 PCBs classified as co-planar achieve the highest degree of planarity out of all the 209
congeners because they are non-ortho-substituted or mono-ortho-substituted, enabling the
PCB to physically become flatter, enabling better ligand binding with the Ahr. Since
PCB-11 is non-ortho-substituted, the chlorine atoms it does have (in the meta positions)
enable it to take on a degree of planarity. In addition, PCB-11 was investigated in the
context of the Ahr since many environmental chemicals act through this pathway and
because little in vivo research exists to show how lower-chlorinated PCBs interact with
the Ahr.
This dissertation research utilizes an in vivo model, zebrafish (Danio rerio) to
examine the potential toxicity of developmental exposures to PCB-11 or its metabolites,
with a focus on the Ahr pathway and metabolic-related endpoints. Zebrafish are an
advantageous model to use for developmental toxicity research because embryos are laid
externally to the mother, the embryos are transparent to facilitate microscopy, zebrafish
share many of the same organ development patterns as humans, and zebrafish share up to
82% of the same gene orthologs implicated in human diseases (49). Additionally, many
transgenic zebrafish lines have been generated with fluorescent tags in the promotor
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regions of genes specific to the liver or pancreas, which further allows for more accurate
assessments of morphological development. For example, transgenic Tg(ins:GFP)
zebrafish under a fluorescence microscope express green fluorescence in the pancreatic
beta cells in the primary islet of Langerhans, allowing for precise visualization and
measurement of this endocrine tissue (50). In addition to transgenic lines, many mutant
zebrafish lines have also been developed to assess the contribution of specific genes on
disease phenotypes. For example, a line was generated to have a mutation in the DNA
binding domain of one of the Nuclear factor erythroid-2 (Nrf2) genes in zebrafish, a gene
important in catalyzing a response to oxidative stress. The generated nrf2afh318-/- mutant
fish have greatly reduced Nrf2a signaling so that toxicant exposures can be carried out
between mutant and wildtype fish to assess Nrf2a function (51). Furthermore, these
mutant and transgenic zebrafish lines have been crossed so that the effects of toxicant
exposure on pancreatic beta cells can be assessed in the context of Nrf2a.
As with much of the research on other PCB congeners, many of the studies on
PCB-11 have been conducted using individual exposures of PCB-11. For example, many
toxicity studies seek to thoroughly evaluate an individual chemical’s route of exposure,
distribution in the body, metabolism in target organs, and routes of storage or excretion,
but these studies generally do not evaluate chemicals in the context of other chemical
exposures. In a realistic setting, humans are exposed to a variety of chemicals daily,
many of which have the potential to interact with each other in an antagonistic, additive,
or synergistic way, and may be compounded by other factors such as pharmaceuticals,
genetic factors, stress, or compounds in food. It is also extremely difficult to conduct
mixture experiments because the complexity in evaluating health endpoints increases
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exponentially when increasing the number of chemicals or the number of endpoints in the
experiment to evaluate. However, while it is important to understand the mechanisms of
action of individual chemicals, it is perhaps just as important to understand how
individual chemicals behave in a mixture setting and should be addressed in toxicity
experiments to better translate findings to human health.
This dissertation examines PCB-11 in both individual and mixture settings.
Before this dissertation work, only one study had evaluated PCB-11 experimentally in a
mixture context: researchers found that after inhaled exposures in rats over a 4-week
period to a PCB-11 supplemented atmospheric mixture resembling the Chicago airshed,
mostly higher-chlorinated PCBs were detected in tissues at the end of the study, with
effects on increased hepatic lipid peroxidation (44). The objective of the mixtures
approach in this dissertation work was not to simulate a complex representative mixture
of many chemicals, but to use environmentally relevant chemicals in combination with
PCB-11 to carefully probe different aspects of the Ahr pathway. In order to translate the
findings of this work to humans, we looked at the Ahr pathway in zebrafish in the context
of ahr2, the Ahr gene that most closely resembles the human AHR gene through which
this pathway is activated (52). Due to genome duplication in the teleost lineage, zebrafish
also have ahr1a and ahr1b genes, and while these genes may play some role in toxicity
outcomes, it is minor in comparison to ahr2 (53). In zebrafish, the Ahr pathway can be
examined in vivo using the ethoxyresorufin-O-deethylase (EROD) bioassay to look at
hepatic cytochrome p450 (Cyp) 1a activity one of the primary enzymes responsible for
the biotransformation of environmental chemicals that activate the Ahr pathway (54). In
this assay, Ahr-mediated induction of Cyp1a activity cleaves 7-ethoxyresorufin to
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resorufin, which is then visible under a fluorescence microscope and representative of
Cyp1a activity (55). Importantly, the Cyp1a enzyme in zebrafish is orthologous to the
human Cyp1A1 enzyme (56), and so studying its function in zebrafish during
environmental chemical exposures can help inform the human response to these
chemicals.
Several studies have shown that catalytic uncoupling of Cyp1a in response to
environmental chemical exposure can result in increased reactive oxygen species (ROS)
and overall toxicity (57-59). Nrf2a plays a significant role in the response to ROS, where
upon ROS activates Nrf2a to translocate into the nucleus from the cytosol to bind to the
Antioxidant Response Element (ARE), which is located in the promotor region of genes
that when translated, can help neutralize ROS and bring the cell back to its normal redox
range (60). While previous research has shown that higher-chlorinated PCBs can generate
ROS, the relationship between lower-chlorinated PCBs and ROS is unclear. This
dissertation work examines the toxicity outcomes of fish exposed to PCB-11 or its
metabolites in the context of Nrf2a and takes two experimental approaches. The first
examines the influence of Nrf2a in the 4-day EROD assay, since cross between the Nrf2
and Ahr pathways has been documented previously (61, 62). The second examines the
contribution of Nrf2a under lower-concentration chronic exposure settings on several
metabolic-related endpoints.
A pilot study prior to the development of this dissertation indicated that individual
exposures to PCB-11 did not produce toxicity effects in the fish, but that PCB-11 had the
ability to interfere with toxicity outcomes in combination with other Ahr agonist
chemicals. However, subsequent work conducted for an RNAseq experiment indicated
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that individual PCB-11 exposures might disrupt lipid metabolism, which is important for
metabolic functioning and its disfunction is related to several metabolic disease
outcomes. The last component of this research incorporates the investigation of Nrf2a
throughout, which has been shown to have crosstalk with the Ahr pathway as well has
been shown to mediate toxicity or play a protective role against exposures to
environmental chemicals (63, 64). Thus, the overarching hypothesis for this
dissertation is that developmental exposures to PCB-11 can interfere with the Ahr
pathway to modify the toxicity of other compounds, as well as affect metabolicrelated outcomes. An overview of the research questions pertaining to the Ahr pathway
within this hypothesis can be seen in Figure 1.4.
PCB-11 or
metabolites

?

Toxicity
outcomes

?
?
Ahr agonist coexposures
mRNA of
cyp1a and
other Ahrresponsive
genes

Oxidative
stress
XRE

How does nonfunctional Nrf2 affect
toxicity outcomes in
the context of PCB11 exposures?

redox
stressrelated
mRNA

ARE
Nucleus
Cytoplasm

Figure 1.4: Overview of the research questions in this dissertation. How does PCB-11
interact with the Ahr pathway in mixture exposures to influence toxicity outcomes? Does
Nrf2a play a role in these outcomes?
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Chapter 2 of this dissertation examines how the parent PCB-11 compound
interacts with the Ahr pathway in both individual and mixture settings in developmental
exposures to 0-20 µM PCB-11 between 1-4 days post fertilization (dpf) using the EROD
assay. This chapter also uses transgenic Tg(gut:GFP) fish to examine the effect of PCB11 on liver development at 4 dpf and samples fish at this timepoint for histological
evaluation. Additionally, this chapter uses RNA sequencing for samples collected at 4 dpf
as an untargeted approach to explore the effects of PCB-11 on gene expression
throughout the organism. Chapter 3 explores the role of the PCB-11 metabolites 4-OHPCB-11 and 4-PCB-11-Sulfate in the Ahr pathway as individual compounds and in coexposure experiments to 0-20 µM from 1-4 dpf using the EROD assay. This chapter also
conducts a chronic exposure paradigm between 1-15 dpf to lower 0.2 µM concentrations
of either parent or metabolite compounds to examine hepatic lipid accumulation at 15 dpf
using Oil-Red-O staining. Finally, Chapter 4 examines the role of Nrf2a in both 1-4 dpf
experiments with the EROD assay as well as in 1-15 dpf experiments. For these latter 15
dpf experiments, the crossed transgenic and mutant zebrafish line Tg(ins:GFP;nrf2afh318-/) was used, and survival, overall growth, and pancreatic beta cell area were assessed. At
15 dpf, subsets of fish were also collected for RNA sequencing and fatty acid profiling.
Overall, lower-chlorinated PCBs such as PCB-11 have generally not been
considered a public health concern. Because of their chemical structure, they generally do
not potently activate the Ahr pathway as higher-chlorinated PCBs do, though this
assessment is usually derived from individual congener exposure studies. Little toxicity
research has been conducted to evaluate the effects of lower-chlorinated PCBs on the Ahr
pathway in the context of mixtures, and whether they might exert other toxicity effects
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outside of the Ahr pathway. This dissertation research provides insight on how a
prevalent lower-chlorinated congener interacts with the Ahr pathway and Cyp1a enzyme
activity in comparison and in co-exposures to the well-characterized higher-chlorinated
and co-planar PCB-126, as well as with prevalent polycyclic aromatic hydrocarbons
(PAHs) beta naphthoflavone (BNF) and benzo[a]pyrene (B[a]P). Much of the research
over the past few decades has focused on the mechanisms of actions of higherchlorinated and co-planar PCBs. However, given the rise in metabolic disease prevalence
coupled with the increasing prevalence of lower-chlorinated PCBs, this dissertation work
provides insight into how one of the most prevalent lower-chlorinated PCB congeners,
PCB-11, potentially exerts toxicity and influences metabolic disease outcomes.
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CHAPTER 2
THE EMERGING CONTAMINANT 3,3’-DICHLOROBIPHENYL (PCB-11)
IMPEDES AHR ACTIVATION AND CYP1A ACTIVITY TO MODIFY
EMBRYOTOXICITY OF AHR LIGANDS IN THE ZEBRAFISH EMBRYO
MODEL (DANIO RERIO)

Reprinted (adapted) with permission from:
Roy MA, Sant KE, Venezia OL, Shipman AB, McCormick SD, Saktrakulkla P,
Hornbuckle KC, Timme-Laragy AR. The emerging contaminant 3,3’-dichlorobiphenyl
(PCB-11) impedes Ahr activation and Cyp1a activity to modify embryotoxicity of Ahr
ligands in the zebrafish embryo model (Danio rerio). Environmental Pollution,
2019;254(Pt A):113027. Epub 2019/08/20. doi: 10.1016/j.envpol.2019.113027. PubMed
PMID: 31421573. PMCID: PMC7027435. Copyright Elsevier.

2.1 Abstract
3,3’-dichlorobiphenyl (PCB-11) is an emerging PCB congener widely detected in
environmental samples and human serum, but its toxicity potential is poorly understood.
We assessed the effects of three concentrations of PCB-11 on embryotoxicity and Aryl
hydrocarbon receptor (Ahr) pathway interactions in zebrafish embryos (Danio rerio).
Wildtype AB or transgenic Tg(gut:GFP) strain zebrafish embryos were exposed to static
concentrations of PCB-11 (0, 0.2, 2, or 20 µM) from 24-96 hours post fertilization (hpf),
and gross morphology, Cytochrome P4501a (Cyp1a) activity, and liver development
were assessed via microscopy. Ahr interactions were probed via co-exposures with PCB-
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126 or beta-naphthoflavone (BNF). Embryos exposed to 20 µM PCB-11 were also
collected for PCB-11 body burden, qRT-PCR, RNAseq, and histology. Zebrafish exposed
to 20 µM PCB-11 absorbed 0.18% PCB-11 per embryo at 28 hpf and 0.61% by 96 hpf,
and their media retained 1.36% PCB-11 at 28 hpf and 0.84% at 96 hpf. This
concentration did not affect gross morphology, but altered the transcription of xenobiotic
metabolism and liver development genes, impeded liver development, and increased
hepatocyte vacuole formation. In co-exposures, 20 µM PCB-11 prevented deformities
caused by PCB-126 but exacerbated deformities in co-exposures with BNF. This study
suggests that PCB-11 can affect liver development, act as a partial agonist/antagonist of
the Ahr pathway, and act as an antagonist of Cyp1a activity to modify the toxicity of
compounds that interact with the Ahr pathway.
2.2 Introduction
The emerging polychlorinated biphenyl (PCB) congener 3,3’-dichlorobiphenyl
(PCB-11) has been identified as a non-legacy, non-Aroclor PCB inadvertently generated
during the commercial production of diarylide azo-type pigments used in consumer
goods such as paper and plastic products (65, 66). It is thought that PCB-11 is mobilized
into water sources via wastewater discharge during pigment manufacturing, and when
consumer goods containing these pigments are discarded or recycled (10, 12, 67). PCB11 also volatizes from paints and resins and can enter the body through inhalation
exposures (22, 24). Additionally, PCB-11 has been detected in food sources such as
commercial cow’s milk (68), and both PCB-11 and its sulfate metabolite have been
detected in human serum (30, 31), including in pregnant women (0.005-1.717 µg/L) (33),
demonstrating an exposure risk in the fetal environment. Despite growing evidence of
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human exposures, little is known about PCB-11 toxicity, particularly for the highlysensitive period of embryonic development. To investigate this knowledge gap, we used
the zebrafish embryo model to assess developmental toxicity, with a focus on potential
interactions with the Aryl hydrocarbon receptor (Ahr) pathway.
The Ahr is a basic-helix-loop-helix/per-Arnt-Sim (bHLH/PAS) transcription
factor family member that is activated by both naturally occurring and synthetic ligands
like polycyclic aromatic hydrocarbons (PAHs) and dioxin-like PCBs (69). The Ahr is
constitutively expressed, but upon ligand binding, translocates from the cytosol to the
nucleus where it forms a heterodimer with the Aryl hydrocarbon receptor nuclear
translocator (Arnt) (5). The Ahr/Arnt heterodimer then binds to Xenobiotic Response
Elements (XREs) in promotor regions of Ahr-responsive genes (70, 71), increasing
production of enzymes that can biotransform the Ahr ligands in Phase I and Phase II
metabolism (6, 72). Zebrafish and human Ahr pathway activation is similar, but it is
important to note that while zebrafish have three Ahr gene isoforms (ahr1a, ahr1b, and
ahr2) (73), toxicity effects have been shown to be primarily mediated by ahr2 (58, 74,
75).
Upon Ahr pathway activation, many ligands are substrates for biotransformation
by the Cyp1a enzyme, and are most often converted to more hydrophilic metabolites for
excretion (76). However, not all Ahr ligands are good substrates for Cyp1a
biotransformation. For instance, the dioxin-like PCB-126 activates the Ahr pathway and
upregulates Cyp1a activity, but exerts toxicity independent of Cyp1a (7, 55, 58); in
zebrafish embryos PCB-126 exposure results in a suite of deformities including
pericardial edema, cranio-facial malformations, and impaired yolk sac utilization. This
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toxicity is rescued only when ahr2 activation is blocked by either antagonizing the
receptor or by genetic means to either knock-out or knock-down the receptor (58). For
ligands that are good substrates for Cyp1a metabolism, another route to toxicity involves
blocked Cyp1a biotransformation processes, where unmetabolized ligands can continue
to activate the Ahr, resulting in enhanced toxicity (55, 58, 59, 77). Cyp1a induction in
zebrafish is similar as in humans (76, 78-80), and this enzymatic activity can be measured
using the well-established in vivo ethoxyresorufin-O-deethylase (EROD) bioassay (58,
81) as a useful tool to investigate the potential toxicity of emerging contaminants that
might act through the Ahr (82, 83).
The environmental presence of PCB-11 is likely to continue, and increase,
through the production of diarylide pigments and the recycling of consumer products, but
little research has been conducted to understand the molecular interactions and health
implications for any quantity of PCB-11. Our objectives for this study were to use the
zebrafish model to test a range of concentrations to understand the molecular actions of
PCB-11, and how it influences morphological development and xenobiotic metabolism.
In addition to examining the effects of single exposures of PCB-11, we took a mixture
approach to understand whether PCB-11 can influence the effects of well-established Ahr
activators, such as PAHs, that are likely to exist in urban locations where PCB-11 has
been detected in air and water samples (24, 67, 84). We used the EROD bioassay to
monitor Cyp1a enzyme activity, fluorescence imaging techniques to look at liver
development, and paired this with Ahr-related gene transcription levels, RNAseq, and
histology as tools to explore whether this emerging contaminant is a public health
concern. Our findings indicate that PCB-11 interacts with the Ahr pathway, impedes liver
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development, and perturbs pathways related to lipid metabolism, but in co-exposures
with other Ahr agonists can more significantly either suppress or exacerbate toxicological
outcomes, depending on the co-exposure.
2.3 Materials and methods
2.3.1 Animal Care
Adult wildtype AB and transgenic Tg(gut:GFP) zebrafish (Danio rerio) were
housed on a 14 h light:10 h dark cycle in a recirculating Aquaneering system (San Diego,
CA) maintained at 28.5 ̊C. Embryos were obtained from breeding groups of 40 fish with
a 2:1 female:male ratio. Embryos were collected at 1 hour post fertilization (hpf),
washed, and stored at low density in 0.3x Danieau’s media [17 mM NaCl, 2 mM KCl,
0.12 mM MgSO4, 1.8 mM Ca(NO3)2, 1.5 mM HEPES, pH 7.6] in an incubator with the
same temperature and light conditions as the adult fish. At 24 hpf, embryos were staged
and screened for normal development before use in experiments. All animal care and
experiments were conducted in accordance with protocols approved by the University of
Massachusetts Amherst Institutional Animal Care and Use Committee (IACUC; Animal
Welfare Assurance Number A3551-01). Animals were treated humanely with due
consideration to the alleviation of stress and discomfort.
2.3.2 Chemicals
PCB-126 and PCB-11 were from Ultra Scientific (North Kingstown, RI), betanaphthoflavone (BNF) from Fisher Scientific (Pittsburg, PA), and 7-ethoxyresorufin-Odeethylase (7-ER) from MP Biomedicals (Solon, OH). All chemicals were dissolved in
100% dimethyl sulfoxide (DMSO) from Fisher Scientific (Fair Lawn, NJ). Stock
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solutions were stored at -20°C in glass amber vials, and were fully thawed and vortexed
before use. For zebrafish concentration analyses, PCB-13 was used as a surrogate
standard (SS) from AccuStandard (New Haven, CT), d5-PCB-30 was used as an internal
standard (IS) from Cambridge Isotope Laboratories (Andover, MA), and pesticide-grade
hexane was used from Fisher Chemical (Beerse, Belgium).

2.3.4 PCB-11 Concentration Analysis
The lowest PCB-11 concentration of 0.2 µM used in this study was selected based
on previous studies that measured aqueous “whole water” (dissolved and particle phase)
concentrations of PCB-11 near industrial effluents (10, 66, 85) and in marine species (8688). We included concentrations one and two orders of magnitude higher in our
experiments based on concentrations of PCB-11 used in previously in a rodent model
(33). PCB-11 adheres to surfaces and particles, but as a lower-chlorinated congener,
readily volatilizes (89). The solubility of PCB-11 in water is 354 µg/L (90) and its
octanol-water partition coefficient is log 5.28 (91). The concentrations of PCB-11 used in
this study are of the dissolved phase only of PCB-11 in water. In order to dissolve the
middle and highest concentrations of PCB-11 used in this study (2 µM and 20 µM) into
an aqueous medium, DMSO was used. In order to understand the amount of PCB-11 that
was taken up into the zebrafish larval tissue, embryos were analyzed at 28 hpf (four hours
after the exposure began) and at 96 hpf (end of exposure period) at the University of Iowa
for whole organism tissue and media analysis of the highest concentration of PCB-11 (20
µM), described in Appendix A. The PCB-11 concentration analysis temperature
programs and ion transitions for this analysis can be found in Appendix B.
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2.3.5 Chemical Exposures
At 24 hpf, zebrafish embryos were manually dechorionated using Watchmakers
forceps. For all experiments, five embryos were exposed in 5 mL of 0.3x Danieau’s water
in 20 mL glass scintillation vials, with at least 2 technical replicates per exposure group
per experiment. Zebrafish were statically exposed from 24-96 hpf to three PCB-11
concentrations (0.2, 2, or 20 µM) or DMSO, either alone for single exposure experiments
or in combination with either PCB-126 or BNF for co-exposure experiments. This time
frame was chosen since ahr2 expression in zebrafish does not become constant until 24
hpf, a time point when cyp1a also starts to express (92). Previous developmental toxicity
experiments with exposures starting at 24 hpf have also shown that both PCB-126 and
BNF activate the Ahr pathway and cause deviations in morphological development,
either alone or in co-exposures (53, 55). For experiments with PCB-126, a final
concentration of 5 nM was used, shown previously to cause malformations in zebrafish
(93). For experiments with BNF, concentrations of either 184 nM (50 μg/L) or 367 nM
(100 μg/L) were used, shown previously to induce Ahr-related gene activity in zebrafish
(55). For EROD experiments, each vial contained 0.5 µg/L of 7-ER, which was added at
24 hpf when dosing occurred. All vials contained a total DMSO concentration of 0.05%
v/v, and all exposures were static between 24-96 hpf. Liver development experiments
used Tg(gut:GFP) embryos, which express GFP in liver tissue starting at about 22 hpf
and is regulated through ef1a (94), in place of AB embryos. EROD, liver development,
qRT-PCR, and RNAseq experiments were repeated at least 3 times, and experiments for
histology endpoints were repeated twice.
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2.3.6 Microscopy and Image Analysis
At 96 hpf, live larvae were sedated by a 10 second exposure to 2% v/v MS-222
solution (prepared as 4 mg/mL tricaine powder in water, pH buffered, and stored at -20°C
until thawed for use) before being mounted on individual 3% methylcellulose drops in a
left-lateral orientation. For EROD imaging experiments, AB larvae were imaged on an
upright Olympus compound fluorescence microscope custom modified by Kramer
Scientific (Amesbury, MA) and equipped with an Axiocam 503 camera (Carl Zeiss Inc.,
Thornwood, NY) and an 89 NorthÒ PhotoFluorÒ II light source (89 NorthÒ, Burlington,
VT). For liver development experiments, Tg(gut:GFP) larvae were imaged in vivo on a
Zeiss Stereo Axio Zoom.V16 (Carl Zeiss Inc.). All measurements for zebrafish length,
EROD light intensity, and liver area were measured with the Zen Lite program (Carl
Zeiss Inc.). Since pericardial edema is a characteristic outcome of fish embryos exposed
to halogenated aromatic compounds (95) like PCB-126, pericardial area was measured on
all fish as a quantitative measurement to represent overall deformities. For all
experiments, transmitted brightfield microscopy images of the whole fish and gut region
were taken with 2x and 10x objectives, and liver/gut area was captured with a 10x
objective on either an RFP filter for EROD experiments or GFP filter for liver
development experiments.
2.3.7 qRT-PCR
For all qRT-PCR experiments, at 96 hpf zebrafish larvae were collected and
pooled in groups of 10-15 larvae after exposure, and preserved in RNAlater (Thermo
Fisher Scientific, Waltham, MA) at -80°C. Zebrafish larvae were thawed, transferred to
lysis buffer, and sonicated by pulsing 3 times with an Emerson Industrial Branson
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Sonifier® (Danbury, CT). RNA isolation was performed using 2-Mercaptoethanol (MP
Biomedicals) and a GeneJET RNA Purification Kit (Thermo Fisher Scientific) following
manufacturer instructions. RNA quantity and quality was assessed using a BioDrop
μLITE spectrophotometer (Cambridge, United Kingdom). Sample cDNA was prepared
using an iScript reaction mix kit (Bio-Rad, Hercules, CA), diluted 1:9 with nuclease-free
water, and stored at -80°C until processing. Each qRT-PCR sample was prepared using
10 μL of 2X iQ SYBR® Green Supermix (Bio-Rad), 5 pM each of forward and reverse
primers (1 μL total), 5 μL of nuclease-free water, and 4 μL (1 ng) of cDNA. Samples
were run on 96-well plates in a CFX Connect Real-Time PCR Detection System (BioRad), and samples were analyzed using the CFX Manager software (Bio-Rad). qRT-PCR
was carried out in duplicate for the aryl hydrocarbon receptor 2 (ahr2) and cytochrome
p4501A1 (cyp1a) genes. The b-actin (actb) gene was used as a housekeeping gene, and
its transcription did not change significantly across exposure groups. The b2Microglobulin (b2m) gene was used to verify gene transcription levels (data not shown).
All gene primer sequences can be found in Appendix C.

2.3.8 RNAseq and Analysis
At 96 hpf, triplicate pools of 18-20 zebrafish larvae exposed to either DMSO or
20 µM PCB-11 were collected for RNAseq and transferred to the UMass Amherst
Genomics Resource Laboratory. Details on RNAseq library preparation and nextgeneration sequencing are in Appendix D. RNAseq data has been deposited into the
NCBI Gene Expression Omnibus (GEO) database with the accession number
GSE118955. Gene ontology and pathway analysis was performed on the Gene Set
Enrichment Analysis (GSEA) platform (Broad Institute, Massachusetts Institute of
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Technology, and Regents of the University of California) using the Kyoto Encyclopedia
of Genes and Genomes (KEGG) gene sets database. Gene ontology and pathway analysis
was also performed using LRpath (http://lrpath.ncibi.org/), which used logistic regression
to calculate KEGG pathways significantly up or downregulated by PCB-11 exposure
(96).
2.3.9 Histology
At 96 hpf, zebrafish exposed to either DMSO or 20 µM PCB-11 (n=4 fish for
both groups), were fixed in 4% v/v paraformaldehyde (Alfa Aesar, Tewksbury, MA) and
preserved in 70% ethanol at 4 C
̊ until processing. Fixed samples were sent to the UMass
Medical School Morphology Core (Worcester, MA), where they underwent tissue
processing on a Shandon Citadel 2000 (Thermo Fisher) and then were paraffin embedded
3-4 per cassette using a Sakura Tissue-Tek (Torrance, CA). The paraffin blocks were
sectioned along the midlines of the zebrafish in a sagittal orientation to facilitate liver
examination, and ten sections were mounted and stained with hematoxylin and eosin
(H&E) according to standard protocols. At UMass Amherst, all sections were imaged at
40x magnification on an EVOS FL Auto Microscope (Thermo Fisher Scientific) and at
63x on a Zeiss Microscope oil objective with Zen software (Zeiss Microscopy).
2.3.10 Statistical Analyses
A one-way Analysis of Variance (ANOVA) with a Tukey-Kramer post-hoc test
was performed accordingly for experiments. All statistical tests were performed with
JMP® Pro software version 13.1.0 (Cary, NC). Statistical significance was considered
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using a 95% confidence interval (α=0.05). For qRT-PCR experiments, gene transcription
fold-changes were calculated using the ΔΔCT method (97).

2.4 Results
2.4.1 PCB-11 exposure concentrations and embryo and larvae body burdens
Zebrafish embryos exposed to either DMSO or 20 µM PCB-11 and their
associated aqueous media were analyzed for PCB-11 concentrations at both 28 hpf (four
hours after dosing) and at 96 hpf (end of their exposure period). Average PCB-11
concentrations detected in zebrafish media were 61.60 ng/mL at 28 hpf and 37.85 ng/mL
at 96 hpf. Average PCB-11 concentrations detected in fish tissue exposed to this media
were 400 ng/mg wet weight (ww) at 28 hpf and 1365.4 ng/mg ww at 96 hpf (Table 2.1).
For fish exposed to DMSO, concentrations of PCB-11 remained relatively stable at 0.38
ng/mg ww at 28 hpf and 1.19 ng/mg ww at 96 hpf; media concentrations for these
exposures remained stable at 0.19 ng/mL at 28 hpf and 0.20 ng/mL at 96 hpf (Table 2.1).
In comparing the amount of PCB-11 used in the initial dosing concentration (20 µM is
22.5 µg or 22,500 ng per 5 mL in each exposure vial), at 28 hpf 0.89% of this amount
was detected in the fish (0.18% per fish), and 1.36% of the initial amount was measured
in their associated media. At 96 hpf, of the initial amount of PCB-11 used in the dosing
concentration, the percentage of PCB-11 detected in the fish increased to 3.03% (0.61%
per fish), and decreased in their associated media to 0.84%.
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Table 2.1: PCB-11 Fish and Media Concentrations
Replicate
1

Replicate
2

Replicate
3

Unit
Mean sd
CV
Fish DMSO:
ng/mg 0.39
0.37
0.39
0.38
0.01
3.31%
28 hpf
Fish DMSO:
ng/mg 1.07
1.44
1.04
1.19
0.22
18.4%
96 hpf
Fish PCB11:
ng/mg 675
254
271
400
238
59.6%
28 hpf
Fish PCB11:
ng/mg 579
1,620
1,900
1,370 695
50.9%
96 hpf
Water DMSO:
ng/mL 0.16
0.19
0.20
0.19
0.02
10.0%
28 hpf
Water DMSO:
ng/mL 0.24
0.17
0.19
0.20
0.04
18.3%
96 hpf
Water PCB11:
ng/mL 86.1
53.3
45.4
61.6
21.6
35.0%
28 hpf
Water PCB11:
ng/mL 35.3
32.0
46.3
37.9
7.46
19.7%
96 hpf
Note: Fish exposed to either DMSO or 20 µM PCB-11 and their associated media were
analyzed for PCB-11 concentrations at both 28 hpf (several hours after dosing) and at 96
hpf (end of their exposure period); fish concentration units are per wet weight. Each
replicate and the mean concentration is listed, with sd=standard deviation and
CV=coefficient of variation.

2.4.2 PCB-11 alone is a weak agonist of the Ahr
Zebrafish embryos exposed to 0.2 µM, 2 µM, or 20 µM PCB-11 were compared
to embryos exposed to a DMSO control for morphology assessments. A small but
significant increase from 0.019 mm2 to 0.029 mm2 in pericardial area was observed for
fish exposed to 20 µM PCB-11, but no other deformities were observed, and no
differences in gross morphological development were observed for zebrafish exposed to
0.2 µM or 2 µM PCB-11 (Figure 2.1A-B). EROD activity was quantified for each
exposure group, and fish exposed to the lowest PCB-11 concentration of 0.2 µM
exhibited a significant 45% increase in EROD activity as compared to the DMSO control,
whereas 2 µM and 20 µM PCB-11 exhibited no change and a statistically significant
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decrease of 25% as compared to the DMSO control, respectively (Figure 2.1C). EROD is
reflective of Ahr activation and Cyp1a enzyme activity; we compared this EROD data to
ahr2 gene transcription and no differences were observed in any of the exposure groups
as compared to the DMSO control (Figure 2.1D). For cyp1a gene transcription, 0.2 µM
and 2 µM PCB-11 did not alter cyp1a transcription, however, 20 µM PCB-11
significantly increased cyp1a transcription by 2.6-fold (Figure 2.1E).
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Figure 2.1: Single exposures to PCB-11 at 96 hpf. (A) Representative images of
zebrafish larvae exposed to DMSO or single concentrations of PCB-11, (B) pericardial
area, and (C) EROD activity for each exposure group (mean ±S EM, n=42-43 fish per
exposure group across 3 experiments, ANOVA with a Tukey post-hoc test, p<0.05). (D)
Gene transcription for DMSO or single exposures of PCB-11 for ahr2 and (E) cyp1a
(mean ± SEM, n=3-4 pooled samples of 15 fish per pool per group, ANOVA with
Tukey’s post-hoc test, p<0.05).
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2.4.3 PCB-11 is an antagonist of the Ahr
A wide variety of chemical structures can interact with the Ahr, and in different
contexts act as partial antagonists and/or agonists. To determine whether PCB-11 could
function as an antagonist, we designed a co-exposure experiment with a well-studied and
potent Ahr agonist, PCB-126. Exposure of zebrafish embryos to 5 nM PCB-126 produces
severe cranio-facial, heart, and cardiovascular deformities, which are dependent on ahr2
(7, 58) and correlate with gene transcription and enzyme activity of Cyp1a. We coexposed embryos to 5 nM PCB-126 and either 0.2 µM, 2 µM, or 20 µM PCB-11
beginning at 24 hpf and compared these groups to single exposures of DMSO and PCB126. At 96 hpf, gross morphological deformities and EROD activity for zebrafish coexposed to PCB-126 and PCB-11 at the 0.2 µM and 2 µM concentrations did not differ
from zebrafish exposed to PCB-126 alone; the EROD activity for these exposure groups
significantly exceeded the DMSO control group by 470-678% (Figure 2.2A). However,
20 µM PCB-11 prevented EROD activity and gross morphological deformities normally
induced by PCB-126 so that the EROD activity and morphology for this co-exposed
group resembled the DMSO control group (Figure 2.2A-C).
We examined ahr2 and cyp1a gene transcription levels for the 20 µM PCB-11 coexposure group, and compared these results to single exposures of DMSO, 20 µM PCB11, and 5 nM PCB-126. PCB-126 significantly increased ahr2 1.7-fold, the PCB-11 +
PCB-126 co-exposure significantly increased ahr2 1.6-fold, and PCB-11 alone
upregulated ahr2 a non-statistically significant 1.3-fold (Figure 2.2D). For cyp1a, gene
transcription for fish exposed to 20 µM PCB-11 alone was upregulated 2.4-fold, though
this was not statistically significant (Figure 2.2E). PCB-126 significantly upregulated
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cyp1a 138-fold, and was reduced to 69-fold in fish co-exposed to 20 µM PCB-11 and
PCB-126 (Figure 2.2E).

A

B

EROD
d

EROD Intensity
(% of DMSO)

800
600

c

c

DMSO

500 µm

400
200

ab

a

ab

ab b

20pM
− +
0.2 µM

20nM
− +

20uM
− +

2 µM

20 µM

PCB-126 +
0.2 µM PCB-11

0
PCB-126
PCB-11

C

DMSO
− +9
0

PCB-126 +
2 µM PCB-11

Pericardial Area
0.12

b

Pericardial
Area (mm 2)

0.10

b

b

0.08
0.06
0.04
0.02

a

a

PCB-126 +
20 µM PCB-11

PCB-126

a

a

a

0.00

DMSO
− +
0

4.5− ng/L
+
PCB-11
0.2 µM

D

4.5− µg/L
4.5− mg/L
+
+
PCB-11
PCB-11
2 µM
20 µM

E

ahr2

Gene Expression
(Fold Change)

2.0

bc
ab

1.5
1.0

c

Gene Expression
(Fold Change)

PCB-126
PCB-11

a

0.5

0.0
PCB-126
PCB-11

DMSO

0
0

20 µM PCB-11 20 µM PCB-11
0
5 nM
+ PCB-126

20 µM

20 µM

PCB-126

5 nM
0

160
140
120
100
80
60
40
20
0

PCB-126
PCB-11

cyp1a

c
b

a
DMSO

0
0

a
20 µM PCB-11 20 µM PCB-11 +
0
5 nM
PCB-126

20 µM

20 µM

PCB-126

5 nM
0

Figure 2.2: PCB-11 and PCB-126 co-exposures at 96 hpf. (A) EROD activity for
single exposures of PCB-11 (white bars) and co-exposures with PCB-126 (black bars),
(B) representative images of EROD activity (red), and (C) pericardial area for single
exposures of PCB-11 (white bars) and co-exposures with PCB-126 (black bars). For (A)
and (C), single and co-exposure experiments were performed separately, standardized to
their respective DMSO groups, and analyzed together (mean ± SEM, n=42-43 fish per
group for single exposure experiments across 3 experiments, n=24-28 fish per group for
co-exposure experiments across 3 experiments, ANOVA with Tukey’s post-hoc test,
p<0.05). (D) Gene transcription for DMSO, 20 µM PCB-11, a 20 µM PCB-11 + 5 nM
PCB-126 co-exposure, and 5 nM PCB-126 quantified for ahr2 and (E) cyp1a (mean ±
SEM, n=3-4 pooled samples of 10 fish per pool per group, ANOVA with Tukey’s posthoc test, p<0.05).
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2.4.4 PCB-11 inhibits Cyp1a activity
In previous co-exposure studies with Ahr agonists that are substrates for Cyp1a
metabolism, inhibition of Cyp1a activity has been shown to potentiate activation of the
Ahr and enhance embryo deformities (55, 58). To determine whether reduced EROD
activity observed in the PCB-126 experiment was due solely to changes in gene
transcription or whether the enzyme action was being impaired, we used a model PAH,
BNF, that has previously been shown to exhibit synergistic embryotoxicity upon Cyp1a
enzyme inhibition via potentiated activation of the Ahr (55, 58). We originally used a
BNF concentration of 367 nM, but this concentration in co-exposures with 20 µM PCB11 resulted in 80% mortality (Appendix E). Therefore, we lowered the BNF
concentration to 184 nM and repeated this experiment, with all subsequent BNF coexposures with 20 µM PCB-11 yielding full survival.
Zebrafish were exposed to 0.2 µM, 2 µM, or 20 µM PCB-11 in combination with
184 nM BNF between 24-96 hpf and compared to zebrafish exposed to DMSO or 184
nM BNF alone. At 96 hpf, EROD activity for larvae co-exposed to BNF and either 0.2
µM or 2 µM PCB-11 resembled the EROD activity of larvae exposed only to BNF, with
all groups having significantly elevated EROD activity of more than 200% greater than
DMSO EROD activity but with normal morphological development (Figure 2.3A-C). In
contrast, 20 µM PCB-11 reduced the EROD activity of fish in co-exposures with BNF to
resemble the EROD activity of the DMSO group, but this co-exposure group experienced
significant gross morphological deformities (Figure 2.3A-C). To validate these
observations, we examined ahr2 and cyp1a gene transcription at 96 hpf for this coexposure group and compared it to DMSO, 20 µM PCB-11, and BNF single exposure

31

groups. BNF significantly upregulated ahr2 transcription 1.2-fold; this transcription in
co-exposures with PCB-11 was reduced to 0.91-fold and was not statistically different
than the DMSO exposure group (Figure 2.3D). For cyp1a, gene transcription for fish
exposed to 20 µM PCB-11 alone was upregulated 3.3-fold in fish, but this was not
significant (Figure 2.3E). BNF significantly upregulated cyp1a 19-fold, and this
transcription was reduced to 13-fold in fish co-exposed to 20 µM PCB-11 and 184 nM
BNF (Figure 2.3E).
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Figure 2.3: PCB-11 and BNF co-exposures at 96 hpf. (A) EROD activity for single
exposures of PCB-11 (white bars) and co-exposures with BNF (black bars), (B)
representative images of EROD activity (red) in gut regions, and (C) pericardial area for
single exposures of PCB-11 (white bars) and co-exposures with BNF (black bars). For
(A) and (C), single and co-exposure experiments were performed separately, standardized
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to their respective DMSO groups, and analyzed together (mean± SEM, n=42-48 fish per
group for single exposure experiments across 3 experiments, n=12-16 fish per group for
co-exposure experiments across 3 experiments, ANOVA with Tukey’s post-hoc test,
p<0.05). (D) Gene transcription for DMSO, 20 µM PCB-11, a 20 µM PCB-11 + 50 µg/L
BNF co-exposure, and 184 nM BNF quantified for ahr2 and (E) cyp1a (mean ± SEM,
n=4-7 pooled samples of 10 fish per pool per group, ANOVA with Tukey’s post-hoc test,
p<0.05).
2.4.5 PCB-11 alters the transcription of genes involved in xenobiotic metabolism,
liver development, and endocrine hormone signaling activity
To assess whether PCB-11 affects the transcription of genes outside of the Ahr
pathway, we performed RNAseq on the 20 µM PCB-11 exposure group. After alignment
and transcript assembly with the Illumina Tuxedo suite on the Illumina Basespace
platform, 372 genes were found to be differentially expressed, and of these differentially
expressed genes (DEGs), 19 were upregulated and 18 were downregulated by more than
2-fold (Table 2.2). Of these genes, cyp1a was upregulated 2.35-fold (data not shown),
consistent with cyp1a upregulation we observed in our qRT-PCR data of between 2.643.25-fold, and jund, involved in drug response, was downregulated more than 2-fold. In
addition to xenobiotic metabolism DEGs, the genes lrp5 and lipca, involved in liver
development and lipid metabolism, were significantly down- and upregulated,
respectively, more than 2-fold. The parathyroid hormone 1a gene, pth1a, was upregulated
6.19-fold (data not shown), and the related genes involved in calcium ion binding oc90
and s100b were upregulated and celsr2 downregulated, all more than 2-fold. Additional
information on unannotated DEGs can be found in Appendix F.
The GSEA platform was used for pathway analysis, using the Kyoto
Encyclopedia of Genes and Genomes (KEGG) database. Upon initial analysis, 22 of 135
gene sets were upregulated and 113 of 135 gene sets were downregulated. Under
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conditions of a nominal p-value of 0.05 and an FDR q-value of 0.20, no gene sets were
significantly upregulated, but 14 gene sets were significantly downregulated (Table 2.2).
While some of these gene sets are involved in xenobiotic metabolism and hormone
signaling, several of these gene sets such as Sphingolipid Metabolism,
Phosphatidylinositol Signaling System, Fatty Acid Metabolism, and the Adipocytokine
Signaling Pathway, are related to lipid signaling and lipid metabolism (Table 2.2). Gene
ontology and pathway analysis was run in parallel on the LRpath platform for
comparison, and 35 pathways were significantly up and downregulated under the same pvalue and FDR q-value conditions (Appendix G). Several of the downregulated pathways
overlap between the two analyses, specifically pathways involved in lipid metabolism. It
is known that higher-chlorinated PCBs can disrupt lipid homeostasis (98) but little
research has investigated the role of lower-chlorinated PCBs on hepatic function (99).

Table 2.2: RNAseq Data. 372 differentially expressed genes were identified, with
nineteen upregulated and eighteen downregulated more than 2-fold. Genes with an * are
annotated with the ENSEMBL gene name from the most recent zebrafish genome build.
All 12,935 genes and their log(2) FPKM values were submitted for evaluation using
GSEA software programmed for the KEGG Pathway gene set, and the pathways
downregulated with a nominal p-value <0.05 and an FDR q-value <0.20 are listed.
Genes upregulated >2-fold
zp3a.2
paplnb
pth1a
nppc
*arf4
oc90
he1b
cyp1a
rn7sk
ndrg1b
pimr110
tfcp2l1
g0s2
npvf
urp2
s100b
*crygm1b
lipca
*rbp1

Genes downregulated >2-fold
zgc:92590
jund
baz2a
klf4
celsr2
lama2
fosab
nrap
acss2l
lrp5
npas4a
opn1lw1
jph1a
fscn2a
csf1ra
wwtr1
zgc:109982
plac8.1

GSEA Downregulated KEGG Pathway

Nominal p-value
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FDR q-value

Sphingolipid Metabolism
Calcium Signaling Pathway
Phosphatidylinositol Signaling System
Acute Myeloid Leukemia
Tight Junction
Basal Cell Carcinoma
Alanine Aspartate and Glutamate
Metabolism
Fatty Acid Metabolism
Melanogenesis
Vascular Smooth Muscle Contraction
ERBB Signaling Pathway
Adipocytokine Signaling Pathway
Adherens Junction
Inositol Phosphate Metabolism

0.042
0.034
0.029
0.043
0.044
0.028
0.043

0.172
0.172
0.176
0.177
0.180
0.181
0.182

0.038
0.035
0.033
0.025
0.031
0.046
0.037

0.182
0.186
0.186
0.188
0.192
0.193
0.194

2.4.6 PCB-11 impedes liver development and increases vacuole formation in
hepatocytes
Based on our previous findings that 20 µM PCB-11 affects the Ahr pathway and
in the RNAseq results also affects several pathways related to hepatic functioning, we
used the transgenic Tg(gut:GFP) zebrafish to examine how PCB-11 affects liver
development at 96 hpf. This is a time point consistent with our previous experiments, and
a stage during which zebrafish livers are elongating ventrally during development into a
functioning hepatic system. At 96 hpf, zebrafish livers in the DMSO, 0.2 µM, and 2 µM
PCB-11 exposure groups reached full extension ventrally, but zebrafish livers in the 20
µM PCB-11 exposure group were impeded in their growth and significantly smaller at an
average of 0.027 mm2 compared to an average of 0.033 mm2 for zebrafish livers in the
DMSO exposure group (Figure 2.4A-B). No differences in overall growth were observed
between exposure groups (data not shown). The livers of fish exposed to either DMSO or
20 µM PCB-11 dose were also examined using histology. Sagittal sections from the
midlines of each fish were compared, and sections from the 20 µM PCB-11 exposure
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group were observed to have greater vacuolization, indicative of lipid droplets, and fewer
numbers of hepatocytes per area of liver tissue as compared to sections from the DMSO
exposure group (Figure 2.4C).
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Figure 2.4: Liver Development at 96 hpf. (A) Representative images of liver area
fluorescing GFP, and (B) quantified for each exposure group (mean ± SEM, n=32-43 fish
per exposure group across 4 experiments, ANOVA with Tukey’s post-hoc test, p<0.05).
(C) Representative images of liver histology sections for zebrafish exposed to DMSO or
20 µM PCB-11 show more vacuoles in livers of PCB-11 exposed fish (H&E stained, n=4
fish per exposure group).
2.5 Discussion
This study is, to our knowledge, the first assessment of embryotoxicity of PCB-11
in the zebrafish model. We show here that exposure to PCB-11 can affect liver
development, act as a partial agonist/antagonist of the Ahr pathway, and act as an
antagonist of Cyp1a activity to modify the toxicity of compounds that interact with the
Ahr pathway. Overall, these data provide insight into predicting embryotoxicity of acute
exposures to PCB-11.
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The concentrations used in the present study ranged from those that were similar
to rodent toxicity studies (high concentration, 20 µM, or 4,500 µg/L) (28, 33) and an
environmentally relevant concentration (low concentration, 0.2 µM, or 45 µg/L). This
low concentration is still several orders of magnitude higher than environmental
concentrations we have observed in water downstream of a paper recycling facility
(Appendices H-J), though it is closer to concentrations that other studies have recorded
(Appendix K). Although our high exposure concentration of 20 µM (and 61.60 ng/mL
detected in the media at 28 hpf) is greater than aquatic concentrations reported to date, it
is important to note that much of the compound was not retained in the water or absorbed
by the embryo. Four hours after the start of the exposure, only 0.89% of the initial PCB11 administered to zebrafish water was detected in the embryos (0.18% per embryo and
1.36% in the associated media at 28 hpf); 72 hours after the exposure began these
percentages increased to 3.03% in developing larvae (0.61% per larvae) and decreased to
0.84% in the associated media at 96 hpf. Thus, most of the compound likely sorbed to the
glass vessel or volatilized before our first sample collection time point at 4 hours after
exposure. At the stages examined in this study, zebrafish do not yet have a functioning
open gut excretion mechanism (100), so while developing larvae may partially
metabolize PCB-11 they absorb, those metabolites would accumulate in their body.
Additional research is needed to examine the toxicokinetics of PCB-11. Despite the large
reduction from the initial 20 µM PCB-11 dosing concentration, these data indicate both
the volatile nature of lower chlorinated PCBs as well as their ability to accumulate in
tissue.
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The small PCB-11 percentage that entered zebrafish tissue impacted developing
zebrafish in exposures to PCB-11 alone (Figure 2.1) and in co-exposures with other Ahr
agonists. Our results showing 20 µM PCB-11 inhibits Ahr pathway activation in coexposures with PCB-126 (Figure 2.2) is consistent with findings reported for lowerchlorinated PCB co-exposure studies in cell culture (42, 101, 102). Interestingly, we also
observed that 20 µM PCB-11 significantly reduces Cyp1a metabolizing activity in coexposures with BNF and results in severe toxicological outcomes (Figure 2.3). We would
expect that any substrate not metabolized would continue to activate the Ahr
synergistically, consistent with previous studies testing Ahr pathway induction in
combination with Cyp1a enzyme inhibition (55, 58); however, we did not observe a
synergistic cyp1a response. If the morphological deformities observed are indeed
mediated through ahr2, we would expect that ahr2 knock-down would rescue these
deformities (74). Another research group tested this hypothesis with weak Ahr agonists in
combination with the PAH fluoranthene, however, knocking down ahr2 failed to rescue
toxicity (103). If this is the case for PCB-11, then it is possible that the observed toxicity
from PCB-11’s antagonistic activity on Cyp1a is mediated through another mechanism.
For example, ahr1a has been implicated in toxicity response (53), though its complete
function requires further characterization.
In addition to PCB-11’s effects on the Ahr pathway, the RNAseq data for this
study highlights its effects on genes and pathways involved in hormone signaling,
xenobiotic metabolism, and lipid metabolism. Similar to the PCB-11 single exposure
experiments we conducted to observe gross morphology and EROD activity, the effects
observed from the RNAseq experiment were modest. Additionally, while 19 genes were
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significantly upregulated more than 2-fold, none of these genes besides cyp1a have been
identified as downstream targets of ahr2 transcriptional activity, supporting the idea that
PCB-11 is only a partial Ahr agonist/antagonist, and influences other gene targets and
outcomes. Of these 19 upregulated genes and the 18 significantly downregulated genes,
pathway analysis using GSEA with an FDR q-value cut-off of 0.20 resulted in no
pathways being significantly upregulated and only 14 KEGG pathways as significantly
downregulated (Table 2.2). Despite these results, downregulation of Tight Junctionrelated genes could result in a degradation of protective barriers in the presence of
xenobiotics (104), and downregulation of the ERBB Signaling Pathway, which regulates
a family of receptor tyrosine kinases governing diverse biological functions, has been
implicated in adverse cardiac development (105); we observed in our single exposure
experiment mild pericardial edema in response to 20 µM PCB-11. Additionally, the
Calcium Signaling Pathway was significantly downregulated and is important in hormone
regulation, cell fate decisions, and more recently has been implicated in liver injury and
regeneration (106). Pathway analysis using LRpath was performed for comparative
purposes (Appendix G). This analysis yielded many more significant results using the
same parameters as the GSEA analysis, with several overlapping downregulated
pathways related to lipid metabolism. Overall, given that the parameters used for the
pathway analyses were not conservative, the results provide modest evidence as to how
single exposures of PCB-11 can affect the pathways discussed previously. Since both of
these analyses yielded overlapping pathway results related to lipid metabolism, and since
our EROD experiments largely reflect activity in the liver, our subsequent experiments
explored PCB-11’s effects on liver development.
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Using the transgenic Tg(gut:GFP) zebrafish line, we observed that 20 µM PCB11 significantly impedes liver development (Figure 2.4). In our histology experiment;
H&E staining of liver tissue also suggests differences in hepatocyte density and
vacuolization between DMSO and 20 µM PCB-11 exposure groups, however, due to a
lack of histological samples, we were unable to quantify these results. Zebrafish are
increasingly useful for studying liver pathogenesis (107), including the effects of nondioxin-like PCBs and their metabolites, which we did not measure in this study. For
instance, the half-life of PCB-11 is as little as a few minutes compared to up to 9.5 hours
for its metabolites in the rodent model (47); half-lives for PCB-11 and its metabolites in
humans is unknown, but both hydroxylated and sulfated metabolites have been detected
in human samples (28, 30, 43). It has been shown that lower-chlorinated PCBs can be
hydroxylated in vivo by Cyp enzymes to initiate hepatocarcinogenesis through direct
DNA adduction (99, 108, 109), but further histological investigation might help elucidate
PCB-11’s potential role in xenobiotic metabolism disruption and liver pathology.
In our present study of the Ahr in response to PCB-11, we probed Cyp1a enzyme
activity, which is classically involved with Phase I xenobiotic metabolism of both
endogenous and exogenous substrates such as certain pharmaceutical drugs and aromatic
hydrocarbon compounds. However, our investigation does not identify other potentially
important Cyp enzymes in xenobiotic metabolism that could be inhibited by PCB-11.
Furthermore, our investigation does not include how PCB-11 might affect crosstalk
between the Ahr pathway and other mechanisms; for instance, we have previously shown
a relationship between the Ahr and the Nrf2 antioxidant signaling pathway (93), and
other studies have identified PCB-11’s agonist/antagonist effects on the Ahr as well as on
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other hormone receptors in rodent cell culture models (42, 48). The Ahr pathway also has
other diverse functions throughout the human body, including roles in immune response
and embryogenesis, where antagonism of Ahr function has been demonstrated to enhance
maintenance of hematopoietic stem cell populations (110). This suggests that PCB-11’s
antagonism of Ahr may potentially impact cell fate decisions in diverse target organs.
The antagonistic effect of PCB-11 on the Ahr observed in this study therefore emphasizes
an important gap in our understanding of the systemic impacts of toxicological and
pharmacological mixtures, and highlights important areas of investigation for future
studies.
In summary, while higher concentrations of single exposures of PCB-11 has mild
effects on development and Ahr function, this work introduces other mechanisms by
which PCB-11 may have adverse health consequences. The antagonistic or competitive
effect of PCB-11 on Ahr and Cyp1a in the presence of classical agonists suggests that
ubiquitous PCB-11 exposures may interact with other toxicants and pharmacological
agents acting through these pathways. While this study focused on the effects of acute
exposures at higher concentrations, further studies could examine the effects of more
environmentally-relevant concentrations under a chronic exposure paradigm. This work
also underscores the importance of characterizing the species composition of mixtures in
environmental risk assessments, as no organism would be exposed to PCB-11 in the
absence of other chemicals, including other PCBs.
2.6 Conclusions
The environmentally relevant concentration of PCB-11 used for laboratory
experiments in this study (0.2 µM) does not appear to cause deviations in embryonic
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development in the zebrafish model in either single or co-exposures with other Ahr
agonists. Of the higher 20 µM PCB-11 concentration tested, 0.61% was absorbed per fish
by 96 hpf. In single exposures, this concentration mildly activates the Ahr and results in
subtle changes in liver histology and significant decreases in liver size. In addition, this
PCB-11 concentration in co-exposures with other Ahr agonists both exacerbates and
inhibits embryonic deformities in zebrafish, depending on the agonist, and inhibits Cyp1a
activity. As many pharmaceuticals and xenobiotic compounds are metabolized via the
Ahr pathway and Cyp family of enzymes, these results suggest that if exposures at this
concentration occur, PCB-11 may potentially cause drug interactions or other
interferences with xenobiotic metabolism for both aquatic life and humans. Additional
studies would help evaluate the effects of co-exposures, outcomes at other life stages, and
verify the molecular actions of this emerging contaminant.
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CHAPTER 3
THE SULFATE METABOLITE OF 3,3’-DICHLOROBIPHENYL (PCB-11)
IMPAIRS CYP1A ACTIVITY AND INCREASES HEPATIC NEUTRAL LIPIDS
IN ZEBRAFISH LARVAE (DANIO RERIO)

Reprinted (adapted) with permission from:
Roy MA, Duche PR, Timme-Laragy AR. The sulfate metabolite of 3,3’-dichlorobiphenyl
(PCB-11) impairs Cyp1a activity and increases hepatic neutral lipids in zebrafish larvae
(Danio rerio). Chemosphere, 2020;260:127609. Epub 2020/07/22. doi:
10.1016/j.chemosphere.2020.127609. PubMed PMID: 32693259; PMCID:
PMC7530052. Copyright Elsevier.

3.1 Abstract
The environmental contaminant 3,3’-dichlorobiphenyl (PCB-11) is widely
detected in environmental samples, and this parent compound along with its metabolites
4-OH-PCB-11 and 4-PCB-11-Sulfate are detected in human serum. Our previous
research in zebrafish (Danio rerio) embryos shows exposure to 20 µM PCB-11 inhibits
Cyp1a enzyme activity and perturbs lipid metabolism pathways. In this study, wildtype
AB embryos underwent acute exposures from 1-4 days post fertilization (dpf) to 0.002-20
µM 4-OH-PCB-11 or 0.2-20 µM 4-PCB-11-Sulfate, with and without co-exposures to
100 µg/L benzo[a]pyrene (B[a]P) or 5 nM 3,3’,4,4’,5-pentachlorobiphenyl (PCB-126),
and were assessed for in vivo EROD activity and morphometrics. Chronic exposures
from 1-15 dpf to assess lipid accumulation using Oil-Red-O staining were also conducted
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with 0.2 µM parent or metabolite compounds, alongside a co-exposure experiment of
0.002-0.2 µM 4-PCB-11-Sulfate and 10 µg/L B[a]P. For acute experiments, 2 and 20 µM
4-OH-PCB-11 was lethal but no Cyp1a or morphological effects were observed at lower
concentrations; 20 µM 4-PCB-11-Sulfate significantly lowered the Cyp1a activity of
B[a]P and PCB-126 but did not alter morphological development. For chronic
experiments, 0.2 µM 4-PCB-11-Sulfate significantly increased lipid accumulation 30% in
single exposures and 44% in co-exposures with B[a]P. Further long-term studies would
better elucidate the effects of this contaminant, particularly in the context of
environmentally-relevant mixtures.

3.2. Introduction
The lower-chlorinated polychlorinated biphenyl (PCB) 3,3’-dichlorobiphenyl
(PCB-11) is an unintentional byproduct of pigment and sealant manufacturing that can
volatilize into air, leach into water sources (24, 66), and is now one of the most
frequently-detected and abundant PCB congeners in these environmental sample
mediums (19, 22). PCB-11 has also been detected in human serum (31), including in
pregnant women (33). Our previous work in zebrafish (Danio rerio) embryos has shown
that in single exposures PCB-11 impedes liver development, causes differential
expression in lipid metabolism-related genes, interacts with the aryl hydrocarbon receptor
(Ahr) pathway, and affects hepatic lipid accumulation. Further, in co-exposures with the
Ahr agonist PCB-126, we found that PCB-11 can act as a partial Ahr antagonist to rescue
toxicological outcomes, while in co-exposures with the model polycyclic aromatic
hydrocarbon (PAH) beta-naphthoflavone (BNF) it can act as a Cyp1a enzyme inhibitor to
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exacerbate toxicological outcomes (111). However, it is not clear whether these observed
effects are due to the parent PCB-11 compound or to one or more of its metabolites.
PCB-11 can undergo biotransformation into several common metabolites (112). For
instance, in male Sprague-Dawley rats PCB-11 is transformed into hydroxylated (4-OHPCB-11) and sulfated (4-PCB-11-Sulfate) metabolites within hours (27, 47). 4-OH-PCB11 and 4-PCB-11-Sulfate are two of the most prevalent PCB-11 metabolites and have
both been detected in human serum (30, 113). In this study, we tested whether these
PCB-11 metabolites contribute to the Ahr interactions we observed with the parent
compound, and also tested whether these metabolites contribute to hepatic lipid
accumulation in the zebrafish model.
The Ahr pathway is conserved between humans and zebrafish, and is
characterized as a basic-helix-loop-helix/per-Arnt-sim (bHLH/PAS) transcription factor
family member that is activated by dioxin-like PCBs, many PAHs, and several other
environmental chemicals (69-71). Upon Ahr ligand binding, the Ahr dissociates from cochaperones heat shock protein 90 (HSP90) interacting protein p23 and hepatitis B virus
X-associated protein 2 (XAP2) in the cytosol and translocates to the nucleus with its
HSP90 dimer (4). There, it forms a heterodimer with the Ahr nuclear translocator (Arnt)
(5) and binds to the xenobiotic response element to upregulate metabolism-related genes
like cyp1a, which is then translated into its enzyme counterpart, Cyp1a, to metabolize the
ligand (6). Genome duplication in zebrafish has given rise to several Ahr and
Cytochrome p450 (Cyp) 1 family genes. Ahr gene isoforms include ahr1a, ahr1b, and
ahr2, though pathway activation for the PCBs and PAHs in this study has been
characterized to occur primarily through ahr2 (79, 114).
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Upregulation of cyp1a in zebrafish is generally the most highly inducible Cyp1
member (74) and is similar to human Cyp1a1 induction through the Ahr (76, 115). Cyp1a
enzymatic activity can be measured using the well-established in vivo ethoxyresorufin-Odeethylase (EROD) bioassay, where the substrate 7-ethoxyresorufin-O-deethylase (7-ER)
binds to Cyp1a induced by the chemical of interest and can then be visualized under a
fluorescence microscope with a red fluorescence protein (RFP) filter (58, 81). Ligands
like BNF that activate the Ahr pathway and subsequent Cyp1a activity are good
substrates for subsequent biotransformation into more hydrophilic substances for
excretion (76). However, ligands like PCB-126 that upregulate the Ahr pathway and
Cyp1a activity, but are not metabolized by Cyp1a, exert toxicity in zebrafish that results
in pericardial edema, yolk sac edema, craniofacial malformations, and decreased swim
bladder inflation when exposures begin at 1 day post fertilization (dpf) (55, 58); these
outcomes are Ahr-dependent (7). Since our previous work showed PCB-11 can act as
both a partial agonist and antagonist of the Ahr pathway, and since biotransformation can
occur fairly quickly, this raises the question as to whether the effects we observed were
direct actions of the parent compound, its metabolites, or some combination of both.
Both 4-OH-PCB-11 and 4-PCB-11-Sulfate fall along the same metabolic
pathway, with PCB-11 either directly hydroxylated by Cytochrome p450
monooxygenases or indirectly via an arene oxide intermediate to form 4-OH-PCB-11,
then undergoing sulfation to form 4-PCB-11-Sulfate (112) (Figure 3.1). The hydroxylated
forms of lower-chlorinated PCBs have been shown to be more transient, but often more
potent activators of the Ahr pathway than their parent compounds (116). Sulfated
congeners such as 4-PCB-11-Sulfate have been shown to rapidly distribute to the liver to
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undergo further biotransformation by Cyps, sulfotransferases (SULTs), or Uridine 5’diphospho-glucuronosyltranserases (UGTs) and then redistribute to other tissues,
potentially to adipose tissues (28, 30). Parent PCB congeners have been shown to affect
hepatic lipid accumulation (39, 117), however, few studies have investigated this
outcome after direct exposure to PCB metabolites. In this study, we hypothesized that 4OH-PCB-11 would have more amplified effects on Cyp1a activity than PCB-11 in the
acute 4-day EROD bioassay, and we tested whether either of the PCB-11 metabolites
would affect hepatic lipid accumulation under a 15-day chronic exposure paradigm
compared to the parent compound.
Volatilization/leaching

SULTs

CYPs
4-OH-PCB-11

PCB-11

4-PCB-11-Sulfate
Cl

Cl

Cl
OSO3

OH
Cl
Environmental exposure

Cl

Cl

Internal body metabolism

Figure 3.1: PCB-11 Metabolism Schematic. PCB-11 can volatilize or leach from the
products it is in. Once inhaled or ingested, PCB-11 is transformed by Cyp enzymes into
4-OH-PCB-11 and then by sulfotransferase enzymes into 4-PCB-11-Sulfate.

3.3. Materials and Methods
3.3.1 Animal Care
Adult wildtype AB zebrafish (Danio rerio) were housed on a 14 h light:10 h dark
cycle in a recirculating Aquaneering system (San Diego, CA) maintained at 28.5 ̊C and
fed twice daily with GEMMA Micro 300 (Skretting, Westbrook, ME). Embryos were
collected from breeding groups with a 2:1 female:male ratio. Embryos were collected
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within 3 hours post-breeding, washed, and stored at low density in 0.3x Danieau’s media
[17 mM NaCl, 2 mM KCl, 0.12 mM MgSO4, 1.8 mM Ca(NO3)2, 1.5 mM HEPES, pH
7.6] in an incubator with the same temperature and light conditions as the adult fish. At 1
dpf, embryos were manually dechorionated using Watchmakers forceps and screened for
normal development before use in experiments. All animal care and experiments were
conducted in accordance with protocols approved by the University of Massachusetts
Amherst Institutional Animal Care and Use Committee (IACUC; Protocol Number 20190067). Animals were treated humanely with due consideration to the alleviation of stress
and discomfort.
3.3.2 Chemicals
3,3’,4,4’,5-pentachlorobiphenyl (PCB-126) was purchased from Ultra Scientific
(North Kingstown, RI), benzo[a]pyrene (B[a]P) from Sigma-Aldrich (St. Louis, MO),
and 7-ethoxyresorufin-O-deethylase (7-ER) from MP Biomedicals (Solon, OH). 3,3’dichlorobiphenyl (PCB-11), 3,3’-dichlorobiphenyl-4-ol (4-OH-PCB-11) and 3,3′dichloro-4-sulfooxy-biphenyl (4-OH-PCB-11-Sulfate) were synthesized at the Iowa
Superfund Research Program (Iowa City, IA) via the Suzuki coupling reaction as
described (45, 118). The authentication of these compounds follow guidelines established
previously (119) and is documented elsewhere (33). The solubility of PCB-11 in water is
354 µg/L (90) and its octanol-water partition coefficient is log 5.28 (91). All chemicals
were dissolved in 100% dimethyl sulfoxide (DMSO) from Fisher Scientific (Fair Lawn,
NJ), stored as stock solutions in glass amber vials at -20°C, and were fully thawed and
vortexed before use.
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3.3.3 Chemical Exposures
The final concentrations of PCB-11, 4-OH-PCB-11, and 4-PCB-11-Sulfate used
in this study ranged from 0.002-20 µM for all experiments. Higher exposure
concentrations were used in the EROD bioassay to compare the effects of the metabolites
to parent compound observed in our previous work (111), and are comparable to
concentrations used in other rodent and cell culture studies (33, 46). Lower
concentrations were used in chronic exposure experiments to mimic environmental and
tissue concentrations observed in other studies (30, 31). For all experiments, wildtype AB
zebrafish embryos were used, and at 1 dpf were manually dechorionated using
Watchmaker forceps and screened for normal development.
For EROD and RT-qPCR experiments, zebrafish were statically exposed from 1-4
dpf to 4-OH-PCB-11 or 4-PCB-11-Sulfate, either alone for single exposure experiments
or in combination with either of the Ahr agonists PCB-126 or B[a]P for co-exposure
experiments, with exposures to DMSO and either of the Ahr agonists as negative and
positive controls, respectively. During this period of development, ahr2 and cyp1a
expression in zebrafish does not become consistent until 1 dpf (92), when exposures to
both 100 µg/L B[a]P (396 nM) and 5 nM PCB-126 activate the Ahr pathway (7, 120);
for PCB-126, 5 nM causes malformations in zebrafish (93), but for B[a]P, 100 µg/L
exposures starting at 1 dpf induces Cyp1a activity which metabolizes the B[a]P and does
not result in any morphological deformities (120). For each exposure group, five embryos
were placed in 5 mL of 0.3x Danieau’s media in a 20 mL glass scintillation vial at 1 dpf,
each vial containing 2 µL PCB-11 metabolite, Ahr agonist, or DMSO, and 0.5 µL 7-ER
for a final DMSO concentration of 0.05% v/v and final 7-ER concentration of 0.5 µg/L.
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Each exposure group contained at least 2 vials, and exposure water was kept static (not
changed) from 1-4 dpf. At 4 dpf, zebrafish were rinsed 3 times with Danieau’s media
before use in microscopy or collection for RT-qPCR. For RT-qPCR experiments, 3-4
vials (15-20 fish) were pooled together per exposure group as 1 sample before storage in
RNAlater. Each experiment was repeated at least 3 times.
For chronic exposure experiments, at 1 dpf dechorionated embryos were exposed
in 5 mL of 0.3x Danieau’s media in 20 mL glass scintillation vials, with 5 embryos per
vial and 4 vials per exposure group. Each vial was dosed with either DMSO, 0.2 µM
PCB-11, 0.2 µM 4-OH-PCB-11, or 0.2 µM 4-PCB-11-Sulfate, with a final DMSO
concentration of 0.05% v/v. Each day from 2-4 dpf, 50% of the media solution was
changed. At 5 dpf, zebrafish were moved to individual vials (1 fish per vial) containing 5
mL of the appropriate Danieau’s-based media solution. From 6-8 dpf, exposure group
solutions were made in system water obtained from the recirculating Aquaneering system
housing the adult fish, and 5 mL of the appropriate solution was added to each vial, so
that at 8 dpf each vial contained 20 mL of solution. From 9-14 dpf, exposure group
solutions were made in system water and 50% of the solution (10 mL) was changed per
vial. After solution changes, fish were fed standard juvenile GEMMA Micro 75
(Skretting, Westbrook, ME) fish starting at 5 dpf. In a separate experiment, the exposure
paradigm described above was repeated for fish exposed to either DMSO, 0.002 µM 4PCB-11-Sulfate + 10 µg/L B[a]P, 0.02 µM 4-PCB-11-Sulfate + 10 µg/L B[a]P, 0.2 µM
4-PCB-11-Sulfate + 10 µg/L B[a]P, or 10 µg/L B[a]P alone. At 15 dpf, all zebrafish were
rinsed 3 times and moved into different vessels for live imaging before fixation for
further analysis. Each experiment was repeated 3 times.
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3.3.4 Oil-Red-O (ORO) Staining
At 15 dpf, chronically-exposed zebrafish that had undergone live imaging were
put into separate 1 dram glass vials, fixed with 4% paraformaldehyde overnight covered
on a rocker, rinsed 2x with 1x PBS, and stored in 70% ethanol at 4°C until processing.
Briefly for ORO staining, zebrafish were rinsed 2x with 1x PBS, submerged in 85%
propylene glycol for 10 min (once removed, this was saved post-removal for the next
day), then 100% propylene glycol for 10 min (once removed, this was saved postremoval for the next day), and then 0.5% ORO made in 100% propylene glycol overnight
on a rocker (121); the next day the ORO was removed and each fish was submerged in
100% propylene glycol (saved from the day before) for 30 min, 85% propylene glycol
(saved from the day before) for 50 min, and then 85% propylene glycol again for 40 min.
Equal amounts of 1x PBS were added to each vial, swirled and left for 5 min, then
removed. Each fish was rinsed 3x with 1x PBS, and then submerged with 100% glycerol
for storage prior to imaging. All ORO steps took place at room temperature.

3.3.5 Microscopy and Image Analysis
For all imaging, live larvae were sedated by a 10 second exposure to 2% v/v MS222 solution (prepared as 4 mg/mL tricaine powder in water, pH buffered, and stored at 20°C until thawed for use) before being mounted on individual 3% methylcellulose drops
in a left-lateral orientation. All imaging took place on a Zeiss Stereo Axio Zoom.V16
equipped with a HXP 200 C light source (Carl Zeiss Inc.). For EROD experiments with 4
dpf zebrafish, whole organism images were captured under brightfield settings at 20x
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total magnification, and the gut region was captured at 100x under both a brightfield
setting and using a red fluorescent protein (RFP) filter. For chronic exposure experiments
with 15 dpf zebrafish, whole organism brightfield images were captured at 20x total
magnification for both live zebrafish and ORO stained zebrafish. For each individual
experiment capturing EROD or ORO light intensity, the same exposure time was used for
each fish across all exposure groups within the same experimental replicate. In addition
to the representative images in the figures, additional representative images for each
experiment are provided in the appendices.
All measurements for zebrafish body length, EROD light intensity, ORO light
intensity, and pericardial area were measured with the Zen Lite program (Carl Zeiss Inc.).
To quantify light intensity for EROD (black and white) images, the software was used to
find the maximum intensity out of the entire image. To calculate background light
intensity, the circle tool was used in a consistent place in each image and the mean
intensity was recorded. To compare fluorescent images between experimental replicates,
both background light intensity and dark pixel intensity (a calculated constant, (122))
were subtracted from the recorded light intensity for every image, and then this figure
was divided by the exposure time. Each experimental replicate was normalized to its
DMSO control, and then data from experimental replicates was merged. To quantify light
intensity for ORO (color) images, the images were blinded and the circle tool was used to
find and record the highest average light intensity in sub-regions of the liver that
excluded pigment. Mean background light intensity was recorded from the same area of
every image accounted for in light intensity calculations. Each experimental replicate was
normalized to its DMSO control, and then data from experimental replicates was merged.
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We measured pericardial area on all 4 dpf zebrafish as a quantitative measurement to
represent overall deformities since pericardial edema is a characteristic outcome of fish
embryos exposed to PCB-126 (95) and other compounds that suppress Cyp1a activity
(59). Swim bladder inflation was scored as 0=not inflated or 1=inflated. All four
measured outcomes for 4 dpf fish were averaged per vial so that each vial of fish was
n=1. All measured outcomes for 15 dpf fish were analyzed so that each fish was n=1
since fish in these experiments were raised in individual vials.

3.3.6 RT-qPCR
For all RT-qPCR experiments, at 4 dpf zebrafish larvae were rinsed 3 times and
pooled in groups of 15-20 larvae, and preserved in RNAlater (Thermo Fisher Scientific,
Waltham, MA) in 1.5 mL Eppendorf tubes at -80°C. Zebrafish larvae were thawed,
transferred to lysis buffer, and sonicated by pulsing 3-5 times with an Emerson Industrial
Branson Sonifier® (Danbury, CT). RNA isolation was performed using 2Mercaptoethanol (MP Biomedicals) and a GeneJET RNA Purification Kit (Thermo
Fisher Scientific) following manufacturer instructions. RNA quantity and quality was
assessed using a BioDrop μLITE spectrophotometer (Cambridge, United Kingdom).
Sample cDNA was prepared using an iScript reaction mix kit (Bio-Rad, Hercules, CA),
diluted 1:9 with nuclease-free water, and stored at -80°C until processing. Each RTqPCR sample was prepared using 10 μL of 2X iQ SYBR® Green Supermix (Bio-Rad), 5
pmol (250 nM) each of forward and reverse primers (1 μL total), 5 μL of nuclease-free
water, and 4 μL (10 ng) of cDNA. Samples were run on 96-well plates in a CFX Connect
Real-Time PCR Detection System (Bio-Rad), and samples were analyzed using the CFX
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Manager software (Bio-Rad). RT-qPCR was carried out in duplicate for the aryl
hydrocarbon receptor 2 (ahr2) and cytochrome p4501A1 (cyp1a) genes. The b-actin
(actb) gene was used as a housekeeping gene, and its transcription did not change
significantly across exposure groups. Gene primer sequences can be found in Appendix C
(123).

3.3.7 Statistical Analyses
For 4 dpf experiments, embryos damaged as a result of dechorionation error were
excluded from analyses (on average one fish per exposure group per experiment). Data
was then analyzed for outliers (0.25 quartile tails) for body length, EROD, and pericardial
area endpoints across all experimental replicates, and individual samples were removed
completely from all analyses if they were flagged as outliers for at least one endpoint. For
each type of experiment, 1-3% of samples were considered outliers. For 15 dpf
experiments, data was analyzed for outliers (0.25 quartile tails) for ORO light intensity
and 1-2% of individual fish were removed from analysis. A one-way Analysis of
Variance (ANOVA) with a Tukey-Kramer post-hoc statistical test was performed for all
experiments with JMP® Pro software version 14.1.0 (Cary, NC). The unit of replication
for 4 dpf experiments was the vial and the unit of replication for 15 dpf experiments was
individual fish. Statistical significance was considered using a 95% confidence interval
(α=0.05). For RT-qPCR experiments, gene transcription fold-changes were calculated
using the ΔΔCT method (97).
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3.4. Results
3.4.1 PCB-11 inhibits Cyp1a enzyme activity induced by B[a]P but not cyp1a gene
expression
We previously showed that 20 µM PCB-11 can inhibit Cyp1a enzyme activity
induced by the model PAH BNF (111). To verify that this effect was consistent with a
more environmentally-relevant PAH, zebrafish were co-exposed under static conditions
from 1-4 dpf to 100 µg/L B[a]P in combination with the same concentrations of PCB-11
used in previous experiments: 0.2, 2, or 20 µM, and at 4 dpf fish were imaged to analyze
cumulative growth, morphology and EROD activity. Fish that were exposed to B[a]P
grew normally (Figure 3.2A), with a significant 270% increase in EROD activity (Figure
3.2B), maintaining normal pericardial area (Figure 3.2C) and swim bladder inflation
(Figure 3.2D). Similar to previous results, 20 µM PCB-11 significantly reduced the
EROD activity induced by 100 µg/L B[a]P, and fish in this co-exposure group had
significantly decreased overall body length, increased pericardial area, and decreased
swim bladder inflation (Figure 3.2D) compared to fish exposed to either DMSO or B[a]P
alone; these morphological and EROD activity outcomes can be seen in Figure 3.2E, and
additional representative images can be found in Appendix L. To verify whether Cyp1a
activity reduction also occurred at the gene transcript level, RT-qPCR was performed on
pooled groups of fish exposed either to DMSO, 20 µM PCB-11 + 100 µg/L B[a]P, or 100
µg/L B[a]P alone. No significant changes were observed for ahr2 (Figure 3.2F). The coexposure group and B[a]P increased cyp1a expression 70-fold and 38-fold (Figure 3.2G),
respectively, suggesting a synergistic response for the co-exposure group, though no
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statistically significant differences were observed between the co-exposure group and
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Figure 3.2: Zebrafish exposed to 0, 0.2, 2, or 20 µM PCB-11 in combination with 100
µg/L B[a]P. A) Body length, B) EROD quantification, C) pericardial area, and D) swim
bladder inflation (mean±SEM, n=6 vials of 3-5 pooled larvae per exposure group across 3
experiments, ANOVA with Tukey’s post-hoc test, p<0.05). E) Representative images of
whole zebrafish and EROD activity. The black arrow indicates significantly increased
pericardial area and the white arrow indicates a significant loss of EROD activity and
lack of swim bladder inflation. Gene expression for F) ahr2 and G) cyp1a are shown
against b-actin as a housekeeping gene (mean±SEM, n=3 sets of 4 pooled vials of 4-5
larvae per exposure group across 3 experiments, ANOVA with Tukey’s post-hoc test,
p<0.05).
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3.2 4-OH-PCB-11 and 4-PCB-11-Sulfate alone do not affect the Ahr pathway
To investigate whether PCB-11 metabolites behave similarly to the parent
compound, concentrations of 4-OH-PCB-11 and 4-PCB-11-Sulfate were used in single
static exposures to zebrafish from 1-4 dpf, and at 4 dpf morphology and EROD activity
was measured. Initially, we exposed zebrafish to both metabolites in concentrations of
0.2, 2, and 20 µM, however, 20% and 0% survival was observed for fish exposed to 2
µM and 20 µM 4-OH-PCB-11, respectively (Appendix M). A concentration one order of
magnitude lower (0.02 µM, or 20 nM) was added for subsequent single exposure
experiments, shown here. No changes in length (Figure 3.3A), EROD activity (Figure
3.3B), or pericardial area (Figure 3.3C) were observed for fish exposed to either of the
metabolites compared to fish exposed to DMSO, however, swim bladder inflation was
significantly decreased 40% for fish exposed to 20 µM 4-PCB-11-Sulfate compared to
fish exposed to DMSO (Figure 3.3D). Fish that were exposed to the PCB-126 positive
control experienced a 6% decrease in length, a 159% increase in EROD activity, and a
142% increase in pericardial area. These morphological and EROD activity outcomes can
be seen in Figure 3.3E, and additional representative images can be found in Appendix N.
In a separate trial to probe whether lower concentrations of 4-OH-PCB-11 could elicit
different responses, we exposed zebrafish to single static exposures of 4-OH-PCB-11 in
concentrations of 0.00002, 0.0002, and 0.002 µM, though we did not observe any
differences in morphology or EROD activity compared to fish exposed to DMSO
(Appendix O). However, the 0.002 µM concentration was added for subsequent coexposure experiments.
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Figure 3.3: Zebrafish exposed to either 0.02-0.2 µM 4-OH-PCB-11, 0.2-20 µM 4PCB-11-Sulfate, or DMSO or 5 nM PCB-126 controls from 1-4 dpf. A) Body length,
B) EROD quantification, C) pericardial area, and D) swim bladder inflation (mean±SEM,
n=8 vials of 3-5 pooled larvae per exposure group across 3-5 experiments, ANOVA with
Tukey’s post-hoc test, p<0.05). E) Representative images of whole zebrafish and EROD
activity. For the PCB-126 positive control fish, the black arrow indicates significantly
increased pericardial area and the white arrow indicates significantly increased EROD
activity and lack of swim bladder inflation.
3.3 4-PCB-11-Sulfate inhibits Cyp1a enzyme activity but not cyp1a gene expression
To investigate whether 4-OH-PCB-11 or 4-PCB-11-Sulfate interact with the Ahr
pathway in the presence of other Ahr agonists, we co-exposed zebrafish to either DMSO,
5 nM PCB-126, or 5 nM PCB-126 in combination with either 0.002-0.2 µM 4-OH-PCB11 or 0.2-20 µM 4-PCB-11-Sulfate from 1-4 dpf and then measured morphological
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development and EROD activity. At 4 dpf, zebrafish exposed to 5 nM PCB-126
experienced a 7% reduction in body length (Figure 3.4A), a 404% increase in EROD
activity (Figure 3.4B), a 132% increase in pericardial area (Figure 3.4C), and no swim
bladder inflation (Figure 3.4D). These morphological and EROD activity outcomes can
be seen in Figure 3.4E, and additional representative images can be found in Appendix P.
We observed that neither metabolite prevented the morphological deformities induced by
PCB-126, however, 20 µM 4-PCB-11-Sulfate significantly reduced EROD activity to
similar levels as in the DMSO exposure group. To investigate whether this reduction also
occurred at the gene transcript level, RT-qPCR to look at ahr2 and cyp1a was performed
on pooled groups of 4 dpf zebrafish that had been exposed to either DMSO, 20 µM 4PCB-11-Sulfate, 20 µM 4-PCB-11-Sulfate + 5 nM PCB-126, or 5 nM PCB-126. Both
exposure groups containing PCB-126 induced about a 1.5-fold change increase in ahr2
and a 150-fold change increase in cyp1a transcript levels (Figure 3.4F), with no
significant differences between the co-exposure group and the group containing PCB-126
alone; thus, 20 µM 4-PCB-11-Sulfate did not inhibit the expression of ahr2 or cyp1a
induced by PCB-126.
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Figure 3.4: Zebrafish exposed to 5 nM PCB-126 and either 0.002-0.2 µM 4-OHPCB-11 or 0.2-20 µM 4-PCB-11-Sulfate from 1-4 dpf. A) Body length, B) EROD
quantification, C) pericardial area, and D) swim bladder inflation (mean±SEM, n=6 vials
of 3-5 pooled larvae per exposure group across 3 experiments, ANOVA with Tukey’s
post-hoc test, p<0.05). E) representative images of whole zebrafish and EROD activity.
The white arrow indicates a significant loss of EROD activity. F) Gene expression for
ahr2 and cyp1a is shown for zebrafish exposed to either DMSO, 20 µM 4-PCB-11Sulfate, 20 µM 4-PCB-11-Sulfate + 5 nM PCB-126, or 5 nM PCB-126, using b-actin as a
housekeeping gene (mean±SEM, n=3-4 sets of 4 pooled vials of 4-5 larvae per exposure
group across 4 experiments, ANOVA with Tukey’s post-hoc test, p<0.05).
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In another experiment to probe whether either metabolite would inhibit Cyp1a
activity and result in toxicological outcomes in co-exposures with B[a]P, zebrafish were
exposed under static conditions from 1-4 dpf to either DMSO, 100 µg/L B[a]P, or 100
µg/L B[a]P in combination with either 0.002-0.2 µM 4-OH-PCB-11 or 0.2-20 µM 4PCB-11-Sulfate, and then morphology and EROD activity were measured. At 4 dpf,
zebrafish exposed to 100 µg/L B[a]P developed normally (Figure 3.5A) with a 140%
increase in EROD activity (Figure 3.5B), and normal pericardial area (Figure 3.5C) and
swim bladder inflation (Figure 3.5D). 20 µM 4-PCB-11-Sulfate significantly reduced the
B[a]P-induced EROD activity to levels observed in the DMSO exposure group, however,
this did not result in morphological deformities for the fish; these morphological and
EROD activity outcomes are shown in Figure 3.5E, and additional representative images
can be found in Appendix Q. In separate experiments we also verified that EROD activity
induced by BNF could be inhibited by 20 µM 4-PCB-11-Sulfate without resulting in
morphological deformities (Appendix R). To investigate whether inhibition of Cyp1a
induced by B[a]P also occurred at the gene transcript level, RT-qPCR to look at ahr2 and
cyp1a was performed on pooled groups of 4 dpf zebrafish that had been exposed to either
DMSO, 20 µM 4-PCB-11-Sulfate, 20 µM 4-PCB-11-Sulfate + 100 µg/L B[a]P, or 100
µg/L B[a]P. Both exposure groups containing B[a]P induced about a 1.6-fold change
increase in ahr2 and a 37-fold change increase in cyp1a transcript levels (Figure 3.5F),
with no significant differences between the co-exposure group and the group containing
B[a]P alone; thus, 20 µM 4-PCB-11-Sulfate did not inhibit the expression of ahr2 or
cyp1a induced by 100 µg/L B[a]P.
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Figure 3.5: Zebrafish exposed to 100 µg/L B[a]P and either 0.002-0.2 µM 4-OHPCB-11 or 0.2-20 µM 4-PCB-11-Sulfate from 1-4 dpf. A) Body length, B) EROD
quantification, C) pericardial area, and D) swim bladder inflation (mean±SEM, n=5-6
vials of 3-5 pooled larvae across 3 experiments per exposure group, ANOVA with
Tukey’s post-hoc test, p<0.05). E) representative images of whole zebrafish and EROD
activity. The white arrow indicates a significant loss of EROD activity and lack of swim
bladder inflation. F) Gene expression for ahr2 and cyp1a is shown for zebrafish exposed
to either DMSO, 20 µM 4-PCB-11-Sulfate, 20 µM 4-PCB-11-Sulfate + 100 µg/L B[a]P,
or 100 µg/L B[a]P, using b-actin as a housekeeping gene (mean±SEM, n=3-4 sets of 4

63

pooled vials of 4-5 larvae per exposure group across 4 experiments, ANOVA with
Tukey’s post-hoc test, p<0.05).
3.4 4-PCB-11-Sulfate increases hepatic neutral lipid accumulation
In previous work, we found that zebrafish exposures to 20 µM PCB-11 from 1-4
dpf misregulated genes involved with lipid metabolism, and appeared to increase vacuole
formation in liver tissue (111). In this study, zebrafish were exposed to either DMSO or
0.2 µM concentrations of PCB-11, 4-OH-PCB-11, or 4-PCB-11-Sulfate under a chronic
exposure paradigm from 1-15 dpf and then collected for ORO staining. We found that 0.2
µM 4-PCB-11-Sulfate significantly increased hepatic lipid accumulation in zebrafish by
30% compared to zebrafish exposed to DMSO (Figures 3.6A-B). In a subsequent
experiment, zebrafish were exposed to either DMSO, 10 µg/L B[a]P, or 10 µg/L B[a]P in
combination with either 0.002, 0.02, or 0.2 µM 4-PCB-11-Sulfate under chronic exposure
conditions from 1-15 dpf. We found that zebrafish exposed to 10 µg/L B[a]P experienced
a non-significant 18% increase in hepatic neutral lipid accumulation, and a dosedependent increase in hepatic lipid accumulation for the co-exposure groups of 11%,
20%, and 44%, with significance for the highest concentration exposure group of 10 µg/L
B[a]P + 0.2 µM 4-PCB-11-Sulfate (Figures 3.6C-D). Additional representative images
for these 15 dpf experiments can be found in Appendix S. Lipid accumulation was also
analyzed for the brain region of each fish, but these increases were not significant for
either experiment (Appendix T).
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Figure 3.6: Zebrafish exposed to single and co-exposures to PCB-11 or metabolites
for 1-15 dpf and evaluated for lipid accumulation. A) Representative images and B)
quantification of ORO staining of zebrafish exposed to either DMSO, 0.2 µM PCB-11,
0.2 µM 4-OH-PCB-11, or 0.2 µM 4-PCB-11-Sulfate from 1-15 dpf (mean±SEM, n=4551 fish per exposure group across 3 experiments, ANOVA with Tukey’s post-hoc test,
p<0.05). The black arrow points to the liver area of the exposure group where
significance was observed. C) Representative images and D) quantification of ORO
staining of zebrafish exposed to either DMSO, 10 µg/L B[a]P, or 10 µg/L B[a]P in
combination with 0.002-0.2 µM 4-PCB-11-Sulfate from 1-15 dpf (mean±SEM, n=37-42
fish per exposure group across 3 experiments, ANOVA with Tukey’s post-hoc test,
p<0.05). The black arrows point to the liver area of the exposure group where
significance was observed. Background contrasting (+20% for single exposure images
and +40% for co-exposure images) was made in the same way for all images for better
clarity.

3.5. Discussion
In this study, two prevalent PCB-11 metabolites, 4-OH-PCB-11 and 4-PCB-11Sulfate, were investigated using the zebrafish model to understand how they affect the
Ahr pathway in larval zebrafish under an acute exposure paradigm, and how they affect
hepatic lipid accumulation in juvenile zebrafish under a chronic exposure paradigm.
PCB-11 is a lower-chlorinated congener that is a byproduct in the manufacturing of many
consumer products, most notably diarylide azo-type pigments, but has only recently
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undergone investigation as a potential public health risk (11). While PCB-11 has been
detected in many water bodies downstream of wastewater treatment plants or industrial
manufacturing (10, 66), it is thought that most of human exposures to PCB-11 occur
through inhalation due to its semi-volatile nature (18, 24). Once inhaled, PCB-11 travels
to the bloodstream and undergoes metabolism in the liver, where metabolites are either
excreted, distributed throughout the body, or further metabolized (124) (Figure 3.1). We
previously used the zebrafish model to conduct waterborne PCB-11 exposures where we
were able to measure PCB-11 reduction in exposure water, uptake into larval tissue, and
toxicological effects (111). In this study, we conducted similar exposures of the 4-OHPCB-11 and 4-PCB-11-Sulfate metabolites to understand whether these metabolites drive
the Ahr pathway effects we observed previously, and to understand whether there would
be longer term hepatic effects after lower-concentration chronic exposures.
In our previous work, we observed that in combination with 50 µg/L BNF, 20 µM
PCB-11 partially inhibited both cyp1a gene transcription and Cyp1a enzyme activity and
resulted in severe toxicological outcomes (111). In this study we used B[a]P as a more
environmentally relevant chemical to probe PCB-11 and metabolite interactions with
Cyp1a activity. In contrast with 50 µg/L BNF co-exposures, 20 µM PCB-11 did not
significantly reduce cyp1a gene expression in co-exposures with 100 µg/L B[a]P,
however, it inhibited the Cyp1a activity (as shown via EROD) induced by B[a]P and still
resulted in severe morphological deformities (Figure 3.2). This could be due to
differences in concentrations used for these two PAHs, where 20 µM PCB-11 may have
been sufficient to inhibit Cyp1a enzyme function induced by 100 µg/L B[a]P but not
sufficient to inhibit cyp1a gene expression; or, there may have been direct inhibition at
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the enzyme level rather than inhibition of transcription via the receptor. Differences could
also exist in receptor-mediated binding between PCB-11 and the two PAHs, as this can
vary greatly between PCB congeners (125).
The PCB-11 metabolites we tested in acute 1-4 dpf single exposures did not
induce changes in Cyp1a activity or morphological outcomes (Figure 3.3). We initially
hypothesized that the 4-OH-PCB-11 metabolite would result in more dramatic effects on
Cyp1a activity, since hydroxylated PCB congener metabolites, including metabolites of
lower-chlorinated and non-dioxin-like congeners can exhibit more potent effects on the
Ahr pathway (116). Pěnčíková et al. reported in a cell culture model that while the parent
PCB-11 compound can have mild effects on Ahr activity, 4-OH-PCB-11 is a significant
inhibitor of Ahr activation (126). Hydroxylated PCB metabolites are potentially more
toxic than their parent compounds (127) and have been reported in human samples in the
same concentration range as parent PCB compounds (32, 112). However, for the
concentrations we tested in our zebrafish model, we did not see any effects on Cyp1a
activity in either single or co-exposure settings, though we did observe increased larvae
lethality for 4-OH-PCB-11 concentrations greater than 0.2 µM, confirming reports that it
is more overtly toxic than the parent compound (127).
While no differences were observed for single exposures of PCB-11 metabolites,
in co-exposure experiments, 20 µM 4-PCB-11-Sulfate inhibited Cyp1a activity, but not
cyp1a gene transcription induced by either 5 nM PCB-126 (Figure 4) or 100 µg/L B[a]P
(Figure 3.5). As with the parent PCB-11 compound co-exposure experiments, this could
again be a PAH concentration-specific outcome. However, 5 nM PCB-126 was also used
as an Ahr agonist in co-exposure experiments and we observed that while 20 µM PCB-11
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significantly reduced both cyp1a gene transcription and Cyp1a enzyme activity (111), 20
µM 4-PCB-11-Sulfate only significantly reduced Cyp1a activity. The main difference
between PCB-11 and 4-PCB-11-Sulfate co-exposure outcomes was that PCB-11 Cyp1a
activity inhibition corresponded to severe morphological deformities for zebrafish larvae,
whereas 4-PCB-11-Sulfate Cyp1a activity inhibition did not. From these results it is clear
that toxicity outcomes differ between the parent and metabolite PCB-11 compounds, and
that Cyp1a inhibition is not a requirement for toxicological outcomes.
Interestingly, when we subsequently tested co-exposures of PCB-11 metabolites
with 50 µg/L BNF in this study, we also observed that 20 µM 4-PCB-11-Sulfate inhibited
Cyp1a activity without causing toxicity (Appendix R). One possibility is that the enzyme
kinetics between the parent PCB-11 compound and sulfate metabolite are different,
where an irreversible inhibition occurs with the parent compound, leading to
toxicological outcomes, but a reversible inhibition occurs with the metabolite (128),
which allows for normal development. Another possibility is that research groups have
clearly demonstrated the toxicological outcomes that occur via Ahr-dependent Cyp1a
enzyme inhibition (58, 59), but that despite Cyp1a inhibition, other enzymes such as
Cyp1b1 or Cyp1c1, could play a role in metabolizing PAH Ahr agonists (129). For
instance, in a cell culture model PCB-11 has been shown to be a constitutive androstane
receptor (CAR) agonist, increasing Cyp2b6 mRNA levels (126). In addition, inhibition of
Cyp1a activity in the presence of non-PAH Ahr agonists such as PCB-126 or 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) has been shown not to influence toxicity, since
neither of these substrates is metabolized by Cyp1a. Overall, more research is needed to
understand how PCB-11 and its metabolites activate and affect hepatic enzyme function.
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Not many studies have yet explored how lower-chlorinated PCBs like PCB-11,
and their metabolites, interact with the Ahr pathway and affect lipid biology. Alam et al.
investigated how exposures of 4-OH-PCB-11 in cells demonstrated a protective role of
functional sirtuin 3 (SIRT3), without which cells exposed to low µM concentrations 4OH-PCB-11 had increased mitochondrial respiration and increased expression of genes
controlling fatty acid biosynthesis, metabolism, and transport (46). In the present study,
we saw an increase in hepatic neutral lipids in fish that were exposed to both single
exposures of 20 µM 4-PCB-11-Sulfate and co-exposures with 10 µg/L B[a]P (Figure
3.5). Dioxin-like PCBs like PCB-126 misregulate adipose biology by increasing free fatty
acids and triglycerides, leading to a non-alcoholic fatty liver disease (NAFLD)
phenotype. In a rodent model some of the root causes of NAFLD after exposures to
dioxin-like PCBs is differential regulation of genes like patatin-like phospholipase
domain-containing protein 3 (pnpla3) and the hepatokine fibroblast growth factor 21
(fgf21). However, non-dioxin-like PCBs have also disrupted the regulation of these genes
(38), perhaps through crosstalk with other transcription factors that affect lipid
metabolism and lead to downstream changes in physiological function (130).
Specifically, an AHR-FGF21 regulatory axis has been established, showing that a
properly-functioning Ahr controls fgf21 signaling, which in turn partially controls the
regulation of the peroxisome proliferator-activator receptor a (ppara) gene, among other
metabolically important genes (40, 41). Other research has also shown that Cyp1a
activation by B[a]P inhibits 17b-estradiol (E2), which subsequently reduces the
expression of PPARa and increases the expression of adipogenic genes (131). We
observed from our previous RNAseq experiment that single exposures to 20 µM PCB-11
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significantly increased cyp1a gene transcription 2.35-fold change, and this corresponded
to significant downregulation 0.57-fold of sterol regulatory element-binding transcription
factor 1 (srebf1) and upregulation 1.38-fold of fatty acid binding protein 10a (fabp10a),
as well as overall downregulation of the KEGG fatty acid metabolism pathway when we
did a bioinformatics analysis (111),
PCB-11 and its metabolites have also been shown to affect endocrine activity in
cell culture models, demonstrating full or partial agonist and antagonist activity against
the androgen receptor (AR) and estrogenic receptor (ER) (42, 43, 126). While our group
has not specifically focused on hormone receptor effects, in our previous RNAseq
experiment we found that one of the most significantly misregulated genes after zebrafish
exposures to 20 µM PCB-11 was the parathyroid hormone 1a (pth1a) gene (111),
orthologous to human parathyroid hormone and important for calcium ion homeostasis.
Other research groups have shown that 4-PCB-11-Sulfate is a high affinity ligand of the
thyroid hormone transport protein transthyretin (TTR) and can cross into brain tissue (28,
45). TTR is a thyroid hormone binding plasma protein that is primarily synthesized in the
liver and plays an important role in transporting thyroxine (T4) to tissues throughout the
body, including the brain (132) and the placenta (133), where it is converted into the
active thyroid hormone triiodothyronine (T3). Many parent PCB congeners, and
particularly their hydroxylated metabolites, have been established as high-affinity TTR
ligands (134) to cause reductions in T4 concentrations in rodent plasma and forebrain
samples (135). Thus, it is interesting that 4-PCB-11-Sulfate also has the ability to do this.
While we originally did not plan to investigate brain-specific outcomes in this study, we
noticed potential differences between exposure groups in brain lipid accumulation, and
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while we did observe an increase in lipid accumulation to nearly the same degree in fish
exposed to 0.2 µM 4-PCB-11-Sulfate alone, and a dose-dependent increase in lipid
accumulation in fish co-exposed to 4-PCB-11-Sulfate + 10 µg/L B[a]P, these increases
were not statistically significant (Appendix T).
In this present study, we tested a wide range of PCB-11, 4-OH-PCB-11, and 4PCB-11-Sulfate concentrations. For the 15 dpf chronic exposure experiments, we
observed significant effects on hepatic lipid accumulation for 4-PCB-11-Sulfate at 0.2
µM. For the 4 dpf acute exposure experiments, we observed significant effects on Cyp1a
activity for 4-PCB-11-Sulfate at 20 µM. These concentrations at which we observed
significant effects are the concentrations of the exposure water and do not reflect internal
body concentrations. Our goal was to emulate internal body concentrations in zebrafish
that would be observed in human serum. While in this study we did not measure how
much of the PCB-11 metabolites in the water were taken up into fish tissue, we did
measure parental PCB-11 uptake in our previous study, where only 0.61% of the PCB-11
in the exposure water was observed in whole body fish tissue at the 4 dpf collection time
(111). If 4-PCB-11-Sulfate uptake into zebrafish tissue is similar to the parental PCB-11
compound, the resulting internal body concentrations from 20 µM water exposures is 2x
the 4-PCB-11-Sulfate concentration reported in human serum (61 nM), and the resulting
internal body concentration from 0.2 µM 4-PCB-11-Sulfate, at which we observed
significant hepatic lipid accumulation, is well within this reported range (30). However,
further research is needed to understand how larval and juvenile stages of zebrafish
metabolize lower-chlorinated PCB congeners.
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This present research highlights the importance of conducting mixtures
assessments of environmental chemicals, as exposures to lower-chlorinated PCB
congeners such as PCB-11 are not likely to occur in isolation. In addition, while it is
important to understand how acute exposures to PCB-11 can affect hepatic enzyme
function in the presence of other chemicals, it is perhaps more important to understand
how lower-concentration chronic exposures to PCB-11 in combination with other
environmentally relevant compounds can affect adipose biology and other endpoints over
time. For instance, NAFLD affects around 25% of the world population and has an
enormous economic burden in many countries (136, 137). It is now recognized that
environmental chemicals play a role in toxicant-induced steatohepatitis (TASH) (138).
Additional work to gather gene-level and tissue-level data on how PCB-11 and its
metabolites affect hepatic lipid biology at different developmental time points would
better illustrate PCB-11’s potential contributions to liver disease development.

3.6. Conclusions
In this study, two prevalent PCB-11 metabolites, 4-OH-PCB-11 and 4-PCB-11Sulfate, were tested in the zebrafish model under an acute exposure paradigm to assess
their effects on Cyp1a activity, and under a lower-concentration chronic exposure
paradigm to assess their effects on hepatic lipid accumulation. Our results show that 20
µM 4-PCB-11-Sulfate inhibited Cyp1a activity induced by Ahr agonists, and that 0.2 µM
4-PCB-11-Sulfate increased hepatic lipid accumulation. Further long-term studies with
the 4-PCB-11-Sulfate metabolite would be beneficial to better understand its public
health risk.
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CHAPTER 4
NRF2A DEPENDENT AND INDEPENDENT EFFECTS OF EARLY LIFE
EXPOSURE TO 3,3’-DICHLOROBIPHENYL (PCB-11) IN ZEBRAFISH (DANIO
RERIO)
In preparation for submission from:
Roy MA, Gridley CK, Li S, Park Y, Timme-Laragy AR. Nrf2A dependent and
independent effects of early life exposure to 3,3’-dichlorobiphenyl in zebrafish (Danio
rerio).

4.1 Abstract
The environmental pollutant 3,3’-dichlorobiphenyl (PCB-11) is a lowerchlorinated polychlorinated biphenyl (PCB) congener present in air and water samples.
Both PCB-11 and its metabolite, 4-PCB-11-Sulfate, are detected in humans, including in
pregnant women. Previous research in zebrafish (Danio rerio) has shown that 20 μM
exposures to PCB-11 or 4-PCB-11-Sulfate starting at 1 day post fertilization (dpf) inhibit
Cyp1a enzyme activity and increase hepatic neutral lipid accumulation in larvae. Here,
we explored whether oxidative stress contributes to the metabolic impacts of PCB-11
using transgenic and mutant zebrafish expressing GFP in pancreatic β-cells Tg(ins:GFP)
crossed with homozygous Wildtype or Mutant nrf2afh318/fh318 embryos with a mutation in
the DNA binding domain of the transcription factor Nrf2, known as the master-regulator
of the adaptive response to oxidative stress. Exposures were conducted from 1-4 dpf with
either 0.2-20 µM PCB-11 or 4-PCB-11-Sulfate, and a co-exposure experiment was
conducted for 0.2-20 µM PCB-11 + 100 µg/L benzo[a]pyrene (B[a]P), and at 4 dpf
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morphology and hepatic Cyp1a enzyme activity were captured in vivo with the
ethoxyresorufin-O-deethylase (EROD) assay. In a separate experiment, Nrf2a Wildtype
and Mutant embryos were exposed from 1-15 dpf to either 0.2 µM 4-PCB-11-Sulfate or
0.05% DMSO, and at 15 dpf subsets of larvae were imaged for overall morphology, βcells in the Islet of Langerhans, and collected for fatty acid profiling and RNAseq. In the
4-day experiments, both exposure and genotype effects were observed. Fish regardless of
genotype exposed to 20 µM PCB-11 or 4-PCB-11-Sulfate experienced reductions in
Cyp1a enzyme activity, and Nrf2a Mutant fish regardless of exposure had 48-113%
increased EROD activity and increased toxicity compared to Wildtype fish, but no
interaction effects were observed. In the 15-day experiments, 80-85% survival was
observed for fish exposed to 4-PCB-11-Sulfate, significantly more than the 65-73%
survival for fish exposed to DMSO. At 15 dpf, exposed fish also had primary pancreatic
islets 10% larger compared to unexposed fish. Nrf2a Mutant fish regardless of exposure
were significantly 3-5% shorter than Nrf2a Wildtype fish, and Nrf2a Mutant fish exposed
to 4-PCB-11-Sulfate experienced a significant 29% decrease in the Omega-3 fatty acid
DHA compared to unexposed Nrf2a Mutant fish. RNAseq revealed 308 differentially
expressed genes, most of which were driven by genotype. These findings suggest that
Nrf2a confers some protection under exposures to PCB-11 or 4-PCB-11-Sulfate, but that
it plays an important role in growth as well as for DHA production in the presence of 4PCB-11-Sulfate. Further research would be beneficial to understand the importance of
Nrf2a throughout the lifecourse, especially in the context of toxicant exposure.

75

4.2. Introduction
The environmental pollutant 3,3’-dichlorobiphenyl (PCB-11) is a semi-volatile
polychlorinated biphenyl (PCB) congener that is one of most abundantly detected PCBs
in indoor and outdoor air samples (22, 24). PCB-11 is most notably generated as an
inadvertent byproduct in industrial azo-type yellow pigment manufacturing through the
use of its parent compound 3,3’-dichlorobenzidine, where PCB-11 is released into the
environment during manufacturing or later through the breakdown of products it is found
in (11, 18). Inhalation is a major route of exposure for humans, and both PCB-11 and one
of its major metabolites, 4-PCB-11-Sulfate, have been detected in human serum,
including in pregnant women (30, 31, 33). Higher-chlorinated and dioxin-like (co-planar)
PCBs are well-established as causing toxicity to humans, however, very little in vivo
toxicity data exists examining lower-chlorinated PCBs like PCB-11. Of particular interest
are interactions with the aryl hydrocarbon receptor (Ahr) pathway, which mediates the
toxicity of co-planar PCBs and other toxicants that co-occur in the environment.
The Ahr pathway is a major route through which dioxin-like PCBs and high
molecular-weight polycyclic aromatic hydrocarbons (PAHs) interact with to either exert
toxicity or to become neutralized as part of the body’s toxicological defense system.
These chemicals can bind to the Ahr, a basic helix-loop-helix/per-Arnt-sim (bHLH/PAS)
transcription factor family member, in the cytosol where it is bound to co-chaperones
heat shock protein 90 (HSP90), HSP90-interacting protein 23 (p23), and hepatitis B viris
X-associated protein 2 (XAP2) (69-71). Upon ligand binding, the Ahr translocates to the
nucleus, dissociates from its chaperone complex (4), and forms a heterodimer with the
Ahr nuclear translocator (ARNT) (5) before binding to the xenobiotic response element
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(XRE) to upregulate genes important for environmental chemical metabolism, like
Cytochrome p450 (Cyp) 1a, or cyp1a. The Ahr pathway is largely conserved between
humans and zebrafish, though genome duplication in zebrafish has given rise to several
Ahr genes such as ahr1a, ahr1b, and ahr2 (114). Zebrafish ahr2 is most predictive of
human Ahr2 responses (74), and zebrafish cyp1a is the most highly inducible member of
the Cyp1 family and is similar to human Cyp1a1 and Cyp1a2 induction via the Ahr (76,
80, 115). Many environmental PAHs like benzo[a]pyrene (B[a]P) induce Cyp1a activity
and are good substrates for Cyp1a biotransformation into more hydrophilic substrates, so
that zebrafish embryos that are exposed to 100 µg/L B[a]P between 1-4 days post
fertilization (dpf) develop phenotypically normal (139). However, other environmental
chemicals like 3,3’,4,4’,5-pentachlorobiphenyl (PCB-126) are Ahr agonists that induce
Cyp1a but are not good substrates for Cyp1a biotransformation. For example, 5 nM PCB126 exposures between 1-4 dpf induce Cyp1a in zebrafish embryos but result in a
collection of deformities such as reduced length, pericardial edema, craniofacial
malformations, and failure of the swim bladder to inflate (53, 111).
Cyp1a enzyme activity can be measured in vivo in zebrafish using the wellestablished ethoxyresorufin-O-deethylase (EROD) assay. Upon developmental exposures
to the environmental chemical of interest, zebrafish embryos are also exposed to the
substrate 7-ethoxyresorufin-O-deethylase (7-ER), which is cleaved by activated Cyp1a to
resorufin and can then be visualized and imaged using a fluorescence microscope (58,
81). Recently, we reported that developmental exposures in larval zebrafish from 1-4 dpf
to 20 µM PCB-11 in combination with other Ahr agonists impeded hepatic Cyp1a
enzyme function, leading to severe toxicological outcomes (111). We also found that 20
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µM exposures to the metabolite 4-PCB-11-Sulfate suppressed Cyp1a enzyme function,
but without resulting in toxicity (139). Inhibition of the catalytic cycle of the Cyp1a
enzyme via uncoupling has been known to generate reactive oxygen species (ROS) (57,
140), which could then activate the Nuclear Factor Erythroid 2-like-2 (Nrf2) pathway.
Nrf2 is a master-regulator of the adaptive response to oxidative stress, employing
glutathione (GSH) in its reduced and oxidized disulfide (GSSH) form as a redox
buffering system to manage both endogenous fluctuations in reactive oxygen species
(ROS) and exogenous environmental chemicals that increase ROS (141, 142). Increased
cytosolic ROS levels stimulate Nrf2 nuclear translocation to bind with the antioxidant
response element (ARE), upregulating a battery of target genes to support a return to a
homeostatic redox range (60, 143). Crosstalk between the Ahr pathway and the Nrf2
pathway has been studied previously (144, 145), and our lab has documented this
crosstalk with PCB-126 exposures in zebrafish, where Mutant fish without functional
Nrf2a experienced significantly more Cyp1a induction and toxicity compared to Nrf2a
Wildtype fish (93).
Nrf2 also plays an important role in embryonic development through the tight
control of redox states at specific stages of cell proliferation and differentiation (146,
147). Zebrafish are a useful model for probing Nrf2, and though genome duplication in
zebrafish has given rise to nrf2a and nrf2b orthologs, nrf2a is the canonical activator of
ARE in response to ROS, while nrf2b plays a negative regulatory role of several key
genes during development (148). Zebrafish with both a loss-of-function mutation for
Nrf2a and that have transgenic labels in specific cells are available for studying the role
of Nrf2a in specific organs in response to environmental chemicals (63, 149).
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In this study, the hypothesis tested was that Nrf2a plays a protective role both in
the toxicity response after Cyp1a enzyme inhibition from PCB-11 or 4-PCB-11-Sulfate
as well as plays a protective role in longer-term chronic exposures to 4-PCB-11-Sulfate.
We investigated the role of Nrf2a in PCB-11 mediated toxicity under two different
exposure settings. First, we examined Cyp1a activity under Nrf2a in 0-20 µM exposures
to PCB-11 or 4-PCB-11-Sulfate between 1-4 dpf. Second, we examined Nrf2a influence
on several metabolic-related endpoints after daily exposure to a lower 0.2 µM
concentration of 4-PCB-11-Sulfate between 1-15 dpf. This latter exposure paradigm was
chosen because of previous work showing that chronic exposures to 0.2 µM 4-PCB-11Sulfate from 1-15 dpf increased hepatic neutral lipid accumulation (139). Our main
objectives for the 15 dpf exposures were to explore the role of Nrf2a on fish development
to a juvenile stage, and to investigate the role of Nrf2a on metabolic-related endpoints
given the presence of a toxicant like 4-PCB-11-Sulfate. At 15 dpf, we also collected
samples for RNAseq to gain a broader understanding of the role of Nrf2a during
development, and in the context of a prevalent environmental chemical.

4.3. Materials and Methods
4.3.1 Animal Care
Zebrafish (Danio rerio) with a loss-of-function nrf2afh318-/- mutation (51) were
generated through the TILLING mutagenesis project (R01 HD076585), obtained as
homozygous embryos from Dr. Mark Hahn at the Woods Hole Oceanographic
Institution, and genotypes were confirmed by PCR as previously described (93). In the
Timme-Laragy lab, Wildtype and Mutant nrf2afh318-/- zebrafish were crossed with
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Tg(ins:GFP) transgenic zebrafish with an AB strain background expressing GFP in
pancreatic β-cells to create the Tg(ins:GFP;nrf2afh318+/+) and Tg(ins:GFP;nrf2afh318-/-)
zebrafish lines. These two zebrafish lines were used for experiments described in this
manuscript, and for simplicity are referred to as “Nrf2a W” for the homozygous Wildtype
Tg(ins:GFP;nrf2afh318+/+) line and “Nrf2a M” for the homozygous Mutant
Tg(ins:GFP;nrf2afh318-/-) zebrafish line in the figures.
Adult zebrafish were housed on a 14:10 h light:dark cycle in a recirculating
Aquaneering system (San Diego, CA) maintained at 28.5 ̊C and fed twice daily with
GEMMA Micro 300 (Skretting, Westbrook, ME). Embryos were collected from tanks
with a 2:1 female:male ratio within 3 hours of breeding, and then were rinsed and stored
at low density in 0.3x Danieau’s media [17 mM NaCl, 2 mM KCl, 0.12 mM MgSO4, 1.8
mM Ca(NO3)2, 1.5 mM HEPES, pH 7.6] in an incubator with the same temperature and
light conditions as the adult fish. At 1 dpf, embryos were manually dechorionated using
Watchmaker’s forceps and screened for normal development before use in experiments.
All animal care and experiments were conducted in accordance with protocols approved
by the University of Massachusetts Amherst Institutional Animal Care and Use
Committee (IACUC; Protocol Number 2019-0067). Animals were treated humanely with
due consideration to the alleviation of stress and discomfort.

4.3.2 Chemicals
3,3’,4,4’,5-pentachlorobiphenyl (PCB-126) was purchased from Ultra Scientific
(North Kingstown, RI), benzo[a]pyrene (B[a]P) from Sigma-Aldrich (St. Louis, MO),
and 7-ethoxyresorufin-O-deethylase (7-ER) from MP Biomedicals (Solon, OH). 3,3’-
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dichlorobiphenyl (PCB-11) and 3,3′-dichloro-4-sulfooxy-biphenyl (4-PCB-11-Sulfate)
were synthesized at the Iowa Superfund Research Program (Iowa City, IA) via the Suzuki
coupling reaction as described (45, 118). The authentication of these compounds
followed guidelines established previously (119) and is documented elsewhere (33). The
solubility of PCB-11 in water is 354 µg/L (90) and its octanol-water partition coefficient
is log 5.28 (91). All chemicals were dissolved in 100% dimethyl sulfoxide (DMSO) from
Fisher Scientific (Fair Lawn, NJ), stored as stock solutions in glass amber vials at -20°C,
and were fully thawed and vortexed before use.

4.3.3 Chemical Exposures
For all experiments, the final concentrations of PCB-11 and 4-PCB-11-Sulfate
used in this study ranged from 0.2-20 µM. Higher exposure concentrations were used in
the 4 day EROD experiments to compare the influence of Nrf2a on effects of the parent
and metabolite compounds observed in our previous work (111, 139), and are comparable
to concentrations used in other rodent and cell culture studies (33, 46). Lower 0.2 µM
concentrations were used in the 15-day experiments to mimic environmental and tissue
concentrations observed in other studies (30, 31), and for comparison with our previous
work (139). These concentrations are several orders of magnitude higher than the
concentrations found in the environment, however, our previous work has demonstrated
that less than 1% of the original concentrations are taken up into fish tissues (111),
resulting in comparable concentrations to those detected in human samples (30, 31, 33).
For 4-day EROD experiments, Nrf2a Wildtype or Mutant zebrafish were exposed without
solution changes from 1-4 dpf to single exposures of PCB-11 or 4-PCB-11-Sulfate, and a
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co-exposure experiment was carried out with PCB-11 and the Ahr agonist B[a]P. Both
single and co-exposure experiments were carried out alongside exposures to DMSO and
either B[a]P or the Ahr agonist PCB-126 as negative and positive controls, respectively.
During this period of development, ahr2 and cyp1a expression in zebrafish does not
become consistent until 1 dpf (92), when exposures to both 100 µg/L B[a]P (396 nM)
and 5 nM PCB-126 activate the Ahr pathway (7, 120); for PCB-126, 5 nM causes
malformations in zebrafish (93), but for B[a]P, 100 µg/L induces Cyp1a activity which
metabolizes the B[a]P and does not result in any morphological deformities for the fish
(120). For each exposure group, five embryos were placed in 5 mL of 0.3x Danieau’s
media in a 20 mL glass scintillation vial at 1 dpf, each vial containing 2 µL PCB-11
metabolite, Ahr agonist, or DMSO, and 0.5 µL 7-ER for a final DMSO concentration of
0.05% v/v and a final 7-ER concentration of 0.5 µg/L. Each exposure group contained at
least 2 vials, and exposure water was kept static (not changed) from 1-4 dpf. At 4 dpf,
zebrafish were rinsed 3 times with Danieau’s media before imaging. Each experiment
was repeated at least 3 times.
For 15-day experiments, at 1 dpf dechorionated Nrf2a Wildtype or Mutant
embryos were exposed in 5 mL of 0.3x Danieau’s media in 20 mL glass scintillation
vials, with 5 embryos per vial and 4 vials per exposure group. Each vial was dosed with
either DMSO or 0.2 µM 4-PCB-11-Sulfate, with a final DMSO concentration of 0.05%
v/v. Each day from 2-4 dpf, 50% of the media solution was replaced. At 5 dpf, zebrafish
were moved to individual 20 mL glass scintillation vials (1 fish per vial) containing 5 mL
of the appropriate Danieau’s-based media solution. From 6-8 dpf, exposure group
solutions were made in system water obtained from the recirculating Aquaneering system
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housing the adult fish, and 5 mL of the appropriate solution was added to each vial each
day, so that at 8 dpf each vial contained 20 mL of solution. From 9-14 dpf, exposure
group solutions were made in system water and 50% of the solution (10 mL) was
replaced per vial. After solution changes, fish were fed standard juvenile GEMMA Micro
75 (Skretting, Westbrook, ME) fish starting at 5 dpf. This experiment was repeated 8
times for a total of 160 zebrafish per each of the 4 exposure groups. At 10 dpf, 2 of the
experimental replicates were imaged and then returned to their individual vials. At 15
dpf, zebrafish from all experimental replicates were rinsed and then subsets of fish were
imaged live or collected for RNAseq or fatty acid profiling.

4.3.4 Microscopy and Image Analysis
For all imaging, live larvae were sedated by a 10 second exposure to 2% v/v MS222 solution (prepared as 4 mg/mL tricaine powder in water, pH buffered, and stored at 20°C until thawed for use) before being mounted individually in drops of 3%
methylcellulose, with larvae in a left-lateral orientation for EROD imaging of the liver
and in a right-lateral orientation for pancreas imaging. All imaging took place on a Zeiss
Stereo Axio Zoom.V16 equipped with a HXP 200 C light source (Carl Zeiss Inc.). For
EROD experiments with 4 dpf zebrafish, whole organism images were captured under
brightfield settings at 20x total magnification, and the gut region was captured at 100x
under both a brightfield setting and using a red fluorescent protein (RFP) filter. For
chronic exposure experiments, whole organism brightfield images were captured at 20x
and 16x total magnification for 10 dpf and 15 dpf, respectively. For each individual
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experiment capturing EROD, the same exposure time was used for each fish across all
exposure groups within the same experimental replicate.
All images were blinded and then endpoints for body length, EROD light
intensity, pancreatic islet area, and pericardial area and then measured with the Zen Lite
program (Carl Zeiss Inc.). To quantify light intensity for EROD (black and white)
images, the software was used to find the maximum intensity out of the entire image. To
calculate background light intensity, the circle tool was used in a consistent place in each
image and the mean intensity was recorded. To compare fluorescent images between
experimental replicates, both background light intensity and dark pixel intensity (a
calculated constant, (122)) were subtracted from the recorded maximum light intensity
for every image, and then this value was divided by the exposure time. Each experimental
replicate was normalized to its respective DMSO control, and then data from
experimental replicates were merged. EROD activity data in Figures 4.1-4.3 display
exposure groups normalized to their own DMSO control per genotype. Overall, Nrf2a
Mutant fish had slightly less EROD activity compared to Wildtype fish, and the figure in
Appendix U displays EROD activity for Figures 4.1-4.3 where all exposure groups are
normalized to the Nrf2a Wildtype DMSO control.
We measured pericardial area on all 4 dpf zebrafish as a quantitative measurement
to represent overall deformities since pericardial edema is a characteristic outcome of fish
embryos exposed to PCB-126 (95) and other compounds that suppress Cyp1a activity
(59). Swim bladder inflation was scored as 0=not inflated or 1=inflated. All four
measured outcomes for 4 dpf fish were averaged per vial so that each vial of up to 5
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pooled fish was n=1. All measured outcomes for 15 dpf fish were analyzed so that each
fish was n=1 since fish in these experiments were raised in individual vials.

4.3.5 Fatty Acid Profiling
At 15 dpf, 5 fish from each exposure group were collected and pooled into a
single Eppendorf tube for each of 6 experimental replicates to make n=6 per exposure
group. Media in each tube was replaced with 100 µL nanopure water, tubes were placed
on ice for 30s, sonicated with an Emerson Industrial Branson SonifierÒ (Danbury, CT),
and stored at -80°C until processing. Lipids in the homogenized samples were extracted
by CHCl3:MeOH (2:1) (150) and methylated with methanolic HCl (1.5 M) as previously
described (151). Fatty‐acid methyl esters were analyzed on a gas chromatography-mass
spectrometer, GC-MS-QP2010 SE (Shimadzu, Japan), using a Supelcowax-10 column
(100 m, 0.25 mm i.d., 0.25 μm film thickness, Sigma Aldrich, St Louis, MO, USA).
Helium was used as the carrier gas and the column oven temperature started at 50 °C,
increased to 200 °C at 20 °C/min, then to 220 °C at 2 °C/min, and held at 220°C for
162.5 min. The injector was maintained at 220 °C (with split ratio of 1:1). For MS, the
interface was 220°C and ion source was 200°C. An electron ionization (EI) with 70 eV
with full scan mode in 35 to 500 m/z range with 0.3s of scan time were used. The fatty
acid methyl esters were identified by comparing their retention times with the standards
and confirmed by the National Institute of Standards and Technology (NIST) mass
spectrum library. In total, 11 fatty acids were measured. The 4 saturated fatty acids
analyzed were Myristic Acid (14:0), Palmitic Acid (16:0), Stearic Acid (18:0), and
Arachidic Acid (20:0). The 3 monounsaturated fatty acids (MUFAs) analyzed were
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Palmitoleic Acid (16:1n-7), Oleic Acid (18:1n-9), and Vaccenic Acid (18:1n-7). The 4
polyunsaturated fatty acids (PUFAs) analyzed were Linoleic Acid (18:2n-6), Arachidonic
Acid (20:4n-6), Eicosapentaenoic Acid (EPA, 20:5n-3), and Docosahexaenoic Acid
(DHA, 22:6n-3). All other fatty acids not measured were classified together as Other.
Data are reported as relative percentages of the total fatty acids.

4.3.6 RNA isolation, RNA library prep, and RNA sequencing (RNAseq)
At 15 dpf, 5 fish from each exposure group were collected and pooled into a
single Eppendorf tube from each of 3 experimental replicates to make n=3 per exposure
group. Tubes were placed in ice for 30s, media was replaced with 500 µL Trizol, and
then tubes were stored at -80°C until processing. RNA was isolated using the RNA Clean
Concentrate Kit with in-column DNase-I treatment (Zymo Research Corp.), following
manufacturer instructions. The quantity of RNA was assayed on a Qubit using an RNA
BR assay (Life Technologies Corp.), and the quality was assessed on an Agilent 2100
Bioanalyzer using an RNA 6000 Nano Assay (Agilent Technologies Inc). Total RNA
was used to isolate poly(A) mRNA and libraries were prepared using the NEBNextÒ
UltraÔ II Directional RNA Library Prep Kit for Illumina (New England Biolabs)
following the manufacturer instructions. The quantity of the library was assayed using a
Qubit DNA HS assay (Life Technologies Corp.), and the quality was analyzed on a
Bioanalyzer (Agilent Technologies Inc). Libraries were pooled and sequenced on an
Illumina NextSeq 500 platform with 76 bp paired-end sequencing chemistry. Data was
automatically uploaded to the Illumina Basespace platform for further processing.

86

RNAseq data was also uploaded to the NCBI Gene Expression Omnibus (GEO) platform
and can be accessed with the accession # PRJNA718696.

4.3.7 Bioinformatics
Raw fastq sequencing files were downloaded from Basespace and uploaded to the
Galaxy web public server at usegalaxy.org to analyze the data (152). The 4 Forward and
4 Reverse files for each of the 12 samples were concatenated into 1 Forward and 1
Reverse file per sample using the “Concatenate datasets tail-to-head (cat)” tool (153), and
then the “fastp” tool was used for preprocessing quality control and trimming (154). The
zebrafish genome GRCz11 was uploaded to Galaxy from ENSEMBL and was used for
read alignment with the “HISAT2” tool. The “Infer Experiment” and the “Convert GTF
to BED12” tools were used to ensure correct strand alignment, and the “MultiQC” tool
was used to view mapping statistics. The “StringTie” tool was used to create gene count
files, the “DESeq2” was used to run differential gene expression analyses, and the
“Filter” tool was used to view the results for protein coding genes. The “Annotate
DESeq2/DEXSeq output tables”, “Join two datasets”, and “Table Compute” tools were
used to prepare files to generate a heatmap of differential gene expression using the
“heatmap2” tool. The “Gene length and GC content” tool was used to generate files for
the “goseq” tool, which was used for Gene Ontology (GO) and Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway analysis using the built-in GRCz10 zebrafish
genome for the tool. The “Volcano Plot” and “Pathview” tools were also used to view
differential gene expression and pathway analysis, respectively. Galaxy training tutorials
were helpful in completing this analysis (155, 156).
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4.3.8 Statistical Analyses
For 4 dpf and 15 dpf experiments, embryos were analyzed for outliers using the
IQR method (IQR*1.5, 0.25 quartile tails) for body length, EROD, and pericardial area
endpoints, and flagged individual samples were removed completely from all analyses. A
Two-Way Analysis of Variance (ANOVA) with a post-hoc Tukey-Kramer or Student’s ttest was used to identify genotype or toxicant exposure effects for length, EROD,
pericardial area, primary pancreatic islet area, and fatty acid profiling endpoints. DMSO
groups were excluded for analyses investigating genotype effects on EROD activity since
both DMSO groups for each genotype were normalized to 100%. A Log-Rank test was
performed for survival and a Wilcoxon nonparametric test was performed for secondary
islet counts. All statistics were conducted with JMP® Pro software version 15.1.0 (Cary,
NC). The unit of replication for 4 dpf experiments was the vial, containing up to 5 pooled
larvae. The unit of replication for 15 dpf growth and pancreas endpoints was the
individual fish, and the unit of replication for fatty acid profiling and RNAseq at 15 dpf
was pooled groups of 5 fish with n=6 per exposure group for fatty acid profiling and n=3
per exposure group for RNAseq. Statistical significance was considered using a 95%
confidence interval (α=0.05).
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4.4. Results
4.4.1 Suppression of Cyp1a by PCB-11 or 4-PCB-11-Sulfate occurs independently of
Nrf2a
We previously showed that exposure to 20 µM PCB-11 significantly reduces
EROD activity in wildtype AB strain zebrafish and results in mild toxicity outcomes
(111). In this experiment for toxicant exposure only, we also observed 20 µM PCB-11 to
significantly stunt growth by 9% (Figure 4.1A), reduce EROD activity by 61% (Figure
4.1B), increase pericardial area 0.002 mm2 (Figure 4.1D), and prevent swim bladder
inflation (Figure 4.1D) compared to unexposed fish, consistent with previous
observations. Significant genotype effects were observed for length and EROD activity,
with Nrf2a Mutant fish on average 2% shorter and with 48% higher EROD activity
compared to Wildtype fish. Nrf2a Mutant fish exposed to 20 µM PCB-11 also
experienced some tail curvature. An interaction effect was observed for EROD activity of
B[a]P. Both genotypes exposed to B[a]P developed phenotypically normal and Nrf2a
Wildtype fish had significantly higher EROD activity at 69% more than DMSO controls,
however, Nrf2a Mutant fish had significantly higher EROD activity compared to
Wildtype fish exposed to B[a]P at 226% more than fish in the DMSO controls (Figure
4.1B). Representative images of whole fish and EROD activity can be seen in Figure
4.1E.
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Figure 4.1: Individual exposures to 20 µM PCB-11 suppresses EROD activity and
mildly increases toxicity, with greater effects in Nrf2a Mutant fish. Zebrafish
embryos were exposed between 1-4 dpf to 0-20 µM PCB-11; 100 µg/L B[a]P was used
as a positive control for EROD activity. A) length of larvae, B) quantified light intensity
of EROD activity normalized to each DMSO control per genotype, C) pericardial area,
D) swim bladder inflation, and E) representative images of whole body and gut area with
EROD activity in red (mean±SEM, n=5-6 vials of pooled larvae across 3 experiments, 2Way ANOVA with Tukey’s post-hoc test, p<0.05, * indicates a significant exposure
effect compared to DMSO controls, † indicates a significant genotype effect, # indicates a
significant interaction effect, W=Wildtype, M=Mutant).
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A co-exposure experiment was conducted to investigate whether differences
between Nrf2a Wildtype and Mutant groups would be more pronounced in a co-exposure
scenario. In past experiments, we observed that co-exposures of 20 µM PCB-11 + 100
µg/L B[a]P resulted in a significant decrease in EROD activity accompanied by
significant toxicity outcomes (139). In this experiment for toxicant exposure only, we
also observed that co-exposures of 20 µM PCB-11 + 100 µg/L B[a]P significantly
decreased length by 9% (Figure 4.2A), lowered EROD activity by 154% below B[a]P
control fish and by 54% below DMSO control fish (Figure 4.2B), increased pericardial
area by 0.039 mm2 (Figure 4.2C), and resulted in no swim bladder inflation (Figure 4.2D)
compared to unexposed fish. Significant genotype effects were observed for length and
EROD activity, with Nrf2a Mutant fish on average 2% shorter and with 52% higher
EROD activity compared to Wildtype fish. No interaction effects were observed.
Representative images of whole fish and EROD activity can be seen in Figure 4.2E.
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Figure 4.2: 20 µM PCB-11 inhibits EROD activity of B[a]P and significantly
increases toxicity, with more pronounced effects in Nrf2a Mutant fish. Nrf2a
Wildtype and Mutant zebrafish embryos were co-exposed between 1-4 dpf to 0-20 µM
PCB-11 and 100 µg/L B[a]P showing A) length of larvae, B) quantified light intensity of
EROD activity normalized to each DMSO control per genotype, C) pericardial area, D)
swim bladder inflation, and E) representative images of whole body and gut area with
EROD activity in red (mean±SEM, n=5-6 vials of pooled larvae across 3 experiments, 2Way ANOVA with Tukey’s post-hoc test, p<0.05, * indicates a significant exposure
effect compared to DMSO controls, † indicates a significant genotype effect,
W=Wildtype, M=Mutant).
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In addition to the parent PCB-11 compound, we previously observed the 4-PCB11-Sulfate metabolite to reduce EROD activity but without accompanied toxicity (139).
Here, we conducted an experiment to investigate the effects of 4-PCB-11-Sulfate on
Nrf2a Wildtype and Mutant fish. We observed that fish exposed to 20 µM 4-PCB-11Sulfate developed phenotypically normal (Figures 4.3A and 4.3C) and had a nonsignificant 32% decrease in EROD activity (Figure 4.3B). We used 5 nM PCB-126 as a
positive control and this exposure resulted in a significant 10% decrease in length (Figure
4.3A), a 340% increase in EROD activity (Figure 4.3B), a significant 0.040 mm2 increase
in pericardial area (Figure 4.3C), and no swim bladder inflation (Figure 4.3D). We
observed that Nrf2a Mutant fish exposed to PCB-126 had significantly greater toxicity
effects beyond Wildtype fish exposed to PCB-126, in alignment with pericardial area and
cyp1a gene expression results observed previously with Nrf2a Mutant fish exposed to 5
nM PCB-126 (93). Significant genotype effects were observed for EROD activity and
pericardial area, with Nrf2a Mutant fish on average having 113% higher EROD activity
and with 0.001 mm2 more pericardial area compared to Wildtype fish. Interaction effects
were also observed for EROD activity and pericardial area endpoints. Representative
images of whole fish and EROD activity can be seen in Figure 4.3E.
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Figure 4.3: EROD activity and pericardial area are slightly increased for Nrf2a
Mutant fish exposed to 4-PCB-11-Sulfate but are exacerbated in Nrf2a Mutant fish
exposed to PCB-126. Zebrafish embryos were exposed between 1-4 dpf to individual
exposures of 0-20 µM 4-PCB-11-Sulfate or 5 nM PCB-126 showing A) length of larvae,
B) quantified light intensity of EROD activity normalized to each DMSO control per
genotype, C) pericardial area, D) swim bladder inflation, and E) representative images of
whole body and gut area with EROD activity in red (mean±SEM, n=12 vials of pooled
larvae across 6 experiments, 2-Way ANOVA with Tukey’s post-hoc test, p<0.05, *
indicates a significant exposure effect compared to DMSO controls, † indicates a
significant genotype effect, # indicates a significant interaction effect, W=Wildtype,
M=Mutant, 4-PCB-11-SO4=4-PCB-11-Sulfate).
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4.4.2 Daily 4-PCB-11-Sulfate exposures increase larval survival
To investigate the influence of Nrf2a on the effects of chronic exposure to 4-PCB11-Sulfate observed previously (139), we conducted 15-day exposures in Nrf2a Wildtype
and Nrf2a Mutant fish. A total of 8 experiments were conducted with 20 fish in each
exposure group per experiment, raised individually in vials from day 5 through day 15.
Each fish was inspected daily for survival and recorded (Appendix V). We observed that
out of 20 fish per experimental replicate, an average of 16.9 fish, or 85%, of Nrf2a
Wildtype fish and an average of 15.9 fish, or 80%, of Nrf2a Mutant fish exposed to 0.2
µM 4-PCB-11-Sulfate survived to 15 dpf. This was significantly greater than the average
of 14.6 fish, or 73%, of Nrf2a Wildtype fish and the average of 13 fish, or 65%, of Nrf2a
Mutant fish exposed to the DMSO vehicle control that survived to 15 days (Figure 4.4).
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Figure 4.4: Fish under chronic exposures from 1-15 dpf to 0.2 µM 4-PCB-11-Sulfate
survive longer than untreated fish. Zebrafish embryos were exposed daily between 115 dpf to 0.2 µM 4-PCB-11-Sulfate or DMSO and survival was checked every day. At 15
dpf fish exposed to 0.2 µM 4-PCB-11-Sulfate survived significantly better than fish
exposed to DMSO (mean±SEM, n=8 experiments of 20 fish grown in individual vials
from 5-15 dpf, Log-Rank test, p<0.05 at 15 days, W=Wildtype, M=Mutant, 4-PCB-11SO4=4-PCB-11-Sulfate).
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4.3.3 Daily 4-PCB-11-Sulfate exposures increase body length and primary
pancreatic islet area in juvenile development to 15 days
Subsets of Nrf2a Wildtype and Mutant zebrafish exposed daily to DMSO or 0.2
µM 4-PCB-11-Sulfate were imaged at 10 dpf and 15 dpf to investigate exposure and
genotype effects on growth and pancreatic islet development. For exposure effects at 10
dpf, fish exposed to 0.2 µM 4-PCB-11-Sulfate were significantly longer by 4% (Figure
4.5A) and had significantly larger primary pancreatic islet area by 12% (Figure 4.5B)
compared to unexposed fish. Genotype effects were not observed for length but were
observed for pancreatic islet area, with Nrf2a Mutant fish experiencing a significant
decrease in area by 7% compared to Wildtype fish. No interaction effects were observed
for these endpoints at this timepoint, and no differences were observed for the number of
secondary islets (Figure 5C). Representative images of whole fish and islets can be seen
in Figure 5D. At 15 dpf, the increases in length and pancreatic islet area for fish exposed
to 0.2 µM 4-PCB-11-Sulfate persisted, with body length significantly longer at 3%
(Figure 4.5E) and pancreatic islet area significantly longer at 8% (Figure 4.5F) compared
to unexposed fish. Genotype effects were observed for length, where Nrf2a Mutant fish
were significantly shorter by 4%, but were not observed for pancreatic islet area. No
interaction effects were observed for these endpoints at this timepoint, and no differences
were observed between exposure groups for the number of secondary islets (Figure 5G).
Representative images of whole fish and islets can be seen in Figure 4.5H.
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Figure 4.5: Nrf2a is important for growth and 0.2 µM 4-PCB-11-Sulfate increases
overall growth and pancreatic islet area independent of Nrf2a. Zebrafish embryos
were exposed daily between 1-15 dpf to 0.2 µM 4-PCB-11-Sulfate or DMSO in 8
experiments of 20 fish per exposure group. At 10 dpf 2 experiments were imaged for A)
length, B) primary islet area, and C) secondary islet counts (n=33-39 fish per exposure
group across 2 experiments, 2-Way ANOVA with Tukey’s post-hoc test for length and
primary islet area, Wilcoxon non-parametric test for secondary islets, p<0.05). D)
Representative images of whole fish and gut area showing islets at 10 dpf. At 15 dpf fish
subsets of all 8 experiments were imaged for E) length, F) primary islet area, and G)
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secondary islet counts (n=54-88 fish per exposure group across 8 experiments, 2-Way
ANOVA with Tukey’s post-hoc test for length and primary islet area, Wilcoxon nonparametric test for secondary islets, p<0.05). H) Representative images of whole fish and
gut area showing islets at 15 dpf. * indicates a significant exposure effect compared to
DMSO controls, † indicates a significant genotype effect, W=Wildtype, M=Mutant, 4PCB-11-SO4=4-PCB-11-Sulfate.

4.3.4 Daily 4-PCB-11-Sulfate exposures decreases DHA in Nrf2a Mutant larvae
At 15 dpf, fish from each exposure group were analyzed for 11 fatty acids. The 4
saturated fatty acids analyzed were Myristic Acid (14:0), Palmitic Acid (16:0), Stearic
Acid (18:0), and Arachidic Acid (20:0). The 3 monounsaturated fatty acids (MUFAs)
analyzed were Palmitoleic Acid (16:1n-7), Oleic Acid (18:1n-9), and Vaccenic Acid
(18:1n-7). The 4 polyunsaturated fatty acids (PUFAs) analyzed were Linoleic Acid
(18:2n-6), Arachidonic Acid (20:4n-6), Eicosapentaenoic Acid (EPA, 20:5n-3), and
Docosahexaenoic Acid (DHA, 22:6n-3). All other fatty acids not measured were
classified together as Other. Among all exposure groups, saturated fatty acids comprised
57-59%, MUFAs 16-17%, PUFAs 16-20%, and Other fatty acids 7-8% of total fatty acids
(Figure 4.6A). Since more variability was observed for PUFAs, individual fatty acids
within this group were examined more closely. Among the Omega-3 fatty acids, Nrf2a
Mutant fish exposed to 0.2 µM 4-PCB-11-Sulfate experienced a slight decrease in EPA
(Figure 4.6B) and a significant decrease in DHA (Figure 4.6C) compared to Nrf2a
Wildtype fish exposed to 4-PCB-11-Sulfate, representing an interaction effect. Among
the Omega-6 fatty acids, no 4-PCB-11-Sulfate exposure effects, Nrf2a genotype effects,
or interaction effects were detected for Arachidonic Acid (Figure 4.6D) or Linoleic Acid
(Figure 4.6E).
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Figure 4.6: Nrf2a Mutant fish exposed to 0.2 µM 4-PCB-11-Sulfate at 15 dpf have
less DHA than Nrf2a Wildtype fish exposed to 4-PCB-11-Sulfate. Zebrafish embryos
were exposed daily between 1-15 dpf to 0.2 µM 4-PCB-11-Sulfate or DMSO and at 15
dpf 5 embryos were pooled from each exposure group from 6 experiments. A) Fatty acid
composition across Saturated (14:0, 16:0, 18:0, and 20:0), Monounsaturated (MUFAs
16:1n-7, 18:1n-9, and 18:1n-7), Polyunsaturated (PUFAs 18:2n-6, 20:4n-6, 20:5n-3, and
22:6n-3), and Other fatty acids totaling 100% for each exposure group. PUFAs were
examined closer and were compared between exposure groups for B) Eicosapentaenoic
Acid (EPA), C) Docosahexaenoic Acid (DHA), D) Arachidonic Acid, and E) Linoleic
Acid (n=6 of 5 pooled fish per exposure group across 6 experiments, 2-Way ANOVA
with Tukey’s post-hoc test, p<0.05, # indicates a significant interaction effect,
W=Wildtype, M=Mutant, 4-PCB-11-SO4=4-PCB-11-Sulfate).
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4.4.5 Differentially expressed genes in juvenile 15-day fish are a result of Nrf2a
genotype
At 15 dpf, 5 fish from each of the 4 exposure groups were pooled in 3
experimental replicates and underwent RNA sequencing. Raw fastq files were uploaded
to the Galaxy web platform and the analysis pipeline and tools used can be viewed in
Figure 4.7A. The DESeq2 tool was used to perform differential expression analysis of the
25,432 protein coding genes detected. When 4-PCB-11-Sulfate exposure was used as the
primary factor and Nrf2a genotype as the secondary factor in the analysis, no
differentially expressed genes (DEGs) with an adjusted p-value <0.05 were detected.
When Nrf2a genotype was used as the primary factor alone, 338 DEGs were detected,
and when 4-PCB-11-Sulfate exposure was added as the secondary factor in the analysis,
308 DEGs were detected with an adjusted p-value <0.05. Normalized gene counts for the
308 DEGs in each of the 12 samples were transformed to z-scores and are displayed in
Figure 4.7B.
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Figure 4.7: RNAseq pipeline and differential gene expression. A) Galaxy pipeline of
data processing and tools utilized (tool names are in parentheses). B) Z-score normalized
differential gene expression for the 308 DEGs with an adjusted p-value <0.05 for the 12
samples across the 4 exposure groups. Blue colors indicate downregulation and red colors
indicate upregulation.
The entire list of genes and their adjusted p-value <0.05 significance status with
genotype as the primary factor and exposure as the secondary factor (308 DEGs) was
submitted to the goseq tool in Galaxy for detection of enriched GO Molecular Function
(MF), Biological Process (BP), and Cellular Component (CC) categories. We observed
49 categories significantly enriched with an adjusted p-value <0.05 (Appendix W). The
top 10 categories are displayed in Figure 4.8A and reveal categories related to Nrf2a
function such as Oxidoreductase activity and Oxidation-reduction process. The same list
was submitted to goseq for KEGG pathway analysis, and we observed 5 KEGG pathways
that were significantly enriched with adjusted p-values <0.05 and include Glutathione
metabolism, Drug metabolism-cytochrome p450, Metabolic pathways, Metabolism of
xenobiotics by cytochrome p450, and Linoleic acid metabolism (Figure 4.8B). All DEGs
for the KEGG Glutathione metabolism and KEGG Linoleic acid metabolism pathways
are displayed with their fold changes.
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Figure 4.8: RNAseq pathway analysis. A) The top 10 significantly enriched GO
categories of 50 categories with an adjusted p-value <0.05. B) All significantly enriched
KEGG pathways with an adjusted p-value <0.05. DEGs and their log2 fold changes are
shown for the Glutathione metabolism and Linoleic acid metabolism pathways.

4.5. Discussion
In this study, we investigated the role of Nrf2a on Cyp1a inhibition and
metabolic-related outcomes after exposure to PCB-11 or 4-PCB-11-Sulfate. In the three
experiments to observe Cyp1a activity, we confirmed previous work demonstrating that
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20 µM concentrations of PCB-11 or 4-PCB-11-Sulfate reduces Cyp1a activity, and we
also observed significant genotype effects in all three experiments, with Nrf2a Mutant
fish experiencing a 48-113% increased EROD activity response compared to Wildtype
fish (Figures 4.1B, 4.2B, and 4.3B). Genotype effects were also observed for body length
in both individual and co-exposure experiments with PCB-11, with Nrf2a Mutant fish 2%
shorter than Wildtype fish (Figures 4.1A and 4.2A), as well as for pericardial area in
individual exposure experiments with 4-PCB-11-Sulfate, with Nrf2a Mutant fish on
average having 0.001 mm2 more pericardial area than Wildtype fish (Figure 4.3C). No
interaction effects were observed for any of the PCB-11 or 4-PCB-11-Sulfate exposure
groups, but these results indicate that Nrf2a may confer some protection in response to
these toxicants, as well as play a role in early developmental growth.
The Nrf2a results observed with PCB-11 and 4-PCB-11-Sulfate are mild
compared with PCB-126, a coplanar congener and classic Ahr agonist that has been used
to clearly show the crosstalk between the Ahr and Nrf2 pathways (93). In this study, we
also observed that Nrf2a Mutant fish exposed to 5 nM PCB-126 had significantly more
EROD induction beyond Wildtype fish exposed to PCB-126 (Figure 4.3B). This
interaction effect was also observed for the phenotypic response, with Nrf2a Mutant fish
exposed to PCB-126 incurring significantly increased pericardial area beyond Wildtype
fish exposed to 5 nM PCB-126 (Figure 4.3C). Interestingly, an interaction effect was also
observed for B[a]P, the other classic Ahr agonist and PAH used as a positive control. In
the individual exposure experiment with PCB-11, Nrf2a Mutant fish exposed to B[a]P
experienced significantly more EROD induction beyond Wildtype fish exposed to B[a]P.
However, this result was not consistent in the next experiment with PCB-11 co-exposures
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where B[a]P was used as a positive control; in that experiment, while Nrf2a Mutant fish
exposed to B[a]P did have increased EROD activity compared to Wildtype fish exposed
to B[a]P, these activities were not significantly different from each other.
A major focus of this work was to also investigate the role of Nrf2a on
development to a juvenile 15 dpf stage and to investigate its role on metabolic-related
endpoints in the presence of exposures to 4-PCB-11-Sulfate. At 15 dpf, fish exposed to 4PCB-11-Sulfate survived significantly better at 85% and 80% survival for Nrf2a
Wildtype and Mutant fish, respectively, compared to 73% and 65% survival for
unexposed Nrf2a Wildtype and Mutant fish, respectively (Figure 4.4). Additionally, fish
that were exposed to 4-PCB-11-Sulfate grew longer and had significantly larger primary
pancreatic islets at both 10 and 15 dpf compared to unexposed fish (Figure 4.5B and
4.5F). In humans, individuals with either Type 1 or Type 2 diabetes are generally
characterized as having reduced pancreas size (157, 158) and lower life expectancies than
individuals without diabetes (159, 160). However, research in murine models has shown
that during early stages of diabetes onset, the pancreas can undergo compensatory and
temporary b-cell proliferation before an eventual decline in overall beta cell mass and
function (161, 162). It would be interesting to investigate whether the increased growth
and survival results persist for fish exposed to 4-PCB-11-Sulfate at later timepoints.
Interestingly, genotype differences were observed at 10 dpf for pancreatic islet area and
at 15 dpf for body length with Nrf2a Mutant fish having reduced growth for both islet
area and length compared to Wildtype fish, but these genotype effects were not consistent
across timepoints and endpoints, and no interaction effects were observed.
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Previous work in our group has shown that a variety of environmental chemicals
can alter pancreas morphology as well as the expression of both pancreas and redox
related genes in zebrafish. For instance, developmental exposure to either butylparaben or
mono-2-ethylhexyl phthalate (MEHP) significantly altered pancreas and redox related
genes, however, butylparaben significantly increased islet area whereas MEHP
significantly decreased islet area at timepoints within 7 dpf (149, 163). Exposures to the
environmental chemicals perfluorooctanesulfonic acid (PFOS) and
perfluorobutanesulfonic acid (PFBS) have also shown disturbances to pancreas
development (164-166) in timepoints up to 7 dpf, but developmental exposure to PFOS
that ended at 4 dpf resulted in significantly increased islet area and increased hepatic
lipids at 15 dpf (167). Our group has probed the influence of Nrf2a in many of these
exposures, and more carefully on pancreatic b-cell morphogenesis with prooxidant and
antioxidant exposures at different windows of development, indicating that the redox
environment and the role of Nrf2a are important for stable b-cell development (63). Our
observations of increased primary pancreatic islet area after exposure to 4-PCB-11Sulfate may signify impaired pancreas function, as both inflammation and hyperglycemia
are adaptive responses of pre-diabetes in humans (168).
At 15 dpf while 4-PCB-11-Sulfate exposure effects were clearly observed for
survival and pancreatic islet endpoints, Nrf2a genotype differences were more clearly
observed for overall growth, fatty acid profiles, and RNAseq data. We observed that
Nrf2a Mutant fish grown to 15 dpf are 3-5% shorter than their Nrf2a Wildtype
counterparts, which is consistent with observations in a previous study (169) and in an
overview of zebrafish Nrf family members at earlier developmental stages (170). In fatty
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acid profiling, Nrf2a did not seem to play a role in any of the 11 fatty acids analyzed,
however, upon exposure to 4-PCB-11-Sulfate, a trended decrease and significant
decrease was observed for the Omega-3 fatty acids EPA and DHA, respectively (Figures
4.6B and 4.6C). Though variations in the relative percentages of individual fatty acids
fluctuated across the 6 experimental replicates, the decreases observed for DHA were
consistent. DHA is an important fatty acid for brain function and cognitive development
early in life, and may play a role in preventing neurodegenerative disorders (171). DHA
has also been shown to activate Nrf2 to maintain redox balance and neuroprotection upon
toxicant exposures to agrochemicals (172). PCB-11 has already been identified as a threat
to the developing brain via dendritic growth and arborization through cAMP response
element-binding protein (CREB) signaling (17, 48), a transcription factor important for
neurogenesis and cognitive development. Interestingly, it has been shown that DHA
treatment also activates CREB to confer neuroprotection (173), including protection of
the hippocampus associated with diabetes (“diabetic encephalopathy”) through reducing
oxidative stress, inflammation, and apoptosis (174). The results from our current study
indicate that Nrf2a may be protective of DHA synthesis especially in the presence of
environmental chemicals such as 4-PCB-11-Sulfate.
The RNAseq analysis of 15 dpf Nrf2a Wildtype and Mutant fish exposed to
DMSO or 4-PCB-11-Sulfate detected 308 differentially expressed genes (DEGs) with an
adjusted p-value <0.05 (Figure 4.7). Most notably, many of these DEGs were related to
Nrf2a genotype and include a number of downregulated glutathione S-transferase (GST)
genes responsible for conjugating reduced glutathione to a variety of electrophilic
substances for biotransformation. Specifically in this study, GST pi 1 (gstp1, -0.67 log2
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fold change), GST omega 1 (gsto1, -0.49 log2 fold change), GST theta 1a (gstt1a, -0.34
log2 fold change), GST rho (gstr, -0.24 log2 fold change), and microsomal GST 3a
(mgst3a, -0.27 log2 fold change) were all downregulated. The enzyme responsible for
catalyzing oxidized glutathione into its reduced form, glutathione reductase (gsr, -0.37
log2 fold change), and an enzyme responsible in glutathione synthesis, glutamatecysteine ligase, catalytic subunit (gclc, -0.25 log2 fold change), were also downregulated.
An antioxidant enzyme responsible for the removal of reactive oxygen species,
superoxide dismutase 2, mitochondrial (sod2, 0.61 log2 fold change), was upregulated.
When the results of the DEG analysis were submitted for gene ontology (GO) and
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, we observed that
most of the significantly enriched GO categories and KEGG pathways were related to
redox balance (Figure 4.8). However, some GO categories close to the 0.05 cutoff
seemed to indicate the influence of 4-PCB-11-Sulfate exposure. For instance, just after
the adjusted p-value 0.05 cutoff, categories such as “sulfur compound metabolic
process”, “response to toxic substance”, “drug catabolic process”, “response to
xenobiotic stimulus”, and “benzene-containing compound metabolic process”, all with an
adjusted p-value <0.1, were identified (data not shown). In addition, one of the
significantly enriched KEGG pathways was the Linoleic acid metabolism pathway,
which includes 3 DEGs from our analysis: cyp2p10, cyp2j20, and cyp2p9, all
downregulated and potentially related to the increased hepatic lipid accumulation that we
observed previously (139). Both zebrafish cyp2j20 and cyp2p10 genes are orthologous to
the human CYP2J2 gene, which is important in fatty acid metabolism (175). CYP2J2 has
also been identified as a target to reduce inflammation, oxidative stress, and in
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attenuating disease phenotypes, including obesity and non-alcoholic fatty liver disease
(NAFLD) (176, 177).
Recent work by another group has shown that oral exposure to PCB-11 in rodents
is primarily distributed to adipose tissue (29), and in our previous work, we observed that
4-PCB-11-Sulfate significantly increased hepatic neutral lipids in zebrafish at 15 dpf
(139). The liver and the pancreas communicate with each other to regulate blood glucose
levels and hepatic storage via pancreatic insulin-producing b-cells and glucagonproducing a-cells, among other important signaling molecules. We did not detect DEGs
that might explain the increased pancreatic islet area we observed. For instance, no
significant changes in gene expression were detected for pancreatic and duodenal
homeobox 1 (pdx1), pancreas associated transcription factor 1a (ptf1a), preproinsulin
(ins), either of the insulin receptors (insra and insrb), or glucagon (gcga). However, the
brain isoform of glycogen phosphorylase (pygb, -0.28 log2 fold change) was significantly
downregulated. Interestingly, the human ortholog PYGB has been associated with the
acute insulin response to glucose (178) and has been identified as a therapeutic target for
the prevention of various tumor progressions, including hepatocellular carcinoma (179).
Glucagon plays a key role in the liver-pancreas axis, regulating amino acid metabolism
(180), and in human patients with fatty liver disease where glucagon signaling is
disrupted, this has been shown to result in insulin resistance and hyper-glucagonemia
(181). Additionally, out of the 10 solute carrier (SLC) DEGs detected, SLC 2a1a
(slc2a1a, 0.59 log2 fold change, orthologous to human SLC2A1) and SLC 2a2 (slc2a2, 0.34 log2 fold change, orthologous to human SLC2A2) are important for glucose
transport activity and are implicated in Type 2 diabetes (182). Follow-up research that
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presents glucose challenges to the fish in this study would be beneficial to understand the
physiological responses of the islet area and gene expression results that were observed.
Overall, this study examined the role of Nrf2a on development and in the context
of developmental exposures to a prevalent lower-chlorinated PCB congener. We
observed in the 4-day EROD experiments that Nrf2a plays a small role in development
and Cyp1a activity, and a more significant role in development and metabolic-related
endpoints in the 15-day experiments. The differences between these two time points
might point to the role of the yolk sac as providing the embryo with the required nutrition
for growth despite lack of functional Nrf2a, and that Nrf2a plays more of a role in
converting nutrients in external food sources into useable forms for the fish. In this study,
Nrf2a Mutant fish at 15 dpf experienced less growth and less of the Omega-3 fatty acid
DHA, especially when also exposed to 4-PCB-11-Sulfate. In addition, the results of the
RNAseq analysis point to the role of Nrf2a in maintaining redox balance, but also in fatty
acid metabolism and glucose transport. Though the samples collected for RNAseq were
of whole pooled fish, future work that is able to collect single-cell or isolated hepatic or
pancreatic tissue might be more beneficial for understanding the effects of Nrf2a and 4PCB-11-Sulfate on these organs.

4.6. Conclusions
The influence of Nrf2a on PCB-11 or 4-PCB-11-Sulfate mediated Cyp1a
suppression was explored in the zebrafish embryo model in short term exposures between
1-4 dpf, as well as investigated in longer term exposures between 1-15 dpf on
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development and metabolic-related endpoints. We observed that Nrf2a plays a minor
protective role in 1-4 dpf exposures to PCB-11 or 4-PCB-11-Sulfate. However, at 15 dpf
Nrf2a appears important for growth and for DHA synthesis in the presence of 4-PCB-11Sulfate. Fish that were exposed to 4-PCB-11-Sulfate survived significantly better and had
12% larger islets at 10 dpf and 8% larger islets at 15 dpf. The underlying reason behind
these effects remain unclear, though perhaps are in alignment with symptoms of early
onset of diabetes. Several differentially expressed genes with adjusted p-values <0.05
were identified that are involved in fatty acid oxidation, glucose transport, and glucagon
signaling. Further studies that examine adulthood effects of Nrf2a in the context of early
developmental environmental chemical exposure would be beneficial.
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CHAPTER 5
DISCUSSION
Polychlorinated biphenyls (PCBs) have been well-known environmental
contaminants for decades. Despite a 1979 ban that inhibited their commercial
manufacturing (183), they continue to persist in the environment and biomagnify up the
food chain, posing risks to human health. Out of the 209 different PCB congeners, most
toxicity research has been conducted on higher-chlorinated congeners with 4-10 chlorine
atoms on the biphenyl structure, particularly co-planar congeners that were used in
Aroclor mixtures for industrial equipment. Co-planar PCBs are characterized as highaffinity ligands of the Aryl hydrocarbon receptor (Ahr) pathway, through which they
exert toxicity (8). Lower-chlorinated congeners with 1-3 chlorine atoms on the biphenyl
structure were also used in Aroclor mixtures, particularly in mixtures developed to have a
lesser overall chlorine percentage (23), but were considered less hazardous to human
health because they do not activate the Ahr pathway to the same degree as their higherchlorinated counterparts. Even though Aroclor mixtures and PCBs overall are no longer
manufactured, individual lower-chlorinated PCBs are still produced inadvertently today
as byproducts of other industrial manufacturing processes (184). This is allowed since the
parent compounds that are used as manufacturing components are not considered PCBs.
Lower-chlorinated PCB byproducts are detected in the environment (84, 185,
186) and are detected in human serum (31), including in pregnant women (33). Because
many of these lower-chlorinated congeners are rapidly metabolized and tend not to
bioaccumulate, their detection in both environmental and human samples indicates their
continuous production and exposure to humans. Few studies have characterized the
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potential toxicity of lower-chlorinated PCBs to human health in in vivo models. This
dissertation work aimed to evaluate one of the most abundantly detected lowerchlorinated PCBs in the environment and in human samples, 3,3’-dichlorobiphenyl
(PCB-11). As PCB-11 was never used as a congener in Aroclor mixtures (23), its
presence in the environment and in humans reflects its contemporary usage. The parent
compound of PCB-11 is 3,3’-dichlorobenzidene and is used in a variety of industrial
manufacturing processes, most notably diarylide azo-type yellow pigment production, but
also in resin and sealant production. PCB-11 is semi-volatile and is released as a
byproduct during manufacturing, or from the products themselves over time (11, 21).
Prior to this dissertation work, several research groups characterized PCB-11’s presence
in the environment (24), its absorption, distribution, metabolism, and excretion in a
rodent model (44, 47), and its interactions with hormone receptors and the Ahr in cell
culture models (42, 126). This dissertation work aimed to build from both of these
foundational studies as well as pilot studies conducted in our lab, to address
developmental toxicity of PCB-11 using the zebrafish (Danio rerio).
The initial studies conducted in our lab aim to assess whether PCB-11 affected the
activity of the hepatic Ahr pathway enzyme Cyp1a using the ethoxyresorufin-Odeethylase (EROD) assay in developmental exposures between 1-4 days post fertilization
(dpf), and whether this was associated with toxicity outcomes. We found that in these
individual congener experiments, 20 µM PCB-11 is a mild Ahr agonist but does not
result in toxicity to zebrafish larvae (111). This work also explored PCB-11 interactions
with the Ahr pathway in mixture experiments with the higher-chlorinated co-planar
3,3’,4,4’,5-pentachlorobiphenyl (PCB-126) or the polycyclic aromatic hydrocarbon
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(PAH) beta-naphthoflavone (BNF), both Ahr agonists. These mixture experiments
allowed us to probe the Ahr pathway in different ways. For example, in co-exposures
with 5 nM PCB-126, 20 µM PCB-11 was able to inhibit the actions of PCB-126 upstream
of the pathway at the Ahr receptor, preventing toxicity; however, in co-exposures with 50
µg/L BNF, 20 µM PCB-11 inhibited Cyp1a activity downstream of Ahr activation, which
exacerbated toxicity (111). These results indicated that PCB-11 can act as both a partial
agonist as well as an antagonist at different parts of the Ahr pathway depending on the
co-exposure, and these assessments were supported through replications of these
experiments and through RT-qPCR experiments to examine gene transcription.
To gain a broader understanding of how PCB-11 might affect gene transcription
beyond the Ahr pathway, we conducted an RNA sequencing (RNAseq) experiment. This
experiment was conducted with an individual exposure of 20 µM PCB-11 compared to
unexposed fish from 1-4 dpf, and when we processed the RNAseq gene transcription
results for pathway analysis, we found that PCB-11 affects several pathways related to
lipid metabolism (111). In supplemental experiments, individual exposures to 20 µM
PCB-11 was found to reduce hepatic growth in a transgenic Tg(gut:GFP) line at 4 dpf,
and at this timepoint 20 µM PCB-11 qualitatively seemed to induce more vacuoles (lipid
droplets) in liver tissue that was processed for histology (111). Collectively, these
experiments helped form the overarching hypothesis for this dissertation: PCB-11 can
interfere with Ahr signaling in the context of mixture exposures, and that while
individual PCB-11 exposure may not cause overt toxicity, it can subtly affect
metabolic-related outcomes, particularly in environmentally relevant chronic
exposure settings. The results of these experiments also formed Chapter 2, titled “The
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emerging contaminant 3,3’-dichlorobiphenyl (PCB-11) impedes Ahr activation and
Cyp1a activity to modify embryotoxicity of Ahr ligands in the zebrafish embryo model
(Danio rerio)”, and was published in the journal Environmental Pollution in 2019.
The concentration of PCB-11 used in this work, 20 µM, is much higher than what
is detected in the environment or in human samples. We suspected that a higher
concentration of PCB-11 in the media was required to achieve physiologically relevant
concentrations, as this has been documented with zebrafish for other environmental
chemicals (187, 188). In this chapter, we conducted our own assessment of PCB-11
uptake into fish tissue from their media, and found that of the 20 µM original exposure,
0.18% was absorbed per embryo (5 embryos per vial) 4 hours after exposure, and by 4
dpf this increased to 0.61% per larvae, whereas 1.36% of the original PCB-11 was
measured in the media 4 hours after exposure, which decreased to 0.84% at 4 dpf (111).
These results support assessments of lower-chlorinated congeners as semi-volatile, but
also that they do have some capacity to bioaccumulate. This indicates a potential
exposure risk to a developing fetus. While higher-chlorinated PCBs and their
hydroxylated metabolites have been documented to cross the placental barrier and enter
fetal tissues (189-191), little information exists for the bioavailability of lowerchlorinated PCBs in humans during gestation. PCB-11 has been measured in human
maternal serum in the range of 0.005-1.717 ng/mL (33), of which the highest value of the
range is equivalent to 7.7 nM. At 4 dpf the 0.61% PCB-11 we detected in larvae is
equivalent to 122 nM, still much higher (21.8x) than the concentrations detected in
human maternal plasma. Despite this discrepancy, the primary goal of this work was to
assess from a mechanistic standpoint how PCB-11 interacts with the Ahr pathway. It is
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also quite possible that while 20 µM PCB-11 is a high concentration, the sum of the
many other lower-chlorinated PCB congeners in addition to PCB-11 could result in a
bioavailable concentration relevant to what was studied in this work.
The work conducted for Chapter 2 raised two main questions that were explored
in Chapter 3 of this dissertation titled “The sulfur metabolite of 3,3’-dichlorobiphenyl
(PCB-11) impairs Cyp1a activity and increases hepatic neutral lipids in zebrafish larvae
(Danio rerio)”, published in the journal Chemosphere in 2020. The first question
stemmed from the understanding of PCB-11’s rapid metabolism, whether the Cyp1a
activity effects we observed in the EROD assay were a result of the parent PCB-11
compound or a result from one of its metabolites. Once in the body, PCB-11 can undergo
diverse metabolism pathways (124), but one pathway seems to dominate, producing the
3,3’-dichlorobiphenyl-4-ol (4-OH-PCB-11) in Phase 1 metabolism, and then 3,3’dichloro-4-sulfooxy-biphenyl (4-PCB-11-Sulfate) in Phase 2 metabolism, both of which
have been detected in human serum (30, 113). To explore this first question, similar
EROD assays were conducted with both of these metabolites, synthesized and
characterized previously by collaborators at the University of Iowa (118, 192), and
graciously sent to us. We found that 4-OH-PCB-11 was much more toxic than PCB-11,
where the highest concentration tested with consistent survival was 0.2 µM, however,
none of the 4-OH-PCB-11 concentrations tested reduced Cyp1a activity (139). The other
metabolite 4-PCB-11-Sulfate did reduce Cyp1a activity at 20 µM concentrations in coexposures with PCB-126 and the PAH Benzo[a]pyrene (B[a]P), however, whereas PCB11 altered the toxicity response of the Ahr agonists, 4-PCB-11-Sulfate did not (139).
These results indicate that while both PCB-11 and 4-PCB-11-Sulfate can inhibit Cyp1a
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enzyme activity, PCB-11 plays an active role in Ahr pathway activity to prevent or
exacerbate toxicity, whereas 4-PCB-11-Sulfate does not interfere with the metabolism of
other Ahr agonists. This finding also suggests that Cyp activity is required for PCB-11
metabolism as outlined by others (26, 112, 124), and that without this activity, PCB-11
itself may play a role in the toxicity outcomes seen in the mixture experiments with
PAHs both in Chapter 2 with BNF and in Chapter 3 with B[a]P.
The second question we wanted to investigate in Chapter 3 was whether lower
human relevant concentrations of PCB-11 in a chronic exposure setting during
development would have effects on lipid-related outcomes. A different exposure
paradigm was implemented, where fish were exposed to 0.2 µM concentrations of either
PCB-11, 4-OH-PCB-11, or 4-PCB-11-Sulfate from 1-15 dpf, grown in individual vials
once external feeding began at 5 dpf, and had daily 50% media solution changes
throughout the experiment. At 15 dpf we observed that 4-PCB-11-Sulfate significantly
increased hepatic neutral lipids, visualized through Oil-Red-O staining (139). We
followed up with another round of 15 dpf experiments, this time with three
concentrations of 4-PCB-11-Sulfate ranging from 0.002-0.2 µM, co-exposed to 10 µg/L
Benzo[a]pyrene (B[a]P). We observed a dose-dependent increase in hepatic neutral
lipids, with the highest 0.2 µM 4-PCB-11-Sulfate co-exposure group with B[a]P
significantly increased compared with unexposed fish (139). In all of these chronic
experiments, no differences in growth or other overt toxicity were noted, indicating that
individual PCB-11 exposure may have unnoticeable effects but that once metabolized to
4-PCB-11-Sulfate, can influence a phenotype that resembles the progression of chronic
diseases like non-alcoholic fatty liver disease (NAFLD). In fact, the results from this
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Chapter 3 study may underrepresent the effects of 4-PCB-11-Sulfate, as this metabolite
has been detected in humans at concentrations 1-2 orders of magnitude higher than the
concentrations used in this study (30). These results support the part of the hypothesis
stating that PCB-11 can have effects on metabolic-related outcomes at environmentally
relevant concentrations under a chronic exposure paradigm.
Chapter 4 of this dissertation added a layer of analysis to the previous studies
conducted in Chapters 2 and 3, asking the question of whether oxidative stress plays a
role in either PCB-11 mediated Cyp1a inhibition, or in chronic exposure settings with
metabolic-related endpoints (in prep for manuscript submission). The work conducted for
this chapter involved similar experiments as the 1-4 dpf EROD assays to examine Cyp1a
activity and the 1-15 dpf chronic exposure experiments. To do this work, a zebrafish line
was used with a mutation in the DNA binding domain of Nrf2a, a transcription factor
known as a master regulator of the response to oxidative stress. These mutants have
impaired upregulation of Nrf2-mediated genes, which render the fish more sensitive to
chemical exposures that generate reactive oxygen species. Wildtype and Mutant Nrf2a
fish were also crossed previously with transgenic Tg(ins:GFP) fish so that pancreatic βcell area could be measured as an endpoint. Three different EROD assay experiments
were carried out involving individual exposures of PCB-11, PCB-11 co-exposures with
B[a]P, and individual exposures of 4-PCB-11-Sulfate. In all of these experiments, 20 µM
concentrations of PCB-11 or 4-PCB-11-Sulfate lowered EROD activity as observed
previously, but regardless of exposure, Nrf2a Mutant fish had significantly higher
induction of EROD activity compared to Wildtype fish (in prep). Exposed Nrf2a Mutant
fish were also shorter and had slightly increased pericardial area compared to Wildtype
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fish, depending on the experiment. However, interaction effects were only observed for
the positive Ahr agonist controls PCB-126 and B[a]P where Nrf2a Mutant fish exposed
to these toxicants had significantly increased EROD activity beyond Wildtype fish
exposed to these toxicants, and in the case of PCB-126, also had significantly increased
pericardial area (in prep). These results suggest that crosstalk with Nrf2a exists more for
strong Ahr agonists that might generate more reactive oxygen species and plays a minor
role for weaker Ahr agonists like PCB-11.
For the 15-day chronic exposure experiments, 8 experimental replicates were
carried out and we observed both genotype and exposure effects. Fish at 15 dpf that were
exposed to 0.2 µM 4-PCB-11-Sulfate survived significantly better, were significantly
longer by 3%, and also had 10% bigger primary pancreatic islets compared to unexposed
fish (in prep). However, Nrf2a Mutant fish regardless of exposure were shorter by 4% at
15 dpf than their Wildtype counterparts, indicating that Nrf2a plays an important but
previously unreported role in developmental growth (in prep). At 15 dpf subsets of
samples were collected for fatty acid profiling and RNAseq, and we found that exposed
Nrf2a Mutant fish had a significant 2% less of the Omega-3 fatty acid Docosahexaenoic
acid (DHA) than exposed Nrf2a Wildtype fish, indicating that Nrf2a-mediated genes are
important for fatty acid synthesis, especially in the context of environmental chemicals
like 4-PCB-11-Sulfate. We also observed a similar trend for the other Omega-3 fatty acid
that we measured, Eicosapentaenoic acid (EPA), though this decrease was not significant
(in prep). Differentially expressed genes (DEGs) in the RNAseq experiment supported
the role of Nrf2a as important for glutathione synthesis, an important endogenous
antioxidant, to maintain redox balance. Further bioinformatic pathway analysis also
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indicated its role in xenobiotic metabolism and metabolic pathways, specifically with the
fatty acid Linoleic acid (in prep). The work in this chapter indicates that chronic
developmental exposures to PCB-11 via 4-PCB-11-Sulfate can impact the metabolically
important primary pancreatic islets as well as Omega-3 fatty acids under properly
functioning Nrf2a.
Overall, this dissertation research used the in vivo zebrafish model to study the
exposure effects of a prevalent lower-chlorinated PCB congener. PCB-11 is perhaps one
of the more well-studied lower-chlorinated PCBs since its identification between 20082010 as one of the most prevalent lower-chlorinated congeners in both air and water
sources (12, 18, 66, 84). Over the last decade, several other studies have gone on to
assess human exposures to PCB-11 (21, 22, 25), characterize its metabolism and
distribution in a rodent model (28, 44, 47), and measure PCB-11 and its metabolites in
human serum (30, 33, 113). Before this dissertation work, PCB-11 was not identified as
strongly interacting with the Ahr pathway, but rather, as a disruptor of thyroid hormone
signaling (44, 45) and as a neurotoxicant (33, 48, 193). Since lower-chlorinated PCBs
undergo much more rapid metabolism in the body compared to higher-chlorinated
congeners, it makes sense that lower-chlorinated PCBs might exert toxicity in different
and more subtle ways compared to the overt effects seen with higher-chlorinated
congeners.
This work confirms prior studies characterizing PCB-11 as a weak ligand of the
Ahr pathway (42). However, this work takes an important mixture approach, finding that
PCB-11 can certainly interfere with Ahr pathway activation or metabolism of other Ahr
ligands, depending on the context. While it does not appear that oxidative stress is greatly
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involved in this interference as with higher-chlorinated PCBs like PCB-126 (57), this
work demonstrates that lower-chlorinated PCBs may have been underestimated in their
ability to interact with the Ahr pathway. Furthermore, while many of the higherchlorinated, and certainly the co-planar, congeners of the 209 PCB congeners have been
studied, there are literally thousands of PCB metabolites, many of which have not been
studied at all but have the potential to accumulate and exert toxicity in different ways
(112, 124). This work demonstrates that while lower-chlorinated PCBs like PCB-11 may
be rapidly metabolized and may not bioaccumulate as with higher-chlorinated PCBs,
metabolites of lower-chlorinated PCBs may be underestimated in their ability to
influence health outcomes as demonstrated in Chapters 3 and 4 of this dissertation with 4PCB-11-Sulfate.
Higher-chlorinated co-planar congeners like PCB-126 exert toxicity on many
organ systems, but the liver is one of the more well-studied target organs affected from
PCB-126 exposure, with consistency in disease pathologies between in zebrafish,
rodents, and humans (194, 195). Specifically, effects on glucose signaling and fatty acid
metabolism have been identified from PCB-126 exposure as precursors for fatty liver
disease (196, 197). Before this dissertation work, the liver was identified as the main site
of metabolic activity for PCB-11, but little work had been conducted to specifically
investigate the liver as a potential target organ for PCB-11 toxicity. The work conducted
in Chapters 2 and 3 identify that developmental exposures to PCB-11 can impede liver
growth, that both PCB-11 and 4-PCB-11-Sulfate can interfere with hepatic Cyp1a
enzyme activity, and that chronic developmental exposures to 4-PCB-11-Sulfate can
result in increased hepatic lipid accumulation (111, 139). Additionally, in the RNAseq
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experiments conducted in Chapters 2 and 4, we identified that PCB-11 and 4-PCB-11Sulfate potentially disrupt lipid metabolism pathways, which is in alignment with other
work identifying in vitro PCB-11 exposures as disrupting the vitamin B6 (pyridoxine)
pathway, involved in glucose and lipid metabolism (26). Increased hepatic lipid
peroxidation has also been observed in rats exposed to a PCB-11 supplemented mixture
representative of a Chicago airshed (44).
Higher-chlorinated co-planar PCBs that activate the Ahr pathway are known to
generate reactive oxygen species (ROS) (57) and several studies have documented the
cross talk between the Ahr and Nrf2 pathways (93, 145, 198). For instance, ROS
generated by co-planar PCBs acting through the Ahr pathway will stimulate the
translocation of Nrf2 into the nucleus to activate the transcription of antioxidant enzymes.
Co-planar and non-co-planar higher-chlorinated PCBs may generate ROS to different
degrees, and it has been shown that different types of PCBs can either have inhibiting or
activating effects on paraoxonase 1 (PON1), PON2, and PON3 antioxidant enzymes,
showing the diversity of antioxidant response depending on the PCB congener (199).
Lower-chlorinated PCBs and their effect on oxidative stress has been less studied and
with mixed results. For instance, in the study that looked at exposures to a PCB-11
supplemented Chicago airshed profile, no effects on glutathione were observed in rats
(44). However, in vitro studies have shown that 4-OH-PCB-11 can inhibit cell
proliferation, increase steady-state levels of ROS, and affect redox homeostasis through
the mitochondrial fidelity protein Sirtuin 3 (SIRT3) (46, 113). While the work conducted
for this dissertation did not specifically examine whether PCB-11 generates ROS or its
effects on glutathione, the experiments conducted with the Nrf2a Mutant zebrafish line
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offer a first assessment as to the sensitivity of an organism to PCB-11 through the lens of
Nrf2a as a ROS sensor.
In addition to the genotype effects observed and measured for Cyp1a activity,
body length, and pericardial area between Nrf2a Wildtype and Mutant fish, we did notice
that Nrf2a Mutant fish exposed to 20 µM PCB-11 had increased tail curvature compared
to the Nrf2a Wildtype fish. Tail curvature is not necessarily a deformity that has been
widely noted in experiments with co-planar PCBs, however one research group compared
toxicity outcomes in zebrafish for several Aroclor mixtures ranging from 42-60%
chlorine composition. Both Aroclor 1016 and Aroclor 1242 have a 42% chlorine
composition, with more than 60% of their overall PCB composition made up of lowerchlorinated congeners with 1-3 chlorine atoms on their biphenyl structure (23). It was
these 2 Aroclor mixtures that this research group found induced the most tail curvature
compared to either the higher chlorine percentage Aroclor mixtures or the higherchlorinated individual PCB congeners tested (200). This study as well as our qualitative
assessment provide some support that lower-chlorinated PCBs induce different toxicity
effects not previously assessed or seen with higher-chlorinated and co-planar congeners.
In addition to the genotype effects observed in the 4-day EROD assays, we did
notice significant effects in the 15-day experiments between Nrf2a Wildtype and Mutant
fish. Notably, a major difference between these 2 exposure paradigms is that during the
4-day experiments, zebrafish obtain all of their nutrition through the yolk sac they are
born with, whereas in the 15-day experiments, zebrafish feed externally from 5-15 dpf.
We found growth differences at 15 dpf between unexposed Nrf2a Wildtype and Mutant
fish and minor growth differences at 4 dpf, indicating that either any differences at the 4
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dpf timepoint were not significantly noticeable yet, or that the yolk sac plays a buffering
role in supplying the embryo with enough nutrients to grow, but that once external
feeding begins, Nrf2a plays an important role in converting nutrients or other essential
components in food to a useable form for the fish. For the fish food that we used in this
study, GEMMA Micro from Skretting USA is composed of 59% protein and 14% lipids
(201), but perhaps the results from our study would differ based on the type or percentage
of protein and lipids. While we did not extensively study how Nrf2a might affect some of
these related pathways, we did assess fatty acid composition in pooled whole fish at 15
dpf and found that Nrf2a seems to affect Omega-3 fatty acid synthesis, a result that is
supported in other research (172), and that in our study, is particularly affected in the
context of 4-PCB-11-Sulfate exposure (in prep).
One of the most interesting findings of the 15-day experiments is that fish
exposed to 4-PCB-11-Sulfate regardless of genotype survived significantly better and had
significantly bigger primary pancreatic islets compared to unexposed fish. It is possible
that our observations could be reflective of some sort of compensatory response where 4PCB-11-Sulfate exposure triggered a survival or adaptive mechanism. If so, perhaps this
mechanism would lead to better long-term exposure adaptation, or conversely, that this
would be a short-term survival mechanism but a tradeoff resulting in overall shorter
lifespan, susceptibility to other environmental exposures, or development of disease. Few
studies have investigated environmental chemical exposures in the context of immediate
adaptation, but one group used larval zebrafish to test a range of concentrations of
triclosan, an antimicrobial and antifungal agent in many consumer products, and found a
concentration-dependent decrease in survival up to a point, but then an increase in
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survival at the highest concentration tested, suggesting that this concentration triggered
an adaptive response; moreover that this concentration perhaps induced enough damage
to initiate repair mechanisms (202). If damage did occur in the 15 dpf fish exposed to 4PCB-11-Sulfate in our study, we were not able to detect it in the experiments and
endpoints we analyzed, nor did we carry this experiment past 15 dpf to understand any
long-term survival or adaptation responses.
While one-time environmental exposure events or accidents can provide insight
into disease development or compensatory mechanisms in specific populations, it is
perhaps more environmentally relevant to focus on the effect of continuous exposures, or
even across generations. Many researchers have carried out studies to understand how
whole populations or sub-populations of humans or animals have adapted to their
environment based on continuous environmental exposures that might normally cause
disease but where an adaptive mechanism or genetic evolution has taken place to render a
kind of immunity. For example, arsenic exposure is associated with cancer and liver
toxicity, however, populations on the Western side of South America have lived with
high levels of naturally occurring arsenic in their drinking water for thousands of years
and have developed certain variants of an arsenic metabolism gene which results in
protection (203). However, other researchers have shown that even though a population
can adapt to an environment with a high level of an environmental pollutant, there could
be tradeoffs. For example, killifish (Fundulus heteroclitus) that live in the Elizabeth
River Superfund site have become resistant to the effects of PAHs, however, this comes
at the expense of reduced swimming performance and reduced ability to respond to
temperature fluctuations (204). One research group that has looked at the long-term
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chronic exposure effects of a mixture of PCBs and polybrominated diphenyl ethers
(PBDEs) in zebrafish, found that exposed fish grew longer but had delayed development
in other areas, delayed spawning, and larval spawn were more susceptible to death under
starvation conditions (205).
Some environmental exposures to human health may be naturally occurring, but
many exposures are a result of human-made chemicals. For instance, PCBs would never
exist if humans did not synthesize them. While their existence proved useful for
expansion of the electrical grid and transportation systems, it has also come at the
expense of human health. We are in a continuous experiment of understanding the longterm human response to either living with or succumbing to disease from PCB exposure,
or some combination of both. Policy choices and the strength of environmental
regulations has certainly played a role in this continuous experiment with PCBs, as well
as with many other chemicals. The U.S. emerged as a global leader in the 1970s and
1980’s in establishing regulations for contaminants in air and water, as well as in
implementing major multilateral environmental agreements (MEAs), but in more recent
times has shown wavering commitment that has been explained as due to a large
influence of domestic political and economic interests (206). For instance, the U.S. is not
part of MEAs such as The Stockholm Convention on Persistent Organic Pollutants,
which is a treaty signed by 184 parties that aims to eliminate or restrict the production of
many chemicals, including PCBs. As a result, while there currently are some restrictions
in the U.S. for PCBs, many higher-chlorinated PCBs have already been released into the
environment, many lower-chlorinated PCBs will continue to be released inadvertently
into the environment, and human exposures to PCBs will continue to occur.
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Within the larger context of public health, there is much unknown about how
environmental chemical exposures impact human health. The toxicity mechanisms of
higher-chlorinated PCBs have been well-characterized over the last 50 years, but
researchers are still investigating the long-term impacts of these congeners, as they still
persist in the environment, and will continue to persist in the environment for many years
to come. However, for chemicals such as lower-chlorinated PCBs that do not cause overt
toxicity in the same way as their higher-chlorinated counterparts, it is much more difficult
to discern subtle effects that these chemicals might impart on human health, including
their influence on long-term effects after chronic exposures, especially given that
exposures will most likely happen in a mixture setting. This dissertation work attempts to
characterize the highly prevalent lower-chlorinated PCB-11 in the context of the Ahr
pathway, as well as to characterize some of the chronic developmental exposure effects
that one of its prevalent metabolites might have at a juvenile time point. This research
contributes to the understanding of this sub-class of PCB compounds and provides insight
into how this compound could potentially impact human health.
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APPENDIX A
PCB-11 CONCENTRATION ANALYSIS
At 28 hpf (four hours after the exposure began) and at 96 hpf, zebrafish were
euthanized with MS-222 and then separated from their media, pooling 5 vials of 5 fish
each together (25 total fish) to form 1 zebrafish sample replicate. Each vial of fish
contained 1 drop of media to maintain their body structure. Media (2 mL) from each of
the 5 vials was pooled together to form 1 media sample replicate. The exposures were
repeated 3 times to obtain 3 replicates of zebrafish and media at both time points. Upon
collection, vials were immediately frozen at -80°C and then shipped on dry ice to the
University of Iowa. The concentrations of PCB-11 in zebrafish tissue and media at were
analyzed at the University of Iowa and compared to 0.05% DMSO controls. Samples
were spiked with SS, digested and cleaned with concentrated sulfuric acid, and extracted
with hexane. A portion of the diluted samples were passed through sulfuric acid:silica gel
(1:2 w/w) columns, and concentrated with nitrogen before spiking with IS to obtain the
PCB concentrations of about 50-100 ng/mL. The samples were analyzed with an
instrumental method modified from US EPA Method 1668C with an Agilent 7890B gas
chromatography (GC) system equipped with an Agilent DB-1701 capillary column (30
m, 0.25 mm i.d., 0.25 μm film thickness; J&W Scientific Inc., Folsom, CA) coupling
with an Agilent 7000D Triple Quadrupoles (QqQ) mass spectrometry (MS) system in
multiple reaction monitoring (MRM) mode (207). The temperature programs and ion
transitions can be found in Appendix C.
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APPENDIX B
INSTRUMENTAL CONDITION FOR ZEBRAFISH AND MEDIA
CONCENTRATION ANALYSIS
Parameter
Injection

Condition
5 µL in Multimode Inlet Large Volume Injection (LVI) mode at
4.4 psi with the following temperature program:
- Initial 45 °C (hold for 0.06 min)
- Ramp at 600 °C/min to 325 °C
Stationary Phase
Agilent DB-1701 capillary column (30 m, 0.25 mm i.d., 0.25 μm
film thickness; J&W Scientific Inc., Folsom, CA)
Mobile Phase
Helium 0.8 mL/min) with the following temperature program:
- Initial 45 °C (hold for 2 min)
- Ramp at 100 °C/min to 75 °C (hold for 5 min)
- Ramp at 15 °C/min to 150 °C (hold for 1 min)
- Ramp at 2.5 °C/min to 280 °C (hold for 5 min)
Ionization
70 eV of Electron Impact (EI) ionization in positive mode.
Other
- Transfer line (280 °C)
Temperatures
- Ionization source (250 °C)
- Quadrupoles (150 °C)
#Cl
IUPAC Name
Congener
SourceC
MS1D
CED
MS2D
A
NameB
2
3,3'-dichlorobiphenyl
PCB11
AS
222.0
25
152.1
2
3,4'-dichlorobiphenyl
PCB13
AS
222.0
25
152.1
3
2,4,6-trichloro
d5-PCB30
CIL
261.0
25
191.1
2
(2',3',4',5',6'- H5)biphenyl
Note: A#Cl is the homologue or the number of chlorines in the molecules. BCongener
names are in accordance with the United States Environmental Protection Agency (US
EPA): the Table of Polychlorinated Biphenyl (PCB) Congeners
(https://www.epa.gov/sites/production/files/2015-09/documents/congenertable.pdf). CAS
is AccuStandard (New Haven, CT, USA) and CIL is Cambridge Isotope Laboratories
(Andover, MA, USA). ERespectively, MS1, CE, MS2 are the precursor ions, the collision
energy (eV), and the product ions used in the multiple reaction monitoring (MRM).
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APPENDIX C
GENE PRIMER SEQUENCES. INFORMATION FOR AHR2, CYP1A, ACTB,
AND B2M

Gene
actb
ahr2
cyp1a
b2m

Forward primer (5’ – 3’)
Temp
Reverse primer (3’ – 5’)
CAACAGAGAGAAGATGACACAGATCA
65
GTCACACCATCACCAGAGTCCATCAC
CTACTTGGGCTTCCATCAGTCG
65
GTCACTTGAGGGATTGAGAGCG
GCATTACGATACGTTCGATAAGGAC
65
GCTCCGAATAGGTCATTGACGAT
CCCAAGGTTCAGGTGTAC
58
CTCTCCGTTCTTCAGCAGTTC
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Reference
(123)
(123)
(123)
(208)

APPENDIX D
RNASEQ LIBRARY PREPARATION AND SEQUENCING
Collected samples were transferred immediately to FastPrep homogenization
tubes containing TRIzol Reagent (Life Technologies) and 0.1 mm RNase free Glass
Beads (Next Advance, Inc.). The content was vortexed for 15 seconds, and homogenized
in FastPrep-24 5G bead beater (MP Biomedicals) using the following parameters – speed:
6.0 m/sec, time: 30 seconds, and adapter: QuickPrep. The homogenate was spun, and the
supernatant was transferred to a sterile tube. Total RNA was purified using the Direct-zol
RNA MicroPrep kit with an in-column DNase-I treatment (Zymo Research Corp.),
following manufacturer instructions. The quantity of RNA was assayed on Qubit using
the RNA BR assay (Life Technologies Corp.), and quality was assessed on an Agilent
2100 Bioanalyzer using RNA 6000 Nano Assay (Agilent Technologies Inc.). The
electropherogram results suggest that the total RNA was intact without any sign of RNA
degradation, and the RNA Integrity Number (RIN) ranged from 6.9 to 9.2. One
microgram of total RNA was used to isolate poly(A) mRNA, convert to cDNA and
prepare libraries using the NEBNext Ultra-II Directional RNA Library Prep Kit for
Illumina (New England Biolabs), following manufacturer instructions. The quantity of
the library was assayed using the Qubit DNA HS assay (Life Technologies Corp), and
quality was analyzed on a Bioanalyzer (Agilent Technologies Inc.). The libraries were of
good quality as primer dimers or adapter dimers were not detected on the Bioanalyzer
electropherogram. Libraries were diluted and normalized for equimolar amount, pooled,
denatured and sequenced on an Illumina NextSeq 500 platform using NextSeq 500/550
High Output v2 kit (75 cycles) with 1×75 sequencing parameter. More than 32 million
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reads were generated per sample. Read alignment was performed with the BaseSpaceâ
RNA-seq Alignment v.1.1.0 App, using the Danio rerio (UCSC danRer7) reference
genome. Transcript assembly and differential expression was assessed with the
BaseSpaceâ Cufflinks Assembly & DE v.2.1.0 App on the Illumina platform.
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APPENDIX E
CO-EXPOSURE DATA FOR PCB-11 + 100 µG/L BNF

Survival of Zebrafish Co-exposed to
PCB-11 and 100 µg/L BNF
120

Survival (%)

100
80
60
40
20
0
DMSO00.05% PCB11
20nM + PCB11
20uM + BNF
BNF
100 20pM
µg/L + PCB11
100 µg/L
100 µg/L
100100ug/L
µg/L
BNF 100ug/L
BNF 100ug/L
BNF 100ug/L
PCB-11
0
0.2 µM
2 µM
20 µM
0

Appendix E Figure: Survival for zebrafish co-exposed to 20 µM PCB-11 + 100 µg/L
BNF at 96 hpf was 20% compared to 80-100% survival for all other exposure groups.
The expected survival frequency for one or more exposure groups was significantly
different than the observed survival frequency (frequency of survival displayed as a
percentage, n=40 fish per group across 3 experiments, chi-squared test with analysis of
means for proportions, p < 0.001).
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APPENDIX F
GENE INFORMATION FOR UNANNOTATED GENES
UCSC
danRer
7 gene
name

Gene
Name

ENSEMBL
ID

ZDBzgc:1102
GENEARF4
86
050417-68

ENSDARG
0000007421
0

ZDBzgc:1538 GENE46
060929898

ENSDARG
0000004073
8

si:ch211
-119o8.7

ZFIN ID

crygm
1b

ZDBGENERBP1
070912-18

ENSDARG
0000003874
2

ZDBzgc:9259
GENEN/A
0
041024-15

ENSDARG
0000004028
2

ZDBzgc:1099 GENE82
050522139

ENSDARG
0000009921
7

N/A

ENSEMBL Website Link

http://useast.ensembl.org/Danio_rerio/
Gene/Summary?g=ENSDARG000000
74210;r=11:4247818442481817;t=ENSDART00000089963
http://useast.ensembl.org/Danio_rerio/
Gene/Summary?g=ENSDARG000000
40738;r=9:2201736822018304;t=ENSDART00000023059
http://useast.ensembl.org/Danio_rerio/
Gene/Summary?g=ENSDARG000000
38742;r=2:3902128239028052;t=ENSDART00000056577
http://useast.ensembl.org/Danio_rerio/
Gene/Summary?g=ENSDARG000000
40282;r=16:2512693525130075;t=ENSDART00000058945
http://useast.ensembl.org/Danio_rerio/
Gene/Summary?g=ENSDARG000000
99217;r=6:24076954-

24087279;t=ENSDART00000163445
Note: Information for the ZFIN ID, ENSEMBL ID, ENSEMBL-assigned gene name
(where available), and link to website for the 5 unannotated genes.
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APPENDIX G
GENE ONTOLOGY AND PATHWAY ANALYSIS USING LRPATH
Name

# of genes

p-value

ECM-receptor interaction
Spliceosome
Ubiquitin mediated proteolysis
Focal adhesion
Arachidonic acid metabolism
Citrate cycle (TCA cycle)
Butirosin and neomycin
biosynthesis
Basal transcription factors
MAPK signaling pathway
Ribosome
Biosynthesis of unsaturated
fatty acids
Alanine, aspartate and
glutamate metabolism
Neuroactive ligand-receptor
interaction
Glycolysis / Gluconeogenesis
Cysteine and methionine
metabolism
Oxidative phosphorylation
Lysosome
RNA transport
Sphingolipid metabolism
Adherens junction
Retinol metabolism
Phenylalanine, tyrosine and
tryptophan biosynthesis
Metabolic pathways
Fatty acid degradation
alpha-Linolenic acid
metabolism
mRNA surveillance pathway
Taurine and hypotaurine
metabolism
Primary bile acid biosynthesis
Sulfur metabolism
PPAR signaling pathway
SNARE interactions in

36
114
93
143
22
27

7.39E-11
2.28E-07
3.68E-06
1.77E-05
3.79E-05
4.41E-04

FDR
q-value
1.12E-08
1.73E-05
1.86E-04
6.72E-04
0.001154
0.009575

3

4.24E-04

0.009575

up

22
173
79

0.001619
0.003213
0.003331

0.030767
0.050637
0.050637

up
down
up

15

0.004567

0.063102

down

31

0.006976

0.08836

down
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0.008355

0.093339

up

58

0.008597

0.093339

up

31

0.010924

0.105156

down

103
90
114
36
57
20

0.011069
0.014396
0.016209
0.014842
0.01627
0.014515

0.105156
0.112414
0.112414
0.112414
0.112414
0.112414

up
up
up
down
down
up

5

0.015724

0.112414

down

806
30

0.021483
0.021386

0.130615
0.130615

down
down

6

0.021202

0.130615

down

59

0.029597

0.165588

up

4

0.030503

0.165588

up

7
6
46
33

0.028893
0.03175
0.036783
0.037594

0.165588
0.166415
0.178569
0.178569

up
down
down
up
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Direction
down
up
up
down
down
down

vesicular transport
One carbon pool by folate
Inositol phosphate metabolism
Hedgehog signaling pathway

11
39
50

0.037477
0.044547
0.044652
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0.178569
0.199622
0.199622

down
down
down

APPENDIX H
ENVIRONMENTAL FIELD SAMPLING
Native predatory fish were sampled at two sites approximately 0.25-0.5 miles
downriver of a paper mill facility located on the Millers River in Western Massachusetts.
Fallfish (Semotilus corporalis) and Smallmouth Bass (Micropterus dolomieu) were
obtained via electrofishing and stored according to Environmental Protection Agency
(EPA) recommendations. Whole fish were analyzed for PCB-11 at Cape Fear Analytical
(Wilmington, NC) using EPA Method 1668A. PCB-11 was detected in the method blank
used to run these samples. Cape Fear Analytical uses a “10x blank” industry standard
whereby the concentration of the PCB congener in the sample must achieve a
concentration that is at least 10-fold greater than the concentration in the method blank in
order for the sample value to be considered as not influenced by background PCB-11
concentrations.
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APPENDIX I
ENVIRONMENTAL SAMPLING MAP

A
Sampling sites
Direction of water flow
Paper mill facility
(output)

N

Sampling site
#2

Stream

Sampling site
#1
Direction of water flow

B

Appendix I Figure: (A) Aerial views (Google Images) of the paper manufacturing
facility and sampling sites located approximately 0.25-0.5 miles downriver of the facility.
(B) One of the wild predatory fish sampled (a Fallfish is pictured here).
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APPENDIX J
CONCENTRATIONS OF PCB-11 DETECTED IN WATER, SEDIMENT, AND
FISH SAMPLES
Surface Water Samples
Water Sample 1
Water Sample 2
Water Sample 3
Sediment Samples
Sediment Sample 1
Sediment Sample 2
Sediment Sample 3

Concentration
(pg/L)
2,380
4,500 U
3,420 U
Concentration
(ng/kg)
43.4 B
18.0 B
38.6 B
Concentration
(ng/kg)
61.6 B
22.5 B
136
41.7 B
104

Fish Length Fish
Wild Fish Samples
(cm)
Weight (g)
Fish Sample 1 (Fallfish)
12.4
16.7
Fish Sample 2 (Fallfish)
14.5
27.2
Fish Sample 3 (Fallfish)
17.3
48.6
Fish Sample 4 (Brown Trout)
24.3
124
Fish Sample 5 (Small Mouth
18.1
70.4
Bass)
Fish Sample 6 (Small Mouth
107
15.7
51.2
Bass)
Fish Sample 7 (Small Mouth
103
17.5
66.5
Bass)
Fish Sample 8 (Small Mouth
59.9 B
19.8
89.6
Bass)
Fish Sample 9 (Small Mouth
33.1 B
21.0
110
Bass)
Fish Sample 10 (Small Mouth
37.5 B
21.0
107
Bass)
Fish Sample 11 (Small Mouth
24.5 B
23.5
140
Bass)
Note: PCB-11 concentrations reported for environmental samples submitted for analysis.
Average PCB-11 concentrations for Fallfish (Semotilus corporalis) were 73.4 ng/kg
(SEM±33.3, n=3) wet weight and 67.0 ng/kg (SEM±13.9, n=7) wet weight for
Smallmouth Bass (Micropterus dolomieu). U-flags indicate that the PCB-11
concentration measured in the sample did not surpass the practical quantification limit
(PQL) for the volume tested. B-flags indicated that PCB-11 was detected in the method
blank for the associated medium (4.75 ng/kg for sediment and 8.20 ng/kg for fish tissue),
and that these reported values were not more than 10x greater than the PCB-11
concentration measured in the associated method blank. All values with flags should be
considered as estimates.
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APPENDIX K
ENVIRONMENTAL PCB-11 CONCENTRATIONS DETECTED IN OTHER
STUDIES AS COMPARED TO THIS STUDY

PCB-11
Concentration
Water
2,380-4,500 pg/L

Study

Sampling Notes

This study

Collected from river surface about
1 foot above river bed, 0.25-0.5
miles downstream of a paper
recycling facility (n=3)
Seawater samples (n=14) collected
from Bedford Basin (Canada) in 1996
and 1998
New Jersey WWTP effluent (n=1)
Average NY City WWTP effluents
(n=14)
NY/NJ harbor WWTP effluents
(n=2) near pigment manufacturers
Average effluents from WWTPs not
near pigment manufacturers
From a river 0.5 km downstream of a
WWTP in Beijing (China)
Portland, OR harbor samples
collected 2004-2007
Antarctic surface snows

6.7-110 pg/L

King et al., 2002

225 ng/L
93.5 ng/L

Litten et al., 2002
Litten et al., 2002

5-116 ng/L

Rodenburg et al.,
2010b
Rodenburg et al.,
2010b
Yu et al., 2013

0.0016-9.4 ng/L
81.2 pg/L
1.7-78 pg/L
10-34 pg/L
5.9-11.5 pg/L
Sediment
18-43.4 ng/kg

Rodenburg et al.,
2015b
Vecchiato et al.,
2015a
Vecchiato et al.,
2015b

Antarctic water samples from 6 lakes
in Terra Nova Bay

This study

2.6-18.7 ng/g

King et al., 2002

0.011-36.9 ng/g

Hu et al., 2011

5.10 pg/g

Wang et al., 2012
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Collected from river bed, 0.25-0.5
miles downstream of a paper
recycling facility (n=3)
Surface samples collected in 1996
from Bedford Basin (Canada)
Sediment cores from Great Lakes,
peak concentrations in 1970s
King Geore Island, Antarctica.
Samples air-dried before transport
and analysis

n.d.-0.61 µg/kg
1.36-1.55 ng/g

n.d-1.77 ng/g
n.d.-29.6 pg/g
0.04-2.57 ng/g
0.22-150 ng/g
Aquatic Species
22.5-136 ng/kg
lipid

Romano et al.,
2013b
Yu et al., 2013

Thi Nai Lagoon (Vietnam) from
surface sediments
Sampled upstream and downstream
of a WWTP in a river in Beijing
(China)
Giuliani et al., 2015b Nador Lagoon (Morocco) sediment
cores, peak concentrations in 1940s
Vecchiato et al.,
Antarctic sediment samples from 6
2015b
lakes in Terra Nova Bay
Wang et al., 2016
Seven major river basins in China
Rodenburg et al.,
Hudson River sediment cores, peak
2017
concentrations in 1970s
This study

9.25 pg/g lipid

Addison et al., 1999

3590 pg/g lipid

Addison et al., 1999

7.53 pg/g lipid

Addison et al., 1999

<2-20 ng/g

King et al., 2002

0.7-9.1 ng/g

King et al., 2002

5.5-1180 pg/g

Zhu et al., 2014

0.25-6.10 ng/g

Pizzini et al., 2017

0.61-35.7 ng/g

Pizzini et al., 2017

0.26-5.12 ng/g

Pizzini et al., 2017
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Three wild species of fish caught
0.25-0.5 miles downstream of a
paper recycling facility (n=11)
Average grey seal (H. grypus)
maternal blubber (n=5) on Sable
Island, Canada in 1995
Average grey seal (H. grypus)
maternal blood (n=5) on Sable Island,
Canada in 1995
Average grey seal (H. grypus) pup
blubber (n=6) on Sable Island,
Canada in 1995
Digestive glands of market-sized
lobsters from 5 sites in Halifax
Harbor (Canada) in 1995
Mussels (Mytilus edulis) from 16-17
sites (n=33, ~25 per site) in Halifax
Harbor (Canada) in 1997 and 1999
Biota (carp, eels, crabs, snails, and
toads) collected near electrical waste
recycling in Taizhao City (China)
Antarctic scallop (A. colbecki) from
Terra Nova Bay 1996-2009
Mediterranean mussel (M.
galloprovincialis) from Adriatic Sea
2013-2014
Manila clam (R. philippinarum) from
Adriatic Sea 2013-2014

APPENDIX L
FIGURE 3.2 ADDITIONAL REPRESENTATIVE IMAGES

DMSO

0.2 µM PCB-11
+ B[a]P

2 µM PCB-11
+ B[a]P

20 µM PCB-11
+ B[a]P

B[a]P

Appendix L Figure: Figure 3.2 additional representative images; EROD images are raw.
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APPENDIX M
% SURVIVAL OF ZEBRAFISH EXPOSED TO EITHER DMSO, 0.2-20 µM 4OH-PCB-11, OR 5 NM PCB-126 BETWEEN 1-4 DPF

% Survival
100

% Survival

80
60
40
20
0

DMSO

DMSO

0.2 µM 4- OH- PCB-11

2 µM 4- OH-PCB-11

20 µM 4- OH-PCB-11

0.2
2
20
----------OH (µM)---------

5 nM PCB-126

PCB-126

Appendix M Figure: % survival of zebrafish exposed to either DMSO, 0.2-20 µM 4OH-PCB-11, or 5 nM PCB-126 between 1-4 dpf (n=20 fish per exposure group across 2
experiments).
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APPENDIX N
FIGURE 3.3 ADDITIONAL REPRESENTATIVE IMAGES

DMSO

0.02 µM OH

0.2 µM OH

0.2 µM Sulfate

2 µM Sulfate

20 µM Sulfate

PCB-126

Appendix N Figure: Figure 3.3 additional representative images; EROD images are raw.
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APPENDIX O
ZEBRAFISH EXPOSED TO EITHER DMSO, 0.00002-0.002 µM 4-OH-PCB-11,

A

Body Length (mm)

OR 5 NM PCB-126 CONTROLS BETWEEN 1-4 DPF

5.0
4.0

a

% EROD Intensity
Pericardial Area (mm 2)

C

D
b

3.0
2.0

DMSO

1.0
0.0

DM SO 0. 05%

DMSO

B

Body Length
a
a
a

500
400
300
200
100
0

OH -P CB- 110. 00002uM

OH -P CB- 110. 0002uM

OH -P CB- 110. 002uM

0.00002 0.0002
0.002
-------------OH (µM)-----------

DMSO 0.05%

DMSO

a
OH-PCB- 11

a

a

OH-PCB- 11 0.0002uM OH-PCB- 11 0.002uM

0.00002uM
0.00002
0.0002
0.002
-------------OH (µM)-----------

Pericardial Area

0.08

0.00002 µM OH

b

EROD
a

PC B-126 5nM

PCB-126

0.0002 µM OH

PCB-126 5nM

PCB-126

b

0.06
0.04

0.002 µM OH

a

a

a

OH -P CB- 110. 00002uM

OH -P CB- 110. 0002uM

a

0.02
0.00

DM SO 0. 05%

DMSO

OH -P CB- 110. 002uM

0.00002 0.0002
0.002
-------------OH (µM)-----------

PCB-126

PC B-126 5nM

PCB-126

Appendix O Figure: Zebrafish exposed to either DMSO, 0.00002-0.002 µM 4-OHPCB-11, or 5 nM PCB-126 controls between 1-4 dpf. A) Body length, B) EROD
quantification, and C) pericardial area (mean±SEM, n=6 vials of 4-5 pooled larvae per
exposure group across 3 experiments, ANOVA with Tukey’s post-hoc test, p<0.05). D)
Representative images of whole zebrafish and EROD activity.
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APPENDIX P
FIGURE 3.4 ADDITIONAL REPRESENTATIVE IMAGES

DMSO

0.002 µM OH
+ PCB-126

0.02 µM OH
+ PCB-126

0.2 µM OH
+ PCB-126

0.2 µM Sulfate
+ PCB-126

2 µM Sulfate
+ PCB-126

20 µM Sulfate
+ PCB-126

PCB-126

Appendix P Figure: Figure 3.4 additional representative images; EROD images are raw.
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APPENDIX Q
FIGURE 3.5 ADDITIONAL REPRESENTATIVE IMAGES

DMSO

0.002 µM OH
+ B[a]P

0.02 µM OH
+ B[a]P

0.2 µM OH
+ B[a]P

0.2 µM Sulfate
+ B[a]P

2 µM Sulfate
+ B[a]P

20 µM Sulfate
+ B[a]P

B[a]P

Appendix Q Figure: Figure 3.5 additional representative images; EROD images are raw.
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APPENDIX R
ZEBRAFISH EXPOSED TO 50 µG/L BNF AND EITHER 0.002-0.2 µM 4-OHPCB-11 OR 0.2-20 µM 4-PCB-11-SULFATE BETWEEN 1-4 DPF

5.0
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A

4.0

a
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+

+

+
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Appendix R Figure: Zebrafish exposed to 50 µg/L BNF and either 0.002-0.2 µM 4-OHPCB-11 or 0.2-20 µM 4-PCB-11-Sulfate between 1-4 dpf. A) Body length, B) EROD
quantification, and C) pericardial area (mean±SEM, n=6 vials of 4-5 pooled larvae per
exposure group across 3 experiments, ANOVA with Tukey’s post-hoc test, p<0.05). D)
Representative images of whole zebrafish and EROD activity. The white arrow indicates
a loss of EROD activity.
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APPENDIX S
FIGURE 3.6 ADDITIONAL REPRESENTATIVE IMAGES
Single Exposures

Co-Exposures

DMSO

DMSO

0.02 µM PCB-11

0.002 µM Sulfate
+ B[a]P

0.02 µM OH

0.02 µM Sulfate
+ B[a]P

0.02 µM Sulfate

0.2 µM Sulfate
+ B[a]P

B[a]P

Appendix S Figure: Figure 3.6 additional representative images; all images are
unadjusted for background contrast.
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APPENDIX T
QUANTIFICATION OF ORO MEASURED IN THE BRAIN

150
125
100
75
50
25
0

B

Single exposures
a

a

a

DMSO

PCB-11 0.2 uM

OH-PCB- 11 0.2 uM

DMSO

0.2
PCB-11

0.2
OH

150
125
100
75
50
25
0
Sulfate
B[a]P

a

% Brain ORO
Light Intensity

% Brain ORO
Light Intensity

A

PCB-11-Sulfate 0.2 uM

0.2 (µM)
Sulfate

Co-exposures
a

DMSO

0
0

a

a

a

PCB-11-Sulfate PCB-11-Sulfate 0.02 PCB-11-Sulfate 0.2
0.002 uM + B[a]P 10 uM B[a]P 10 ug /L uM B[a]P 10 ug /L
ug/L

0.002
10

0.02
10

0.2
10

a

B[ a]P 10 ug/L

0 (µM)
10 (µg/L)

Appendix T Figure: A) Quantification of ORO staining of zebrafish exposed to either
DMSO, 0.2 µM PCB-11, 0.2 µM 4-OH-PCB-11, or 0.2 µM 4-PCB-11-Sulfate between
1-15 dpf (mean±SEM, n=45-51 fish per exposure group across 3 experiments, ANOVA
with Tukey’s post-hoc test, p<0.05). B) Quantification of ORO staining of zebrafish
exposed to either DMSO, 10 µg/L B[a]P, or 10 µg/L B[a]P in combination with 0.0020.2 µM 4-PCB-11-Sulfate between 1-15 dpf (mean±SEM, n=37-42 fish per exposure
group across 3 experiments, ANOVA with Tukey’s post-hoc test, p<0.05).
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APPENDIX U
EROD QUANTIFICATION FOR FIGURES 4.1-4.3 NORMALIZED TO THE
NRF2A WILDTYPE DMSO CONTROL
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Appendix U Figure: Nrf2a Wildtype and Mutant zebrafish EROD activity normalized to
the Nrf2a Wildtype control in each experiment for A) 0-20 µM PCB-11(mean±SEM,
n=5-6 vials of pooled larvae across 3 experiments), B) 0-20 µM PCB-11 + 100 µg/L
B[a]P (mean±SEM, n=5-6 vials of pooled larvae across 3 experiments), or C) 0-20 µM 4PCB-11-Sulfate (mean±SEM, n=12 vials of pooled larvae across 6 experiments).
Statistical analysis was conducted using 2-Way ANOVAs with Tukey’s post-hoc test,
p<0.05, * indicates an exposure effect compared to DMSO controls, † indicates a
genotype effect, # indicates an interaction effect, W=Wildtype, M=Mutant.
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APPENDIX V
RAW SURVIVAL DATA FOR FIGURE 4.4
Day
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Notes: Exp. Rep=Experimental replicate, WT=Nrf2a Wildtype, MM=Nrf2a Mutant,
SO4=4-PCB-11-Sulfate
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APPENDIX W
SIGNIFICANTLY ENRICHED GO CATEGORIES FOR FIGURE 4.8
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39

MF

0.00657214

GO:0004364

5

27

tetrapyrrole binding
cellular response to toxic
substance
oxidoreductase activity, acting on
paired donors, with incorporation
or reduction of molecular oxygen
cellular amino acid metabolic
process
oxidoreductase activity, acting on
single donors with incorporation
of molecular oxygen,
incorporation of two atoms of
oxygen
oxidoreductase activity, acting on
single donors with incorporation
of molecular oxygen
glutathione transferase activity

MF

0.00657214

GO:0017001

5

30

BP

0.00716409

GO:0016667

6

46

MF

0.00863297

GO:0016999

7

70

BP

0.00899362

GO:0004024

3

5

MF

0.00899362

GO:0051903

3

5

antibiotic catabolic process
oxidoreductase activity, acting on
a sulfur group of donors
antibiotic metabolic process
alcohol dehydrogenase activity,
zinc-dependent
S-(hydroxymethyl)glutathione
dehydrogenase activity

MF

0.00899362

Category
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GO:0051186

14

308

cofactor metabolic process

BP

0.01346659

GO:0044282

11

193

small molecule catabolic process

BP

0.01610285

GO:0046292

3

6

formaldehyde metabolic process

BP

0.01610285

GO:0046294

3

6

formaldehyde catabolic process

BP

0.01610285

GO:0005737

102

5926

cytoplasm

CC

0.0216792

GO:0006749

5

35

BP

0.0216792

GO:0016765

6

56

MF

0.0216792

GO:0004022

3

7

MF

0.0216792

GO:0016209

6

64

glutathione metabolic process
transferase activity, transferring
alkyl or aryl (other than methyl)
groups
alcohol dehydrogenase (NAD)
activity
antioxidant activity

MF

0.0216792

GO:0006568

3

7

tryptophan metabolic process

BP

0.02416885

GO:0006569

3

7

BP

0.02416885

GO:0006586

3

7

BP

0.02416885

GO:0042436

3

7

BP

0.02416885

GO:0046218

3

7

BP

0.02416885

GO:0034599

5

41

BP

0.03659584

GO:0071466

7

89

BP

0.04211079

GO:0032440

2

2

MF

0.04211079

GO:0110095

3

9

tryptophan catabolic process
indolalkylamine metabolic
process
indole-containing compound
catabolic process
indolalkylamine catabolic process
cellular response to oxidative
stress
cellular response to xenobiotic
stimulus
2-alkenal reductase [NAD(P)]
activity
cellular detoxification of aldehyde

BP

0.04211079

GO:0110096

3

9

BP

0.04211079

GO:0006081

5

40

BP

0.04211079

GO:0046185

3

9

cellular response to aldehyde
cellular aldehyde metabolic
process
aldehyde catabolic process

BP

0.04211079

GO:0034308

4

23

BP

0.0483049

GO:1901605

9
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primary alcohol metabolic process
alpha-amino acid metabolic
process

BP

0.0483049
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